Web Catalog CRS

List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000055 Acamprosate calcium - reference spectrum
Effective from 2012/1/3

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
1585
Extra
Price
charges
79
l
Y0000116 Acamprosate impurity A
50 mg
3-aminopropane-1-sulphonic acid
1585
+5C
79
Y0000500 Acarbose
94.7 mg
94.7 mg CHNO
2089
+5C
79
Y0000354 Acarbose for identification
10 mg
2089
+5C
79
Y0000427 Acarbose for peak identification
40 mg
2089
+5C
79
A0040000 Acebutolol hydrochloride
50 mg
0871
+5C
79
Y0000359 Acebutolol impurity B
10 mg
-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)
0871
+5C
79
Y0000127 Acebutolol impurity C
20 mg
N-(3-acetyl-4-hydroxyphenyl)butanamide
0871
+5C
79
Y0000128 Acebutolol impurity I
0.004 mg
N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide
0871
+5C
79
Y0000056 Aceclofenac - reference spectrum
n/a
1281
79
Y0001094 Aceclofenac for peak identification
10 mg
1281
+5C
79
Y0000085 Aceclofenac impurity F
20 mg
benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
1281
+5C
79
Y0000086 Aceclofenac impurity H
10 mg
[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid
1281
+5C
79
Y0000810 Acemetacin
100 mg
1686
+5C
79
Y0000811 Acemetacin impurity A
10 mg
+5C
79
Y0000842 Acemetacine impurity mixture
0.06 mg
+5C
79
A0070000 Acesulfame potassium
50 mg
+5C
79
A0070020 Acesulfame potassium impurity B
50 mg
+5C
79
A0100000 Acetazolamide
100 mg
+5C
79
Y0001084 Acetazolamide for system suitability
0.0068 mg
0454
+5C
79
Y0000002 Acetylcholine chloride
50 mg
1485,1971
-20C
79
A0150000 Acetylcysteine
50 mg
Batch 2 is valid until 29 February 2012
0967
+5C
79
A0152000 Acetylcysteine impurity C
10 mg
88.5% CHNOS; N,N'-diacetyl-L-cystine ; Batch 6 is valid until 31

January 2011
0967
+5C
79
A0153000 Acetylcysteine impurity D
10 mg
N,-diacetyl-L-cysteine
0967
+5C
79
Y0000565 -Acetyldigoxin
50 mg
2168
+5C
79
Y0000642 -Acetyldigoxin for peak identification
10 mg
2168
+5C
79
A0200000 Acetylsalicylic acid
15 mg
0309
+5C
79
A0208000 N-Acetyltryptophan
125 mg
Batch 1 is valid until 31 July 2011
1383
+5C
79
A0202000 N-Acetyltyrosine
200 mg
1384
Y0000693 Acholeplasma laidlawii BRP
1 ml
20607
A0220000 Aciclovir
75 mg
Y0001271 Aciclovir for peak identification 1
0.3 mg
0.003 mg
Y0001269 Aciclovir for peak identification 2

Council of Europe, all rights reserved 2012
propoxy]phenyl]
Yes
Yes
1686
4-chlorobenzoic acid
1686
Yes
1282
5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide ; Batch 2 is valid
until 30 June 2011
1282
Yes
0454
Batch 2 is valid until 31 January 2012
Yes
Yes
0968
0968
Yes
Yes
+5C
79
-80C
120
+5C
79
+5C
79
79
0968
Yes
+5C
a
For extra charges, please see supply terms and conditions.

Order
Reference Standard
Code
Y0001264 Aciclovir for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
0968
+5C
Extra
Price
charges
79
a
A0225000 Acitretin
100 mg
99.7% CHO
1385
+5C
g(b)
79
Y0001121 Adapalene
100 mg
99.9% CHO
2445
+5C
79
Y0001120 Adapalene impurity C
6 mg
1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 1 is valid until 31 July

2011
2245
+5C
79
Y0001119 Adapalene for peak identification
2.022 mg
2445
+5C
79
A0230000 Adenine
50 mg
0800,1486
+5C
79
A0230200 Adenosine
50 mg
1486
+5C
79
Y0000110 Adipic acid
50 mg
1586
+5C
79
Y0000882 Adrenaline
5 mg
2303
+5C
79
Y0000883 Adrenaline with impurity F
10 mg
2303
+5C
79
A0300000 Adrenaline tartrate
100 mg
Batch 4 is valid until 31 August 2011
+5C
79
0.005 mg
Batch 1 is valid until 30 April 2012
+5C
79
New Y0000740 Adrenaline impurity mixture

Y0000707 Adrenaline tartrate with impurity A
15 mg
Y0000728 Agnus castus fruit standardised dry extract
200 mg
0.13% CHO
A0325000 Alanine
60 mg
A0325100 Albendazole
50 mg
A0325200 Alcuronium chloride
50 mg
5 mg
New A0325450 Alfacalcidol
99.8% CHO ; Batch 6 is valid until 31 March 2012
Yes
Yes
0254
0254,2303
Yes
0254
Yes
+5C
79
2147
Yes
-20C
79
0614,0752
+5C
79
1386
+5C
79
1285
-20C
g(c)
79
1286
-20C
e(d)
300
79
+5C
79
79
+5C
79
A0325451 Alfacalcidol - reference spectrum
n/a
A1225000 Alfadex
150 mg
A0325500 Alfentanil hydrochloride - reference spectrum
n/a
1062
A0325800 Alfuzosin hydrochloride
10 mg
1287
Y0000832 Alfuzosin for system suitability
10 mg
1287
+5C
79
A0349000 Allantoin
60 mg
1288
+5C
79
A0350000 Allopurinol
50 mg
99.9% CHNO
0576
+5C
79
A0350010 Allopurinol impurity A
10 mg
5-amino-1H-pyrazole-4-carboxamide
0576
+5C
79
A0350020 Allopurinol impurity B
10 mg
5-formylamino-1H-pyrazole-4-carboxamide
0576
+5C
79
A0350030 Allopurinol impurity C
10 mg
5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide
0576
+5C
79
A0350040 Allopurinol impurity D
10 mg
ethyl 5-amino-1H-pyrazole-4-carboxylate
0576
+5C
79
A0350050 Allopurinol impurity E
20 mg
ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate
0576
+5C
79
A0351000 Allylstrychnine bromide
10 mg
1285
-20C
g(c)
79
Y0000235 Almagate
25 mg
2010
+5C
79
Y0000255 Almagate - reference spectrum
n/a
2010
79
A0357000 Alprazolam - * psy
100 mg
1065
+5C
79
A0360000 Alprenolol hydrochloride
100 mg
0628,0876
+5C
79
1286
89.5% [CH0] ; Batch 2 is valid until 31 January 2011
13.4% carbonic acid
1070,1487
Yes

Order
Code
Y0000054 Alprostadil
Reference Standard

Batch n
1
Y0000606 Altizide
Y0000843 Altizide impurity B
Y0000687 Alverine citrate

Y0000595 Alverine for peak identification
Y0000607 Alverine impurity D
A0363000 Amantadine hydrochloride
Quantity Sale
per vial Unit
50 mg
1 99.2% CHO
150 mg
1 99.9% CHClNOS
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
g(c)
1488
-20C
0370,2185
+5C
79
2185
+5C
79
+5C
79
+5C
79
15 mg
5 mg
2156
0.125 mg
2156
10 mg
2156
+5C
79
100 mg
0463
+5C
79
A0363700 Ambroxol hydrochloride
125 mg
1489
+5C
79
A0900000 Amfetamine sulfate - reference spectrum
n/a
0368
79
A0365000 Amidotrizoic acid dihydrate
100 mg
A0368000 Amikacin
200 mg
91.4 % CHNO
A0365900 Amikacin sulfate
200 mg
The batch 3 is not suitable for use in the assay or in the test for related
substances in monograph 1290:01/2010. Amikacin CRS A0368000 is also
needed. See leaflet.
Y0001117 Amikacin for system suitability
20 mg
A0370000 Amiloride hydrochloride
100 mg
Y0000020 Amiloride impurity A
10 mg
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate
Y0000173 4-Aminobenzoic acid
60 mg
Batch 1 is valid until 31 March 2012
A0420000 Aminocaproic acid
50 mg
A0460000 7-Aminodesacetoxycephalosporanic acid
20 mg
A0496000 Aminoglutethimide
125 mg
A0496005 Aminoglutethimide impurity A
20 mg
A0496020 Aminoglutethimide impurity D
10 mg
A0575000 Amiodarone hydrochloride
100 mg
Y0000129 Amiodarone impurity D
20 mg
Y0000130 Amiodarone impurity E
20 mg
10 mg
A0590004 Amisulpride impurity B
Y0000563 Amitriptyline hydrochloride

Y0000049 Amlodipine besilate
3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
Yes
+5C
79
1289,1290
Yes
+5C
79
1290
Yes
+5C
79
1289,1290
Yes
+5C
79
0651
+5C
79
0651
+5C
79
1687
+5C
79
0874
+5C
79
0708,0813
+5C
79
1291
+5C
79
(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)
1291
+5C
79
3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)
1291
+5C
79
0803
+5C
g(b)
79
(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone ; Batch 2
is valid until 31 July 2011
0803
+5C
79
(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
0803
+5C
79
Batch 1 is valid until 31 May 2012
1490
+5C
79
10 mg
4-amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethyl sulphonyl)-2hydroxybenzamide
1490
+5C
79
10 mg
0464
+5C
79
150 mg
1491
+5C
79
Y0001067 Amlodipine for peak identification
10 mg
+5C
79
Y0001068 Amlodipine impurity A
10 mg
+5C
79
New A0590000 Amisulpride
0873
Cefadroxyl impurity B
99.7% CHClNOS
1491
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
1491
Yes

Order
Reference Standard
Code
Y0001069 Amlodipine impurity B

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate
Y0001070 Amlodipine impurity G
10 mg
Y0000302 Ammonio methacrylate copolymer(type A) - reference

spectrum
n/a
Y0000303 Ammonio methacrylate copolymer(type B) - reference

spectrum
n/a
A0650000 Amobarbital - * psy
A0700000 Amobarbital sodium - * psy
A0800000 Amoxicillin trihydrate
Monograph
Leaflet
Storage
1491
+5C
1491
+5C
Extra
Price
charges
79
g
79
2081
79
2082
79
500 mg
0594
+5C
79
500 mg
0166
+5C
79
100 mg
86.2% CHNOS
0167,0168,02
60,
0577,0578,08
13, 1140,1653
+5C
79
Y0000005 Amphotericin B
100 mg
Batch 4 is not suitable for microbiological assay (see leaflet). ; Batch 3 is valid
until 28 February 2011
1292
Yes
-20C
79
Y0001014 Amphotericin B for peak identification
10 mg
1292
Yes
-20C
79
Y0001361 Amphotericin B for microbiological assay
100 mg
944 IU per mg
20702
Yes
-20C
79
A1000000 Ampicillin (anhydrous)
250 mg
97.6% CHNOS
0167,0168,05
78, 1168,1169
+5C
79
A1100000 Ampicillin trihydrate
150 mg
0168,0260,05
77,
0578,0808,22
11, 2212
+5C
79
Y0001386 Angelica dahuria root
160 mg
2556
-20C
79
A1200000 Anhydrotetracycline hydrochloride
15 mg
93.3% CHNO
0210,0211,16
54
+5C
79
Y0001244 Amylmetacresol
285 mg
99.5% CHO
Y0001245 Amylmetacresol for peak identification
10 mg
A1210000 Antazoline hydrochloride
50 mg
Y0000172 Apomorphine hydrochloride - reference spectrum
A1220000 Alpha-apo-oxytetracycline
A1230000 Beta-apo-oxytetracycline
20 mg
A1250000 Aprotinin solution BRP
0.5 ml
Y0001154 Aprotinin for system suitability
2.7 mg
A1269000 L-Arabinitol
10 mg
Y0000806 Arbutin
100 mg
A1270000 Arginine
50 mg
dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate
2405
Yes
+5C
79
2405
Yes
+5C
79
0972
+5C
79
n/a
0136
79
20 mg
0198
+5C
79
+5C
79
0579,0580
0198
Yes
+5C
79
0580
Yes
+5C
79
1381
+5C
79
-20C
79
+5C
79
22.3 Ph. Eur. Units per ml
1054
Arginine CRS 2 is suitable for monographs 01/2008:0806, 04/2008:1654,
0806,0930,16
01/2008:2114 and 01/2008:0930 only ; Batch 2 is valid until 31 January 2012
54, 2114
93.5% CHO
Yes

Order
Reference Standard
Code
Y0000304 Arginine aspartate

Batch n
1
Quantity Sale
per vial Unit
20 mg
1
Information
Monograph
Storage
Extra
Price
charges
79
a
2096
+5C
0805,0885,09
98
+5C
79
A1271000 Arginine hydrochloride
50 mg
Y0001323 Aristolochia
140 mg
Y0001185 Aristolochic acid I
1 mg
Y0001175 Aristolocholic acid for system suitability
1 mg
Y0000079 Articaine hydrochloride
100 mg
Y0000080 Articaine impurity A
15 mg
Y0000081 Articaine impurity E
10 mg
A1300000 Ascorbic acid
100 mg
Vitamin C
Y0001024 Ascorbic acid impurity C
20 mg
Y0001170 Ascorbic acid impurity D
10 mg
Y0000800 Ascorbyl palmitate
10 mg
Y0000305 Asparagine monohydrate
60 mg
A1320000 Aspartame
40 mg
A1321000 Aspartame impurity A
10 mg
A1330000 Aspartic acid
50 mg
Y0001171 Astragaloside IV
40 mg
2435
A1340000 Atenolol
100 mg
0703
Y0001089 Atenolol for system suitability
5 mg
0703
Y0001327 Atorvastatin calcium trihydrate
150 mg
95.2% CHFNO
2191
Y0001328 Atorvastatin impurity A
10 mg
desfluoroatorvastatin
Y0001329 Atorvastatin impurity B
10 mg
3-epi-atorvastatin
Y0001330 Atorvastatin impurity C
10 mg
Y0001331 Atorvastatin impurity D
10 mg
Y0001332 Atorvastatin impurity E
10 mg
New Y0000424 Atracurium besilate
Leaflet
20821
Yes
+5C
79
20821
Yes
+5C
79
20821
Yes
+5C
79
1688
+5C
79
methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate
1688
+5C
79
methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate
1688
+5C
79
0253,0958,17
91
+5C
79
D-xylo-hex-2-ulosonic acid (D-sorbosonic acid)
0253,1791
+5C
79
94.9% CHO; methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate)
0253,1791
+5C
79
0807
+5C
79
2086
+5C
79
0973
+5C
79
0973
+5C
79
0750,0797
+5C
79
-20C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2191
+5C
79
2191
+5C
79
fluoroatorvastatin
2191
+5C
79
3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide
2191
+5C
79
ent-atorvastatin
2191
+5C
79
98.5% CHNOS ; Batch 1 is valid until 30 April 2012
1.00 mg CHNO
2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)
120 mg
1970
Yes
+5C
g(b)
79
Y0000503 Atracurium for impurity F identification
5 mg
1970
Yes
+5C
g(b)
79
Y0000504 Atracurium for peak identification
5 mg
1970
Yes
+5C
g(b)
79
Y0000878 Atropine
30 mg
2056
+5C
79
Y0000845 Atropine for peak identification
0.25 mg
Y0000816 Atropine impurity B
10 mg
A1400000 Atropine sulfate
50 mg
50 mg
Y0000029 Azaperone
0068,2056
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)
+5C
79
0068,2056
Yes
+5C
79
0068
+5C
79
79
1708
+5C
a

Order
Code
A1500000 Azathioprine
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
0369
+5C
Extra
Price
charges
79
a
Y0001240 Azathioprine impurity A
10 mg
1-methyl-4-nitro-1H-imidazol-5-amine
0369
+5C
79
New Y0001246 Azathioprine impurity G
5 mg
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine) ; Batch 1 is valid until 30 April 2012
0369
+5C
79
Y0000326 Azelastine hydrochloride
25 mg
1633
+5C
79
Y0000327 Azelastine impurity B
5 mg
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane
1633
+5C
79
Y0000328 Azelastine impurity D
5 mg
4-(4-chlorobenzyl)phthalazin-1(2H)-one
1633
+5C
79
Y0000329 Azelastine impurity E
5 mg
3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
1633
+5C
79
Y0000306 Azithromycin
200 mg
94.6% CHNO
1649
Yes
+5C
79
Y0000637 Azithromycin for peak identification
15 mg
1649
Yes
+5C
79
Y0000641 Azithromycin for system suitability
0.05 mg
Batch 3 is valid until 30 June 2011
1649
Yes
+5C
79
Y0000307 Azithromycin impurity A
10 mg
6-demethylazithromycin ; Batch 1 is valid until 30 June 2011
+5C
79
Y0000285 B19 virus DNA for NAT testing BRP
150 mg
B19 virus DNA content log 5.8 IU per ml for plasma pool testing by NAT
Yes
-20C
e(d)
242
B0070000 Bacampicillin hydrochloride
120 mg
92.9% CHClNOS
B0100000 Bacitracin zinc
150 mg
62.9 IU per mg
B0200000 Baclofen
50 mg
B0200050 Baclofen impurity A
50 mg
91.5% CHClNO; ()-4-amino-3-(4-chlorophenyl)butyric acid lactam
0653
Y0001273 Baicalin
10 mg
88.5% CHO
2438
B0250000 Bambuterol hydrochloride
100 mg
B0300000 Barbital - * psy
500 mg
Y0000295 Basic butylated methacrylate copolymer -reference

spectrum
n/a
1975
B0305000 Beclometasone dipropionate anhydrous
150 mg
Y0000351 Beclometasone dipropionate monohydrate
10 mg
Y0000352 Beclometasone dipropionate for system suitability
10 mg
Y0000469 Beclometasone dipropionate for peak identification
10 mg
Y0001073 Beclometasone dipropionate impurities F and N
0.052 mg
Y0001025 Benazepril hydrochloride
160 mg
Y0001038 Benazepril for system suitability
0.016 mg
Y0001026 Benazepril impurity A
10 mg
B0400000 Bendroflumethiazide
100 mg
Y0000564 Bendroflumethiazide impurity A
5 mg
Y0000044 Benfluorex hydrochloride
50 mg
1649
See leaflet,
0557,
1527,1646
0808,0852
+5C
79
0465,0466,20
702
-20C
79
0653
+5C
79
+5C
79
+5C
79
1293
+5C
79
0170
+5C
79
79
+5C
79
Yes
0654,0809,14
49, 1709
99.1% CHClO
+5C
79
0654,1709
1709
Yes
+5C
79
0654,1709
Yes
+5C
79
1709
Yes
+5C
79
+5C
79
+5C
79
2388
+5C
79
0370
+5C
79
0370
+5C
79
1601
+5C
79
2388
99.5 % CHClNO
2388
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide
Yes

Order
Reference Standard
Code
Y0000043 Benfluorex hydrochloride for system suitability

Batch n
1
Quantity Sale
per vial Unit
360 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1601
+5C
1010,1172,12
54, 1708
+5C
79
B0470000 Benperidol
100 mg
B0477000 Benserazide hydrochloride
50 mg
1173
+5C
79
B0477010 Benserazide impurity A
20 mg
()-2-amino-3-hydroxypropanohydrazide
1173
+5C
79
Y0001071 Benserazide impurity C
10 mg
(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
1173
+5C
79
Y0001079 Benserazide for peak identification
10 mg
1173
Yes
+5C
79
Y0001064 Benzaldehyde
150 mg
0372,0371
Yes
+5C
79
Y0001060 Benzalkonium chloride for system suitability
20 mg
0371,0372
Yes
+5C
79
B0490000 Benzarone
10 mg
(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
1393
+5C
79
B0500000 Benzathine benzylpenicillin
125 mg
90.7% CHNOS
24.1% CHN (N,N'-dibenzylethylenediamine)
0373
+5C
79
Y0000775 Benzbromarone
10 mg
1393
+5C
79
B0550000 Benzethonium chloride
100 mg
0974
+5C
79
B0600000 Benzocaine
50 mg
0011,1088
+5C
79
Y0000647 Benzophenone
40 mg
1784
+5C
79
Y0000167 Benzyl alcohol
50 mg
+5C
79
B0670000 Benzyl benzoate - reference spectrum
n/a
0705
79
B0680000 S-Benzylmercaptoacetyltriglycin
10 mg
1372
+5C
79
B0700000 Benzylpenicillin potassium
50 mg
0113,0148,01
49
+5C
79
B0900000 Benzylpenicillin sodium
200 mg
99.4% CHNNaOS; Penicillin G sodium
0113,0114,01
48, 0149
Yes
+5C
79
Y0001149 Berberine chloride
20 mg
84.3% CHClNO
1831,2500
Yes
B0950000 Betadex
200 mg
88.4% [CHO]
New Y0000391 Betahistine dihydrochloride
50 mg
B0990000 Betahistine mesilate
100 mg
B1000000 Betamethasone
75 mg
B1030000 Betamethasone acetate
B1040000 Betamethasone dipropionate

Y0001416 Betamethasone dipropionate for peak identification
Y0001418 Betamethasone dipropionate for system suitability
B1045000 Betamethasone sodium phosphate
B1054000 Betamethasone 17-valerate
0256,0371,03
72,1827
See leaflet
Yes
+5C
79
1070,1487,18
04
+5C
79
1665
+5C
79
1071
+5C
79
0312,0354,03
88, 0561,0811
+5C
79
100 mg
0548,0975
+5C
79
100 mg
0809
+5C
79
10 mg
0809
Yes
+5C
79
10 mg
0809
Yes
+5C
79
100 mg
0549,0810
+5C
79
100 mg
0322,0811
+5C
79

Order
Reference Standard
Code
B1055000 Betamethasone 21-valerate

Batch n
3
Quantity Sale
per vial Unit
15 mg
1
Information
Monograph
Leaflet
0811
Storage
+5C
Extra
Price
charges
79
g
Y0001027 Betamethasone valerate for system suitability
25 mg
0811
Yes
+5C
79
Y0001065 Betamethasone valerate impurity mixture
0.018 mg
0811
Yes
+5C
79
B1103000 Betaxolol hydrochloride
60 mg
1072
+5C
79
B1103100 Betaxolol impurity A
10 mg
(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol
1072
+5C
79
Y0001354 Betaxolol impurity C
5 mg
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
1072
-20C
79
Y0001360 Betaxolol for peak identification
15 mg
1072
+5C
79
B1115000 Bezafibrate
100 mg
1394
+5C
79
15 mg
2196
+5C
79
New Y0001448 Bicalutamide for system suitability
Yes
Yes
Y0001078 Bicisate labelling kit
24 mg
2123
+5C
79
B1110000 Bifonazole
100 mg
1395
+5C
79
B1110004 Bifonazole impurity B
10 mg
1395
+5C
79
Y0001421 Bifonazole for system suitability
10 mg
1395
+5C
79
Y0001059 Bilberry dry extract
250 mg
3.44% of cyanidin 3-O-glucoside chloride (CHClO)
2394
-20C
79
B1116000 Biotin
20 mg
Vitamin H ; Batch 1 is valid until 31 May 2011
1073
+5C
79
B1120000 Biperiden hydrochloride
60 mg
1074
+5C
79
B1121000 Biperiden impurity A
20 mg
(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)
1074
+5C
79
B1140000 Bisacodyl
50 mg
0595
+5C
79
Y0000608 Bisacodyl for peak identification
10 mg
0595
+5C
79
Y0000694 Bisacodyl for system suitability
5 mg
0595
+5C
79
Y0000812 Bisoprolol fumarate
50 mg
+5C
79
Y0000877 Bisoprolol for peak identification
1 mg
Bisoprolol for system suitability method A CRS has been renamed as

Bisoprolol for peak identification CRS.
1710
Yes
+5C
79
1 mg
Bisoprolol for system suitability method B CRS has been renamed as

Bisoprolol for system suitability CRS ; Batch 1 is valid until 30 April 2012
1710
Yes
+5C
79
B1141000 Bleomycin sulfate
7 mg
8910 IU per vial; bleomycin A : 67.0%; Bleomycin B : 29.2%;

demethylbleomycin A : 2.6%
0976,20702
Yes
-20C
79
Y0000434 Boldine
30 mg
98.8% CHNO ; Batch 1 is valid until 31 January 2012
1396, 1816
Yes
+5C
79
B1142000 Bordetella pertussis mouse antiserum BRP
0.5 mg
Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial

Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial
See leaflet,
20716
Yes
-20C
90
B1143000 Bromazepam - * psy
60 mg
0778,0879
+5C
79
Y0000645 Bromazepam for system suitability - * psy
10 mg
0879
+5C
79
B1145000 Bromhexine hydrochloride
100 mg
0706
+5C
79
Y0000200 Bromhexine impurity C
10 mg
0706
+5C
79
B1150000 Bromocriptine mesilate
30 mg
0596
-20C
g(c)
79
Y0000677 Bromocriptine mesilate for system suitability
5 mg
0596
-20C
g(c)
79
100 mg
New Y0000813 Bisoprolol for system suitability
B1152000 Bromperidol
4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate
Yes
Yes
1710
N-(2-aminobenzyl)-N-methylcyclohexanamine
Yes
Yes
79
0616,1178
+5C
a

Order
Reference Standard
Code
B1152050 Bromperidol decanoate

Batch n
1
Quantity Sale
per vial Unit
60 mg
1
Information
Monograph
Leaflet
Storage
1397,1431
+5C
Extra
Price
charges
79
a
B1153000 Brompheniramine maleate
100 mg
0977,1196
+5C
79
Y0000468 Brotizolam - * psy
10 mg
2197
+5C
79
Y0000470 Brotizolam impurity B
10 mg
2197
+5C
79
B1155000 Brucella melitensis Rev. 1 strain BRP - * Biotox
1 mg
B1157300 Budesonide
110 mg
Y0001148 Budesonide for system suitability
10 mg
B1156000 Bufexamac
100 mg
B1157400 Buflomedil hydrochloride
100 mg
B1157410 Buflomedil impurity B
20 mg
B1158000 Bumetanide
150 mg
Y0000309 Bumetanide impurity A
5 mg
3-nitro-4-phenoxy-5-sulphamoylbenzoic acid
Y0000310 Bumetanide impurity B
5 mg
3-amino-4-phenoxy-5-sulphamoylbenzoic acid
B1160000 Bupivacaine hydrochloride
100 mg
Y0000088 Bupivacaine impurity B
20 mg
Y0000089 Bupivacaine impurity E
20 mg
Y0001108 Buprenorphine - * psy
10 mg
Y0001109 Buprenorphine hydrochloride - * psy
10 mg
Y0001122 Buprenorphine for system suitability - * psy
10 mg
B1168000 Buserelin
2 mg
B1168020 D-His-Buserelin
0.5 mg
Y0000131 Buspirone hydrochloride
5 mg
Y0000471 Buspirone for system suitability
2 mg
1711
B1170000 Busulfan
50 mg
0542
Y0001304 Butyl methanesulfonate
40 L
20537,20538,
20539
B1217000 Butyl parahydroxybenzoate
100 mg
See leaflet
Y0001357 Butyl parahydroxybenzoate impurity E
15 mg
2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)
B1212000 Butylhydroxyanisole
50 mg
B1215000 Butylhydroxytoluene
50 mg
Plastic additive 07
Y0000472 Cabergoline
100 mg
99.8% CHNO
C0100000 Caffeine
70 mg
See leaflet
Y0000787 Caffeine for system suitability
20 mg
Batch 1 is valid until 30 September 2011
C0166000 Calcifediol
5 mg

9
2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)
0793
Yes
+5C
e(b)
79
1075
Yes
+5C
79
1075
Yes
+5C
79
1179
+5C
79
1398
+5C
79
1398
+5C
79
1076
+5C
79
1076
+5C
79
1076
+5C
79
0541
+5C
79
(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
0541
+5C
79
6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide
0541
+5C
79
1180
+5C
79
1181
+5C
79
99.7% CHO
4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one
1180,1181
+5C
79
1077
-20C
79
1077
-20C
79
1711
+5C
79
+5C
79
+5C
79
+5C
79
2.00 mg per vial of CHNO
0881,1216
Yes
Yes
+5C
79
0881
Yes
+5C
79
0880
+5C
79
0581,30103,
30105,30106,
30107
+5C
79
1773
Yes
-20C
79
0267,0268,15
04
Yes
+5C
79
0267, 0268
Yes
+5C
79
150
1295
-20C
e(d)

Order
Reference Standard
Code
C0166001 Calcifediol - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
79
Yes
+5C
79
1295
Y0000499 Calcipotriol (anhydrous) - reference spectrum
n/a
Y0000473 Calcipotriol monohydrate
5 mg
Y0000474 Calcipotriol monohydrate - reference spectrum
n/a
79
C0200000 Calcitonin (salmon)
0.98 mg
0.98 mg per vial of CHNOS
0471
-20C
79
Y0000632 Calcitonin-Gly
0.4 ml
About 0.9 mg per ml
0471
-20C
79
C0200010 N-acetyl-cys1-calcitonin
20 mg
about 0.1mg N-acetyl-cys-1-calcitonin per vial ; Batch 3 is valid until 31 May

2011
0471
-20C
79
C0225000 Calcitriol
10 mg
100.0% CHO
0883
-20C
e(d)
C0226000 Calcitriol - reference spectrum
n/a
0883
79
C0249000 Calcium ascorbate - reference spectrum
n/a
1182
79
C0250000 Calcium folinate
100 mg
C0299000 Calcium glucoheptonate
60 mg
C0300000 Calcium gluconate
100 mg
C0340000 Calcium levulinate dihydrate
250 mg
C0350000 Calcium oxalate monohydrate
500 mg
C0400000 Calcium pantothenate
60 mg
C0405000 Camphor (racemic)
50 mg
Y0001388 Candesartan cilexetil
60 mg
2375
Y0001387 Candesartan cilexetil for peak identification
50 mg
2375
Yes
Y0001389 Candesartan cilexetil for system suitability
10 mg
2573
Yes
C0410000 Canrenone
50 mg
0688
C0426000 Caprylic acid
200 mg
Y0000671 Capsaicin
50 mg
C0430000 Captopril
10 mg
Y0001182 Captopril for system suitability
20 mg
Y0001219 Captopril impurity B
10 mg
87.4% CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2carboxylic acid
Y0001220 Captopril impurity C
10 mg
Y0001221 Captopril impurity D
10 mg
Y0000435 Captopril impurity E
10 mg
Y0000113 Carbachol
50 mg
C0450000 Carbamazepine
200 mg
2011
Extra
Price
charges
79
l
2011,2284
93.9% CHO
2284
85.5 % CHCaNO
Calcium digluconate
0978,1606
+5C
79
1399
+5C
79
0172,0658,09
79,
1047,1399,21
64
+5C
79
+5C
79
+5C
79
0470
+5C
79
0655,1600
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1296
20234
Loss of 12.1% m/m (U= 0.2%, n=10, k=2.23)
1000
Yes
1401,1471
+5C
79
1859,2336,23
37
+5C
79
1079
+5C
79
1079
+5C
79
1079
+5C
79
84.8% CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid
1079
+5C
79
85.4% CHBrO; (2RS)-3-bromo-2-methylpropanoic acid
1079
+5C
79
(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid
1079
+5C
79
1971
+5C
79
0543
+5C
79
98.6% CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide
100.0% CHNO
10

Order
Reference Standard
Code
Y0000033 Carbamazepine impurity A

Batch n
5
C0451000 Carbasalate calcium - reference spectrum
Y0001161 Carbasalate impurity B

C0455000 Carbenicillin sodium
C0460000 Carbidopa
C0465000 Carbimazole
Quantity Sale
Information
per vial Unit
10 mg
1 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)
Monograph
0543
n/a
5 mg
1185
50 mg
0956
50 mg
100 mg
C0470000 Carbocisteine
60 mg
C0499900 Carbon dioxide - reference spectrum
n/a
C0550000 Carboplatin - reference spectrum
n/a
Y0000475 Carboprost trometamol
40 mg
Y0000536 Carboprost trometamol - reference spectrum
n/a
1712
Y0000035 Carisoprodol
50 mg
Y0000036 Carisoprodol impurity A
10 mg
Y0001214 Carmellose
10 mg
C0580004 Carmustine - reference spectrum
n/a
C0580010 Carmustine impurity A
20 mg
1187
Y0000846 Carprofen for veterinary use
30 mg
2201
Y0000884 Carprofen for system suitability
5 mg
2201
Y0000192 Carteolol hydrochloride - reference spectrum
n/a
1972
Y0000193 Carteolol for system suitability
30 mg
1972
Y0000075 Carvedilol - reference spectrum
n/a
1745
Y0000103 Carvedilol impurity C
10 mg
C0600000 Casein BRP
100000 mg
C0630000 Cefaclor
450 mg
C0640000 Delta-3-Cefaclor
20 mg
C0650000 Cefadroxil
250 mg
93.7% CHNOS
C0675000 Cefalexin monohydrate
150 mg
94.2% CHNOS ; Batch 2 is valid until 31 May 2011
C0682000 Cefalotin sodium
100 mg
98.8% CHNNaOS
Y0000505 Cefalotin for impurity B identification
10 mg
C0682300 Cefamandole nafate
125 mg
Y0000240 Cefapirin sodium
100 mg
C0682400 Cefatrizine propylene glycol
150 mg
81.8% CHNOS
C0682410 Cefatrizine impurity A
60 mg
Leaflet
Storage
+5C
1185
Extra
Price
charges
79
a
l
79
+5C
79
+5C
79
0755
+5C
79
0884
+5C
79
0885
+5C
79
0375
79
1081
79
-20C
79
79
1689
+5C
79
1689
+5C
79
2360
+5C
79
1187
79
-20C
g(c)
79
+5C
79
+5C
79
79
79
79
99.1% CHNO
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate
1,3-bis(2-chloroethyl)urea
1712
Yes
+5C
1745
+5C
79
0350
+5C
131
0986
+5C
79
0986
-20C
79
0260,0577,08
13
+5C
79
+5C
79
0987
+5C
79
0987
+5C
79
99.0% CHNNaOS
1402
+5C
79
98.5% CHNNaOS
1650
+5C
79
(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol
95.0% CHClNOS
0708,0814
Yes
79
1403
+5C
a
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-179
1403
+5C
a
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
11

Order
Code
C0682800 Cefazolin
Reference Standard

Batch n
3
Quantity Sale
Information
per vial Unit
150 mg
1 99.6% CHNOS ; Batch 2 is valid until 30 September 2011
150 mg
1 95.2% CHClNOS
Monograph
Leaflet
Storage
0988
Yes
+5C
Y0000633 Cefepime dihydrochloride monohydrate
Y0000634 Cefepime dihydrochloride monohydrate for system

suitability
15 mg
2126
Y0001336 Cefepime impurity E
10 mg
(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
C0684000 Cefixime
200 mg
C0684750 Cefoperazone dihydrate
100 mg
C0684800 Cefoperazone sodium - reference spectrum
n/a
Y0000420 Cefotaxime acid
80 mg
C0685000 Cefotaxime sodium
30 mg
Y0000506 Cefotaxime for peak identification
10 mg
C0688000 Cefoxitin sodium
100 mg
97.4% CHNNaOS
0990
Y0001305 Cefpodoxime proxetil
70 mg
97.1% CHNOS
2341
Y0001318 Cefpodoxime proxetil for impurity H identification
10 mg
2341
Y0001306 Cefpodoxime proxetil for peak identification
10 mg
Y0001371 Cefprozil
120 mg
Y0001368 Cefprozil impurity mixture
10 mg
Y0001372 Cefprozil impurity A
20 mg
Y0001367 Cefprozil for peak identification
10 mg
C0690000 Cefradine
300 mg
93.9%
; Batch 3 is valid until 31 May 2011
Y0000568 Cefradine for peak identification
15 mg
Y0001174 Cefradine impurity mixture
0.04 mg
C0690500 Ceftazidime
200 mg
85.3% CHNOS ; Batch 1 is valid until 1 February 2011
Y0001111 Ceftazidime for peak identification
10 mg
C0690510 Ceftazidime impurity A
15 mg
Extra
Price
charges
79
a
+5C
79
+5C
79
2126
-20C
g(c)
79
88.8% CHNOS
1188
-20C
79
94.2% CHNOS ; Batch 1 is valid until 31 December 2011
1404
+5C
79
79
2126
Yes
Yes
1404
94.3% CHNOS
0989
+5C
79
0708,0989
+5C
79
+5C
79
+5C
79
Yes
-20C
79
Yes
-20C
79
2341
Yes
-20C
79
2342
Yes
+5C
79
2342
Yes
+5C
79
+5C
79
0989
Yes
2342
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)
2342
Yes
+5C
79
Yes
+5C
79
Must be used with Cefradine impurity mixture CRS Y0001174
0167,0168,05
78,
0708,0814
0814
Yes
+5C
79
Must be used with Cefradine for peak identification Y0000568
0814
Yes
+5C
79
+5C
79
+5C
79
1405
+5C
79
0991
+5C
79
0991
+5C
79
1405
1405, 2344
89.9% CHNOS ; (6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(1carboxy-1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5- thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate (delta-2ceftazidime)
Yes
C0691000 Ceftriaxone sodium
80 mg
Ceftazidime impurity A CRS is currently not available, it has been temporarily

replaced
by Ceftazidime for peak identification CRS (Y0001111)
90.4% CHNNaOS
C0692000 Ceftriaxone impurity A
10 mg
E-isomer
C0694990 Cefuroxime axetil
60 mg
97.4% CHNOS
1300
+5C
79
C0695000 Cefuroxime sodium
150 mg
96.7% CHNNaOS
0988,0992
+5C
79
Y0000311 Celiprolol hydrochloride
10 mg
1632
+5C
79
Y0000312 Celiprolol impurity I
0.02 mg
1632
+5C
79
1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
12

Order
Reference Standard
Code
New Y0000239 Celiprolol for peak identification

Batch n
2
Quantity Sale
Information
per vial Unit
20 mg
1 Batch 1 is valid until 30 June 2012
Monograph
Leaflet
Storage
1632
Yes
+5C
Y0000784 Cellulose acetate
40 mg
0887
C0698005 Cellulose acetate butyrate - reference spectrum
n/a
1406
Y0001054 Cellulose acetate phthalate
10 mg
0314
C0700000 Cephaline hydrochloride
15 mg
0080,0081,00
93,
0094,1530,18
75
C0980650 Cetirizine dihydrochloride
100 mg
1084
C0980651 Cetirizine impurity A
10 mg
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine
1084
Y0001197 Cetirizine for peak identification
1.01 mg
Replaces Cetirizine impurity mixture CRS
1084
C0984100 Cetostearyl isononanoate - reference spectrum
n/a
C0990000 Cetyl alcohol
250 mg
Y0000073 Cetyl palmitate 15
60 mg
+5C
79
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
79
0540,0702,08
01,
0802,0847,09
69, 1411
+5C
79
1906
+5C
79
1906
+5C
79
0379
+5C
79
Yes
1085
100% CHO
Extra
Price
charges
79
a
Y0000074 Cetyl palmitate 95
50 mg
New C1000000 Cetylpyridinium chloride
20 mg
C1050000 Chenodeoxycholic acid
125 mg
1189,1275
+5C
79
Y0000104 Chitosan hydrochloride
30 mg
1774
+5C
79
C1100000 Chlorambucil
100 mg
0137
+5C
79
Y0001298 Chlorambucil for system suitability
10 mg
0137
+5C
79
Y0001299 Chlorambucil with impurity G
10 mg
0137
+5C
79
C1200000 Chloramphenicol
500 mg
0071,0473,07
09
+5C
79
C1300000 Chloramphenicol dipalmitate
100 mg
0473
+5C
79
C1350000 Chloramphenicol disodium disuccinate
25 mg
0709
+5C
79
C1400000 Chloramphenicol palmitate isomer
100 mg
0473
+5C
79
C1425000 Chloramphenicol sodium succinate
1500 mg
0709
+5C
79
C1435000 Chlorcyclizine hydrochloride
100 mg
1086
+5C
79
C1450000 Chlordiazepoxide - * psy
50 mg
0656,1974
+5C
79
C1500000 Chlordiazepoxide hydrochloride - * psy
100 mg
0474
+5C
79
Y0000476 Chlordiazepoxide impurity A
10 mg
0474,0656
+5C
79
C1510000 Chlorhexidine
50 mg
0658
+5C
79
C1520000 Chlorhexidine diacetate
10 mg
0657
+5C
79
C1540000 Chlorhexidine dihydrochloride
50 mg
0659
+5C
79
91.1% CHClNNaO
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide
13
Yes

Order
Reference Standard
Code
C1530000 Chlorhexidine for performance test

Batch n
5
Quantity Sale
per vial Unit
50 mg
1
Information
Y0000569 Chlorogenic acid
20 mg
96.9% CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5trihydroxycyclohexanecarboxylic acid
C2223030 1-(4-Chlorophenyl)-1-phenylethanol
15 mg
Clemastine fumarate impurity C
C1650000 Chloroquine sulfate
200 mg
C1700000 Chlorothiazide
100 mg
C1800000 Chlorphenamine maleate
100 mg
Y0000436 Chlorphenamine impurity A
0.01 mg
Y0000437 Chlorphenamine impurity C
10 mg
C1900000 Chlorpromazine hydrochloride
200 mg
Y0000507 Chlorpromazine impurity A
10 mg
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)
Y0000479 Chlorpromazine impurity D
10 mg
Y0000508 Chlorpromazine impurity E
10 mg
New Y0001449 Chlorpromazine impurity F
Monograph
Leaflet
Storage
0657,0658,06
59
Yes
+5C
Extra
Price
charges
79
g
0897,1823,18
24,
1866,1897,23
89
+5C
79
1190
-20C
g(c)
79
0544,0545
+5C
79
0385,0394
+5C
79
0386,0977,10
84, 1196
+5C
79
2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile ; Batch 2 is valid until 30 September 2011
0386
+5C
79
(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine
0386
+5C
79
0475,20303
+5C
79
0475
+5C
79
3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)
0475
+5C
79
2-chloro-10H-phenothiazine
0475
+5C
79
3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
0475
+5C
79
1087
+5C
79
1087
+5C
79
0815,1365
+5C
79
+5C
79
+5C
79
+5C
79
2 mg
C1905000 Chlorpropamide
100 mg
C1905020 Chlorpropamide impurity B
50 mg
1,3-Dipropylurea
C1915000 Chlorprothixene hydrochloride
50 mg
2.0% E-isomer
C1950000 Chlortalidone
150 mg
99.5% CHClNOS
Y0000779 Chlortalidone for peak identification
1.017 mg
C2000000 Chlortetracycline hydrochloride
100 mg
New Y0001451 Chlortetracycline for system suitability
n/a
20 mg
0173
Yes
+5C
79
500 mg
100% CHO ; Vitamin D3
0072,0574,05
75,
0598,1192,11
93
Yes
-20C
g(c)
79
C2150000 Cholecalciferol for system suitability
1 mL
Batch 5 is valid until 30 November 2011
-20C
g(c)
79
C2155000 Cholesterol
100 mg
99.5% CHO ; Batch 2 is valid until 31 December 2011
0072,0082,05
74,
0575,0598
0993
+5C
79
C2158000 Cholic acid
60 mg
1189
+5C
79
Y0000280 Chondroitin sulfate sodium
250 mg
100% HO(CHNNaOS)
2064
+5C
79
Y0000593 Chondroitin sulfate sodium (marine)
100 mg
2064
+5C
79
New C2100000 Cholecalciferol
0546
0546
89.7% CHClNO
5.5% CHClNO
14
Yes
0173
Yes

Order
Reference Standard
Code
C2160000 Chymotrypsin BRP

Batch n
2
Quantity Sale
per vial Unit
100 mg
1 6.01 microkatals per mg
Information
Monograph
Leaflet
Storage
0476,0694
+5C
Extra
Price
charges
79
a
Y0000040 Ciclopirox
100 mg
1407
+5C
79
C2162701 Ciclopirox impurity A
20 mg
()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid
1302,1407
+5C
79
C2162702 Ciclopirox impurity B
20 mg
6-cyclohexyl-4-methyl-2H-pyran-2-one
1302,1407
-20C
79
New C2162700 Ciclopirox olamine
150 mg
1302
+5C
79
C2163000 Ciclosporin
120 mg
98.5% CHNO
0994
+5C
79
Y0000361 Ciclosporin for system suitability
5 mg
0994
+5C
79
C2170000 Cilastatin sodium
10 mg
1408
+5C
79
C2174000 Cilazapril
50 mg
1499
+5C
79
C2174002 Cilazapril impurity A
25 mg
1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate
1499
+5C
79
C2174005 Cilazapril impurity D
10 mg
(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid
1499
+5C
79
C2175000 Cimetidine
50 mg
0756
+5C
79
C2175500 Cimetidine hydrochloride
100 mg
1500
+5C
79
Y0001130 Cimetidine for peak identification
10 mg
0756
Yes
+5C
79
Y0001146 Cimetidine for system suitability
0.5085 mg
756
Yes
+5C
79
C2177000 Cinchocaine hydrochloride
60 mg
1088
+5C
79
Y0000176 Cineole
180 mg
1973
+5C
79
C2180000 Cinnarizine
100 mg
0816
+5C
79
Y0000362 Ciprofibrate
5 mg
2013
+5C
79
Y0000363 Ciprofibrate for system suitability
5 mg
2013
+5C
79
Y0000198 Ciprofloxacin
20 mg
1089
+5C
79
C2190000 Ciprofloxacin hydrochloride
100 mg
+5C
79
Y0000199 Ciprofloxacin hydrochloride for peak identification
10 mg
+5C
79
C2190050 Ciprofloxacin impurity A
10 mg
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)
+5C
79
C2210000 Cisplatin
100 mg
99.7% [PtCl(NH)]
0599
+5C
79
Y0001018 Cisplatin impurity A
10 mg
trans-diamminedichloroplatinum (II)
0599
+5C
79
Y0001019 Cisplatin impurity B
10 mg
94.1% [PtCl(NH)]-; amminetrichloroplatinate(-)
0599
+5C
79
Y0001008 Citalopram hydrobromide
5 mg
2288
+5C
79
Y0001007 Citalopram hydrochloride
5 mg
2203
+5C
79
Y0000855 Citalopram for system suitability
0.06 mg
2203,2288
+5C
79
A1202000 Citric acid (anhydrous)
50 mg
0455
+5C
79
C2219000 Citric acid monohydrate
50 mg
0456
+5C
79
Y0000639 Cladribine
50 mg
+5C
g(b)
79
Y0000609 Cladribine for peak identification
10 mg
+5C
g(b)
79
0888,1353
93.6% CHClFNO
0888,1089
99.1% CHClNO
Yes
0888,1089,22
29
Yes
Yes
2174
2174
15
Yes
Yes

Order
Reference Standard
Code
Y0000610 Cladribine impurity C

Batch n
1
Quantity Sale
Information
per vial Unit
5 mg
1 2-chloro-7H-purin-6-amine
160 mg
1 97.7% CHNO ; Batch 2 is valid until 31 March 2012
Monograph
Leaflet
2174
Storage
+5C
Extra
Price
charges
79
g(b)
Y0000320 Clarithromycin
1651
Yes
+5C
79
Y0000321 Clarithromycin for peak identification
30 mg
1651
Yes
+5C
79
Y0000269 Clazuril for system suitability
10 mg
1714
Yes
+5C
79
Y0001193 Clazuril
10 mg
1714
+5C
79
C2221000 Clebopride malate
100 mg
1303
+5C
79
C2223000 Clemastine fumarate
100 mg
1190
+5C
79
C2248000 Clenbuterol hydrochloride
30 mg
1409
+5C
79
C2248010 Clenbuterol impurity B
10 mg
1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
1409
+5C
79
C2250000 Clindamycin hydrochloride
200 mg
94.4% CHClNOS
0582,0583,09
96
+5C
79
C2269000 Clindamycin phosphate
250 mg
95.7% CHClNOPS
0996
+5C
79
Y0000364 Clioquinol
5 mg
2111
+5C
79
Y0000205 Clobazam - reference spectrum
n/a
79
Y0000241 Clobazam impurity A
10 mg
7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
1974
+5C
79
Y0000559 Clobetasol propionate
40 mg
99.6% CHClFO
2127
+5C
79
Y0000570 Clobetasol for peak identification
2 mg
+5C
79
Y0000571 Clobetasol impurity J
0.4 mg
+5C
79
C2285000 Clobetasone butyrate
50 mg
1090
+5C
79
Y0001137 Clobetasone butyrate for system suitability
30 mg
1090
+5C
79
Y0000888 Clodronate disodium tetrahydrate
5 mg
1777
+5C
79
Y0000885 Clodronate impurity D
5 mg
1777
+5C
79
Y0000313 Clofazimine
150 mg
2054
+5C
79
Y0000358 Clofazimine for system suitability
10 mg
2054
+5C
79
C2300000 Clofibrate
0.5 ml
0318
+5C
79
C2320000 Clomifene citrate
50 mg
0997,1046
+5C
79
C2332000 Clomifene citrate for performance test
50 mg
0997
+5C
79
C2360000 Clomipramine hydrochloride
100 mg
0889
+5C
79
Y0000132 Clomipramine impurity C
10 mg
94.5% CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
0889
+5C
79
Y0000133 Clomipramine impurity D
10 mg
3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
0889
+5C
79
Y0000134 Clomipramine impurity F
5 mg
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
0889
+5C
79
C2385000 Clonazepam - * psy
50 mg
1974,0415
+5C
79
Y0000286 Clonazepam - reference spectrum
n/a
C2385015 Clonazepam impurity B
5 mg
1974
2127
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
(chloromethylene)bis(phosphonic acid)
44% of Z-isomer CHClNO
Yes
2127
Yes
Yes
Yes
79
0890
l
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one ; Batch 1 is valid until
79
0890
+5C
a
28 February 2011
16

Order
Reference Standard
Code
C2400000 Clonidine hydrochloride

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
0477
+5C
Extra
Price
charges
79
f
Y0000801 Clonidine impurity B
20 mg
0477
+5C
79
Y0000833 Clopamide
40 mg
1747
+5C
79
Y0000848 Clopamide for system suitability
10 mg
1747
+5C
79
Y0001333 Clopidogrel hydrogen sulfate
60 mg
2531
+5C
79
Y0001335 Clopidogrel impurity A
10 mg
+5C
79
Y0001334 Clopidogrel for system suitability
100 mg
2531
+5C
79
Y0000392 Closantel sodium dihydrate
20 mg
1716
+5C
79
Y0000393 Closantel for system suitability
20 mg
1716
Yes
+5C
79
C2424400 Clostridia (multi-component) rabbit antiserum(for

vaccines-vet.use)BRP
1 mg
see information on the accompanying leaflet
0362,0363,03
64, 0697
Yes
-20C
90
C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP
1 mg
0.20 IU per vial (determined using toxin neutralisation test)
20708
Yes
-20C
90
C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP
1 mg
34 IU per vial
See leaflet,
0697
Yes
-20C
90
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.

use) BRP
1 mg
15 IU per vial
See leaflet,
0697
Yes
-20C
90
C2430000 Clotrimazole
100 mg
0757
+5C
79
Y0000818 Clotrimazole impurity E
15 mg
0757
+5C
79
Y0000849 Clotrimazole for peak identification
1 mg
C2450000 Cloxacillin sodium
200 mg
93.9% CHClNNaOS
C2460000 Clozapine
60 mg
Y0000758 Clozapine for peak identification
0.41 mg
1 mg
1191
Factor V : 0.73 IU per vial, Factor VIII : 0.74 IU per vial, Factor XI : 0.59 IU per 0903,1646,20
vial, Factor XIII : 0.79 IU per vial
740,20722
Y0000162 Cocaine hydrochloride - reference spectrum
n/a
C2480000 Cocoyl caprylocaprate
40 mg
Y0000722 Codeine - * narc
20 mg
C2500000 Codeine - reference spectrum
n/a
Y0000334 Codeine impurity A
10 mg
C2500100 Codeine hydrochloride dihydrate - reference spectrum
n/a
C2510000 Codergocrine mesilate
60 mg
C2580000 Colchicine
15 mg
Y0000209 Colchicine for system suitability
10 mg
0758
Y0000374 Colestyramine
10 mg
1775
New Y0001472 Coagulation Factors V, VIII, XI and XIII plasma
1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole
(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid
Batch 1 is valid until 31 October 2011
Yes
2531
0757
Yes
+5C
79
0661,0663,06
68, 2260
Yes
+5C
79
1191
+5C
79
Yes
+5C
79
Yes
-20C
90
79
+5C
79
+5C
79
79
79
79
0073
1411
0076,1839,18
41
See leaflet
Yes
0074,0075,00
76
7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan
0074,0075,00
76, 1412
+5C
1412
17
1416,2060
+5C
79
0758
+5C
79
+5C
79
+5C
79
Yes

Order
Reference Standard
Code
C2600000 Colistimethate sodium

Batch n
2
Y0000277 Colistin sulfate
C2700000 Colistin sulfate for microbiological assay
C2725000 Copovidone - reference spectrum

C2800000 Cortisone acetate
Quantity Sale
Information
per vial Unit
20 mg
1 285000 IU per vial CHNNaOS
25 mg
1 33.7% colistin E2, 2.6% colistin E3, 3.3% colistin E1-I, 3.1% colistin
E1-7MOA, 44.2 % colistin E1.
25.0 mg of colistin sulphate per vial
Monograph
Leaflet
0319,20702
0320
Storage
+5C
Extra
Price
charges
79
a
Yes
-20C
79
Yes
-20 C
79
79
0321,0736,07
67
+5C
79
2120
+5C
79
25 mg
n/a
250 mg
Y0000438 Coumarin
80 mg
99.9% CHO
C2900000 Cotton wool standard for neps
1000 mg
0036
+5C
79
Y0001053 Crospovidone
5 mg
0892
+5C
79
C2970000 Crotamiton
100 mg
99.2% CHNO (sum of E and Z-isomers); 3.5% Z-isomers
1194
-20C
79
70 mg
N-ethyl-N-(2-methylphenyl)but-3-enamide ; Batch 2 is valid until 31 March

2012
1194
-20C
79
Y0001061 Cyanidin chloride
20 mg
99.1% CHClO
2394
+5C
79
C3000000 Cyanocobalamin
20 mg
Vitamin B12
+5C
79
C3090000 Cyclizine hydrochloride
50 mg
0269,0270,05
47,
0710,1505
1092
+5C
79
Y0000886 Cyclizine impurity A
15 mg
1-methylpiperazine
1092
+5C
g(b)
79
Y0000887 Cyclizine impurity B
10 mg
diphenylmethanol (benzhydrol)
1092
+5C
79
C3200000 Cyclobenzaprine hydrochloride
100 mg
0408,0464
+5C
79
C3245000 Cyclopentolate hydrochloride
50 mg
1093
+5C
79
Y0001088 Cyclopentolate for system suitability
60 mg
1093
+5C
79
C3250000 Cyclophosphamide
50 mg
0711
+5C
79
C3280000 Cyproheptadine hydrochloride
30 mg
0817,0846
+5C
79
Y0001095 Cyproheptadine impurity C
5 mg
0817
+5C
79
C3283000 Cyproterone acetate
30 mg
1094
+5C
79
Y0001390 Cyproterone acetate for peak identification
5 mg
1094
Yes
+5C
79
Y0001223 Cyproterone impurity mixture
0.01 mg
1094
Yes
+5C
79
C3290000 Cysteine hydrochloride monohydrate
50 mg
0895
+5C
79
C3300000 Cystine
100 mg
0998
+5C
79
C3350000 Cytarabine
150 mg
0760
+5C
79
Y0000733 Dacarbazine
20 mg
1691
+5C
79
Y0000734 Dacarbazine impurity A
20 mg
89.4% CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine) ; Batch 1 is valid until 31 December 2011
1691
+5C
79
Y0000735 Dacarbazine impurity B
10 mg
87.9% CHO; 5-amino-1H-imidazole-carboxamide
1691
+5C
79
D0070000 Dalteparin sodium
250 mg
0828
+5C
79
Y0000600 Danaparoid sodium
10 mg
+5C
79
New C2970005 Crotamiton impurity A
576 000 IU per vial; For microbiological assay only

0891
147 anti-factor Xa units per ampoule, 4.3 anti-factor IIa units per ampoule
18
2090
Yes
Yes
Yes

Order
Code
D0100000 Dapsone
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
0077
+5C
Extra
Price
charges
79
a
D0125000 Daunorubicin hydrochloride
100 mg
98.5% CHClNO
0662
+5C
79
D0120000 Daunorubicinone
10 mg
Daunorubicin aglycone
0662
+5C
79
D0160000 Deferoxamine mesilate
30 mg
0896
-20C
79
D0201000 Dehydrohexetidine
50 mg
1221
+5C
79
Y0000611 Dembrexine hydrochloride monohydrate
10 mg
2169
+5C
79
D0300000 Demeclocycline hydrochloride
100 mg
D0350000 N-Demethylerythromycin A
10 mg
Y0000228 Demethylflumazenil - reference spectrum
n/a
D0406000 Deoxyminoxidil
0.25 mg
D0406200 Deptropine citrate
60 mg
D0430000 Dequalinium chloride
50 mg
D0431000 Dequalinium chloride for performance test
50 mg
Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate
1 mL
D0480000 Desacetylvinblastine
1 mg
1276
Y0000879 Desflurane - reference spectrum
n/a
1666
Y0000807 Desflurane impurity A
1 ml
D0500000 Desipramine hydrochloride
100 mg
D0600000 Deslanoside
150 mg
D0630000 Desmethylmetrifonate
30 mg
D0650000 Desmopressin
0.99 mg
Y0000509 Desogestrel
50 mg
Y0000510 Desogestrel for system suitability
10 mg
1717
D0400000 Desoxycortone acetate
100 mg
0322,0809,08
50, 1327
Y0000001 Detomidine hydrochloride
100 mg
D0660020 Detomidine impurity B
20 mg
D0700000 Dexamethasone
60 mg
D0710000 Dexamethasone acetate
100 mg
0548,0933,09
75, 2237
Y0001169 Dexamethasone acetate impurity E
0.013 mg
Y0001177 Dexamethasone for system suitability
10 mg
2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine
0176
+5C
79
0179,0274,04
90,
0552,1098
1917
+5C
79
79
0937
+5C
79
1308
+5C
79
1413
+5C
79
1413
+5C
79
-20C
79
-80C
g(d)
79
79
92.4% CHClNO
0332,0333
Dermatan sulfate 10 mg/mL

Oversulfated chondroitin sulfate 2.5 mg/mL
Yes
1666
+5C
79
0481
+5C
79
0482
+5C
79
1133
+5C
79
0712
-20C
79
99.9% CHO
1717
+5C
79
+5C
79
+5C
79
1414
+5C
79
1414
+5C
79
0312,0388,05
48,
0768,1376,22
37
+5C
79
+5C
79
+5C
79
+5C
79
1,1'-oxybis(1,2,2,2-tetrafluoroethane)
98.8% CHO
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol
9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate
Yes
0548
0388
19
Yes
Yes

Order
Reference Standard
Code
Y0000538 Dexamethasone isonicotinate

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
2237
Storage
+5C
Y0000511 Dexamethasone isonicotinate for impurity C identification
10 mg
2237
+5C
79
D0718000 Dexamethasone pivalate
50 mg
1327
+5C
79
D0720000 Dexamethasone sodium phosphate
100 mg
0549,0735,08
10
+5C
79
D0720800 Dexchlorpheniramine maleate
60 mg
1196
+5C
79
D0730000 Dexpanthenol
5 mg
0761
+5C
79
D0731000 Dextran
25 mg
0999,1000,10
01
+5C
79
D0731005 Dextran 1
50 mg
+5C
79
D0732000 Dextran Vo
10 mg
20239
+5C
79
D0733000 Dextran 4 for calibration
50 mg
M 3050-M 3850
20239
+5C
79
50 mg
M 8800 - M 10450
20239
+5C
79
50 mg
M 30500- M 40900
20239
+5C
79
50 mg
M 58900- M 70300
20239
+5C
79
50 mg
M 121800- M 238200
20239
+5C
79
D0738000 Dextran 40 for performance test
50 mg
20239
+5C
79
D0739000 Dextran 60/70 for performance test
50 mg
20239
+5C
79
Y0000744 Dextranomer
50 mg
2338
+5C
79
D0740000 Dextromethorphan hydrobromide
100 mg
0020
+5C
79
Y0000261 Dextromethorphan impurity A
5 mg
0020
+5C
79
Y0001058 Dextropropoxyphene hydrochloride - * narc
10 mg
0713
+5C
79
Y0001150 Dextropropoxyphene for system suitability - * narc
5 mg
0713
+5C
79
D0940000 Diazepam - * psy
30 mg
0022
+5C
79
Y0000596 Diazepam for system suitability - * psy
0.5 mg
0022
+5C
79
D0950000 Diazoxide
50 mg
0550
+5C
79
D0970000 Dibenzocycloheptene
20 mg
0817
+5C
79
D1000000 Dibenzosuberone
100 mg
0464,0817,09
41
+5C
79
Y0000480 Dibrompropamidine diisetionate
10 mg
2300
+5C
79
Y0000481 Dibrompropamidine for system suitability
20 mg
2300
+5C
79
D1010000 Dibutyl phthalate
1 ml
0762
+5C
79
Y0000275 Dichlorodiaminocyclohexaneplatinum
10 mg
2017
+5C
79
Y0000264 Diclazuril for veterinary use - reference spectrum
n/a
1718
79
Y0000259 Diclazuril for system suitability
20 mg
1718
+5C
79
D1039990 Diclofenac potassium

100 mg
Dexamethasone sodium phosphate CRS 4 is suitable for 01/2008:0810,

01/2008:0549 and 01/2008:0735 only. ; Batch 3 is valid until 28 February
2011
Average molecule mass : 930-1000

Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
ent-3-methoxymorphinan
20
1506
Yes
Extra
Price
charges
79
a
Yes
Yes
Yes
Yes
79
1508
+5C
g

Order
Reference Standard
Code
New D1040000 Diclofenac impurity A

Batch n
7
Quantity Sale
Information
per vial Unit
0.005 mg 1 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 5 is valid until 1
February 2011
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
1002,1281,15
08
+5C
0661,0663,06
68
+5C
79
1197
+5C
79
2200
+5C
79
D1050000 Dicloxacillin sodium
250 mg
93.0% CHClNNaOS
D1060000 Dicycloverine hydrochloride
100 mg
Y0000439 Didanosine
10 mg
Y0000440 Didanosine for system suitability
10 mg
+5C
79
Y0000441 Didanosine impurity A
10 mg
1,7-dihydro-6H-purin-6-one (hypoxanthine)
2200
+5C
79
Y0000442 Didanosine impurity G
10 mg
9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)
2200
+5C
79
D1200000 Dienestrol
150 mg
100% CHO
0483,0484
+5C
79
D1250000 Diethanolamine fusidate
50 mg
0798,0848
+5C
79
D1300000 Diethylcarbamazine citrate
250 mg
0271
+5C
79
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum
n/a
79
D1410000 Diethyl phthalate
1 ml
D1500000 Diethylstilbestrol
100 mg
D1600000 Diethylstilbestrol dimethyl ether
10 mg
D1700000 Diethylstilbestrol monomethyl ether
10 mg
Y0001423 Difloxacin hydrochloride
60 mg
Y0001429 Difloxacin impurity G
15 mg
D1750000 Diflunisal
30 mg
D1800000 Digitoxin
250 mg
Y0000640 Digoxigenin
5 mg
D1900000 Digoxin
30 mg
Y0000554 Digoxin for peak identification
10 mg
0079
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum
n/a
1310
Y0000232 Dihydralazine for system suitability
10 mg
1310
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum
n/a
Y0000053 17 alpha-dihydroequilin
10 mg
D1945000 Dihydroergocristine mesilate
250 mg
D1950000 Dihydroergotamine mesilate
100 mg
Y0000831 Dihydroergotamine for peak identification
10 mg
D1952000 Dihydroergotamine tartrate
150 mg
100.0% CHNO. Dried at 100-105C at constant weight
0600
D1954000 Dihydrostreptomycin sulfate
25 mg
0485
Y0000544 Dihydrotachysterol
30 mg
99.6% CHO ; Batch 1 is valid until 31 January 2011
2014
5 mg
Y0000482 Dihydrotachysterol for system suitability

2200
99.9% CHNO
Yes
1198
0897
+5C
79
0483,0484
+5C
79
0484
+5C
79
0484
+5C
79
2239
+5C
79
2239
+5C
79
0818,0864
+5C
79
0078,0117
+5C
79
0079
+5C
79
Dried at 100-105C for 2 h. 100% CHO
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
99.0% CHO
+5C
79
Yes
+5C
79
79
Yes
+5C
79
79
1512
-20C
79
1416,2060
+5C
79
0551
+5C
79
+5C
79
+5C
79
-20C
79
-20C
g(d)
79
98.5% CHO
0079
1776
98.2% CHO
0551
21
Yes
Yes
79
2014
Yes
-20C
g(d)

Order
Reference Standard
Code
D1980000 Diltiazem hydrochloride

Batch n
5
Quantity Sale
per vial Unit
300 mg
1
Information
Monograph
Leaflet
Storage
1004
+5C
Extra
Price
charges
79
g
Y0001141 Diltiazem for system suitability
10 mg
1004
+5C
79
D2000000 Dimenhydrinate
100 mg
0601
+5C
79
Y0000234 N,N-Dimethylacetamide - reference spectrum
n/a
1667
79
Y0001103 Dimenhydrinate for peak identification
1 mg
0601
+5C
79
D2050000 Dimethyl sulfoxide
1 ml
+5C
79
D2200000 Dimeticone
200 mg
+5C
79
D2205000 Dimetindene maleate
50 mg
1417
+5C
79
D2255000 Dinoprost trometamol
60 mg
98.2% CHNO
1312
-20C
79
D2250000 Dinoprostone
100 mg
99.8% CHO
D2250015 Dinoprostone impurity C
10 mg
(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)
Y0000094 Diosmin
50 mg
93.7% CHO
Y0000095 Diosmin for system suitability
5 mg
D2600000 Diphenhydramine hydrochloride
100 mg
Y0000135 Diphenhydramine impurity A
10 mg
D2630000 Diphenoxylate hydrochloride - reference spectrum
Replaces Diltiazem impurity A CRS
Yes
0763
0138,1470
99.9% dimeticone ; Batch 3 is valid until 31 October 2011
Yes
1311
-20C
79
1311,1488
-20C
240
1611
+5C
79
1611
+5C
79
0023,0601,11
90
+5C
79
0023,0601
+5C
79
79
+5C
79
2-(diphenylmethoxy)-N-methylethanamine
n/a
0819
New Y0001415 Diphenoxylate hydrochloride - * narc
15 mg
0819
New Y0001430 Diphenoxylate for system suitability - * narc
10 mg
+5C
Y0000258 Diphtheria toxin BRP - * Biotox
1 ml
Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml)

Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge
test in guinea pigs)
Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig
intradermal skin test)
Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below
cause cytotoxic effects.
See leaflet,
0443
Yes
+5C
g(b)
90
D2700000 Diphtheria vaccine (adsorbed) BRP
32 mg
97 IU per vial
See leaflet,
20706
Yes
-20C
90
Y0000376 Dipivefrine hydrochloride
100 mg
1719
+5C
79
Y0000394 Dipivefrine for system suitability
10 mg
1719
+5C
79
D2750100 Dipotassium clorazepate - reference spectrum
n/a
0898
79
D2800000 Diprophylline
100 mg
0486
+5C
79
D2850000 Dipyridamole
50 mg
1199
+5C
79
Y0000802 Dipyridamole for peak identification
2 mg
1199
+5C
79
D2880000 Dirithromycin
100 mg
1313
+5C
79
D2900000 Disodium edetate
100 mg
0232
+5C
79
D2920000 Disopyramide
100 mg
1006
+5C
79
D2922000 Disopyramide phosphate
100 mg
1005
+5C
79
0819
97.4% CHNO
22
Yes

Order
Code
D2950000 Disulfiram
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
0603
+5C
Extra
Price
charges
79
g
D2953000 Dithranol
50 mg
1007
+5C
79
D2953025 Dithranol impurity C
20 mg
Dithranol-dimer
4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione
1007
+5C
79
D2953050 Dithranol impurity D
20 mg
94.9% CHO; 1-hydroxyanthracen-9(10H)-one
1007
+5C
79
D2954000 Dobutamine hydrochloride
100 mg
1200
+5C
79
Y0001239 Dobutamine impurity mixture
0.1 mg
1200
+5C
79
Y0001133 Docetaxel trihydrate
160 mg
+5C
79
Y0001155 Docetaxel for system suitability
10 mg
+5C
79
D2954600 Docosahexaenoic acid ethyl ester
150 mg
+5C
79
D2954500 Docusate sodium - reference spectrum
n/a
79
Y0000365 Dodecyl gallate
30 mg
D2955000 Domperidone
150 mg
D2957000 Domperidone maleate
150 mg
D2960000 Dopamine hydrochloride
50 mg
Y0000612 Dopexamine dihydrochloride
10 mg
Y0000613 Dopexamine impurity B
10 mg
2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol
Y0000614 Dopexamine impurity F
10 mg
4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol
Y0000726 Dorzolamide hydrochloride
50 mg
Y0000727 Dorzolamide impurity A
5 mg
Y0000750 Dorzolamide for system suitability
5 mg
2359
D2962000 Dosulepin hydrochloride
100 mg
1314
D2962005 Dosulepin impurity A
50 mg
1314
Y0001385 Angelica pubescent root
500 mg
2557
D2963000 Doxapram hydrochloride
50 mg
1201
Y0000208 Doxapram impurity B
10 mg
(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one
Y0000553 Doxazosin mesilate
60 mg
99.2% CHNOS
Y0000551 Doxazosin impurity D
10 mg
Y0000552 Doxazosin impurity F
10 mg
Y0000838 Doxepin hydrochloride
5 mg
1096
Y0000851 Doxepin for system suitability
1 mg
1096
Yes
New D2975000 Doxorubicin hydrochloride
150 mg
99.4% CHClNO ; Batch 5 is valid until 31 May 2012
0714,0662,15
90
D3000000 Doxycycline hyclate
50 mg
92.9% CHClNO corresponding to 85.9% CHNO
0272,0820
Y0000163 Doxylamine hydrogen succinate - reference spectrum
n/a
Yes
2449
93.6% CHNO
2449
Yes
2063,20429
98.4% DHA ethyl ester
1418
2078
+5C
79
1009
+5C
79
1008
+5C
79
0664,1200
+5C
79
1748
+5C
79
1748
-20C
79
1748
-20C
79
2359
+5C
79
2359
+5C
79
+5C
79
+5C
79
+5C
79
-20C
79
+5C
79
1201
+5C
79
2125
+5C
79
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
2125
+5C
79
2-chloro-6,7-dimethoxyquinazolin-4-amine
2125
+5C
79
+5C
79
+5C
79
Yes
-20C
g(c)
79
Yes
+5C
79
79
(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide
(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide
1589
23
Yes
Yes

Order
Reference Standard
Code
New Y0000160 Doxylamine impurity A

Batch n
2
Quantity Sale
Information
per vial Unit
10 mg
1 N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine ; Batch 1
is valid until 30 April 2012
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1589
+5C
1008,1009,10
10, 1172
+5C
79
D3100000 Droperidol
150 mg
Y0001105 Drospirenone
60 mg
99.9% CHO
2404
+5C
79
Y0001115 Drospirenone impurity E
0.06 mg
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)
2404
+5C
79
New Y0001455 Duloxetine impurity A
10 mg
(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
2594
+5C
79
Y0001004 Dydrogesterone
50 mg
99.5% CHO
2357
+5C
79
Y0001005 Dydrogesterone impurity A
6 mg
9,10-pregna-4,6,8(14)-triene-3,20-dione
2357
+5C
79
Y0001006 Dydrogesterone impurity B
5 mg
pregna-4,6-diene-3,20-dione
2357
+5C
79
Y0000249 Ebastine - reference spectrum
n/a
79
Y0000247 Ebastine impurity C
10 mg
4-(diphenylmethoxy)piperidine
2015
+5C
79
Y0000248 Ebastine impurity D
10 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one
2015
+5C
79
Y0001236 Econazole
10 mg
2049
+5C
79
E0050000 Econazole nitrate
100 mg
0513,0665,09
21, 0935,
1017,1018
+5C
79
Y0000254 Econazole for system suitability
20 mg
0665,2049
Yes
+5C
79
E0085000 Eicosapentaenoic acid ethyl ester
200 mg
2063,20429
Yes
Y0000537 Emedastine difumarate
10 mg
Y0000512 Emedastine impurity E
10 mg
E0100000 Emetine hydrochloride
100 mg
E0110000 Enalapril for system suitability
20 mg
1420
Y0001211 Enalapril impurity mixture
0.06 mg
1420
E0109000 Enalapril maleate
50 mg
1420
Y0000615 Enalaprilat dihydrate
100 mg
1749
Y0000629 Enalaprilat for system suitability
10 mg
1749
Y0000678 Enalaprilat impurity G
0.005 mg
Y0000136 Enilconazole
60 mg
Y0000137 Enilconazole impurity E
20 mg
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol
E0150000 Endotoxin standard BRP
11 mg
10000 IU per vial
E0180000 Enoxaparin sodium
200 mg
E0180500 Enoxolone
100 mg
Y0001259 Enrofloxacin
5 mg
2015
93.6% EPA ethyl ester CHO

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.
(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
+5C
79
2242
+5C
79
2242
+5C
79
0080,0081,00
93,
0094,1530,18
75
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1749
+5C
79
1720
+5C
79
1720
+5C
79
Yes
-20C
79
0828,1097
+5C
79
1511
+5C
79
2229
+5C
79
24
20614
Yes
Yes

Order
Reference Standard
Code
Y0001160 Enrofloxacin for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
2229
Yes
+5C
Yes
Extra
Price
charges
79
g
Y0001249 Entacapone
160 mg
99.9% CHNO
2574
+5C
79
Y0001250 Entacapone impurity A
10 mg
Z isomer of entacapone
2574
+5C
79
E0200000 Enterokinase BRP
500 mg
0350
+5C
79
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor
50 mg
0715
+5C
79
E0300000 Ephedrine hydrochloride - * Drug Precursor
150 mg
99.8% CHClNO
Yes
+5C
79
E0400000 4-Epianhydrotetracycline hydrochloride
20 mg
87.1% CHNO.HCl ; Batch 5 is valid until 29 February 2012
Yes
+5C
79
E0430000 4-Epichlortetracycline hydrochloride
20 mg
94,8% CHClNO
0173
+5C
79
E0440000 4-Epidemeclocycline hydrochloride
20 mg
0176
+5C
79
E0500000 6-Epidoxycycline hydrochloride
50 mg
0272,0820
+5C
79
Y0001139 Epinastine hydrochloride
20 mg
2411
+5C
79
Y0001128 Epinastine hydrochloride for system suitability
10 mg
E0530000 4-Epioxytetracycline
40 mg
81.1% CHNO
E0550000 Epirubicin hydrochloride
100 mg
96.4% CHClNO
E0600000 4-Epitetracycline hydrochloride
30 mg
Y0000052 Equilin
15 mg
Y0001325 Equisetum palustre
200 mg
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE

Strain A/eq/Newmarket/77
See leaflet,
0249
E0850021 Eq Influenza Subtype 2 American-like/Newmarket Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/1/93
E0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/2/93
Y0000712 Eq Influenza Subtype 2 American-like/South Africa Horse

Antiserum BRP
1 mg
E0900000 Ergocalciferol
500 mg
E1000000 Ergometrine maleate - * Drug Precursor
50 mg
20 mg
E1200000 Ergotamine tartrate - * Drug Precursor
100 mg
Y0000051 Erysipelas ELISA coating antigen BRP
0.4 mg
Y0000177 Erythritol
1
4
New E1100000 Ergosterol
E1300000 Erythromycin for microbiological assay

0487,0488,04
89,
1367,2451
0210,0211,16
54
2411
99.7% CHO
100.0% CHO ; Vitamin D2
+5C
79
0198,0199
Yes
+5C
79
0662,0714,15
90
-20C
79
0210,0211,16
54
+5C
79
1512
-20C
79
1825
+5C
79
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
-20C
g(c)
79
0082,0574,05
75,
0598,1192,11
93
0223
+5C
79
0082
-20C
g(c)
79
0.5ml Freeze dried (0.367g protein)
See leaflet,
0064
1000 mg
99.8% CHO
250 mg
960 IU per mg
25
0224
1803
Yes
+5C
79
-20C
90
+5C
79
79
20702
-20C
a

Order
Code
E1305000 Erythromycin A
Reference Standard

Batch n
3
Quantity Sale
per vial Unit
250 mg
1 97.0% CHNO
Information
Monograph
Leaflet
Storage
0179,0274,02
93,
0490,0552,10
98
Yes
-20C
E1310000 Erythromycin B
50 mg
98.4% CHNO
-20C
79
E1320000 Erythromycin C
50 mg
97.6% CHNO
-20C
79
E1400000 Erythromycin estolate
100 mg
+5C
79
E1500000 Erythromycin ethylsuccinate
10 mg
E1500800 Erythromycin stearate
50 mg
0274
+5C
79
0490
+5C
79
E1515000 Erythropoietin BRP
37.5 mg
Y0000324 Esketamine hydrochloride - reference spectrum
n/a
-20C
150
79
Y0000338 Esketamine impurity D
10 mg
1742
Y0001028 Esomeprazole magnesium trihydrate
10 mg
2372
+5C
79
+5C
79
Y0000749 Essential oil
1000 mg
2098
E1600000 Estradiol benzoate
250 mg
0139
+5C
79
+5C
79
Y0000852 Estradiol benzoate for system suitability
10 mg
0139
Y0000045 Estradiol butyrate
10 mg
1614
+5C
79
+5C
79
E1620000 Estradiol hemihydrate
100 mg
Y0000314 Estradiol for peak identification
10 mg
0821
+5C
79
+5C
79
Y0000046 Estradiol valerate
50 mg
E1680000 Estriol
50 mg
1614
+5C
79
1203
+5C
79
E1680005 Estriol impurity A
20 mg
9,11-didehydroestriol
1203
15 mg
1512
+5C
79
+5C
79
E1800000 Etacrynic acid
100 mg
0457
Y0001263 Etacrynic acid for system suitability
10 mg
0457
+5C
79
+5C
79
E1830000 Etamsylate
30 mg
E1840000 Ethacridine lactate monohydrate
50 mg
1204
+5C
79
1591
+5C
79
E1850000 Ethambutol hydrochloride
250 mg
Y0000803 Ethambutol for system suitability
10 mg
0553
+5C
79
0553
+5C
79
A1202800 Ethanol (anhydrous) - reference spectrum
E1860100 Ethanol 96% - reference spectrum
n/a
1318
79
n/a
1317
79
200 mg
Y0001124 Ethinylestradiol for system suitability
25.31 mg
E2000000 Ethionamide
100 mg
E2150000 Ethosuximide
30 mg
New E1700000 Estrone
New E1900000 Ethinylestradiol
0179,0274,04
90,
0552,1098
0179,0274,04
Extra
Price
charges
79
g
90,
0552,1098
0552
1316
35280 IU per vial
Yes
Yes
1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)
Yes
Yes
0821,1203
Yes
Yes
Yes
0140,0821,09
40
Yes
+5C
79
0140
Yes
+5C
79
0141
+5C
79
0764
+5C
79
26

Order
Reference Standard
Code
E2250000 Ethosuximide impurity A

Batch n
4
Quantity Sale
Information
Monograph
per vial Unit
30 mg
1 (2RS)-2-ethyl-2-methylbutanedioic acid ; Batch 3 is valid until 1 February 2012
0764
Leaflet
Storage
+5C
Extra
Price
charges
79
a
E2195000 Ethyl acetate - reference spectrum
n/a
0899
79
E2195900 Ethylcellulose - reference spectrum
n/a
0822
79
E2202000 1-N-Ethylgaramine sulfate
50 mg
+5C
79
E2205500 1,1'-Ethylidenebistryptophan
+5C
79
Y0000617 Ethyl indole-3-carboxylate
10 mg
2102
+5C
79
E2300000 Ethylmorphine hydrochloride - reference spectrum
n/a
0491
79
E2400000 Ethylnicotinamide
150 mg
E2425000 Ethyl parahydroxybenzoate
150 mg
E2450000 Etifenin
25 mg
E2451000 Etilefrine hydrochloride
75 mg
E2451010 Etilefrine impurity A
20 mg
Y0000572 Etidronate disodium
10 mg
E2470000 Etodolac
60 mg
E2470050 Etodolac impurity H
10 mg
Y0000768 Etodolac for peak identification
10 mg
E2499900 Etofenamate
40 mg
E2499901 Etofenamate for peak identification
15 mg
Batch 1 is valid until 31 December 2011
1513
E2499914 Etofenamate impurity G
20 mg
2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate
E2500000 Etofylline
100 mg
E2503000 Etomidate
50 mg
E2503004 Etomidate impurity B
25 mg
E2600000 Etoposide
150 mg
Y0001365 Etoposidefor for system suitability
10 mg
E5000000 Eugenol
500 l
F0005000 Famotidine
100 mg
Y0000382 Famotidine for system suitability
10 mg
Y0000409 Famotidine impurity D
10 mg
3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide
1012
Y0000556 Febantel
110 mg
99.9% CHNOS
Y0000660 Febantel for system suitability
10 mg
Y0000731 Felbinac
10 mg
Y0000732 Felbinac impurity A
20 mg
4-acetyl biphenyl
F0030000 Felodipine
120 mg
1013
Y0000415 Felypressin
0.994 mg
0.00167 mg 2
1351
84.4% of 1-N-Ethylgaramin sulphate

0.00167 mg per vial of CHNO ; Batch 3 is valid until 28 February 2011
1272,1383
Yes
0233
+5C
79
0409,0431,09
00,
1262,1263,21
34
+5C
79
0585
+5C
79
1205
+5C
79
1205
+5C
79
1778
+5C
79
1422
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1513
+5C
79
0492
+5C
79
1514
+5C
79
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate
1514
+5C
79
98.4% CHO
0823
+5C
79
+5C
79
1100
+5C
79
1012
+5C
79
+5C
79
+5C
79
2176
+5C
79
2176
+5C
79
2304
+5C
79
2304
+5C
79
+5C
79
-20C
79
100.0% CHO; batch 2 valid until 31/12/10 excepted for use with
monograph 0900.
2-ethylamino-1-(3-hydroxyphenyl)ethanone
1422
2-(7-ethylindol-3-yl)ethanol
1422
Yes
1513
0823
1012
1634
27
Yes
Yes
Yes
Yes

Order
Code
F0040000 Fenbendazole
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
150 mg
1
Information
Monograph
Leaflet
Storage
1208,1458
+5C
Extra
Price
charges
79
g
F0040010 Fenbendazole impurity A
20 mg
methyl(1-benzimidazol-2-yl)carbamate
1208
+5C
79
F0040020 Fenbendazole impurity B
20 mg
methyl[5(6)-chlorobenzimidazol-2-yl]carbamate
1208
+5C
79
F0041000 Fenbufen
100 mg
1209
+5C
79
F0048000 Fenofibrate
100 mg
100.0% CHClO
1322
+5C
79
F0048005 Fenofibrate impurity A
20 mg
(4-chlorophenyl)(4-hydroxyphenyl)methanone
1322
+5C
79
F0048010 Fenofibrate impurity B
10 mg
2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)
1322
+5C
79
F0048035 Fenofibrate impurity G
25 mg
1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate
1322
+5C
79
Y0000756 Fenoterol for peak identification
1.2 mg
0901
+5C
79
F0050000 Fenoterol hydrobromide
100 mg
0901
+5C
79
F0054990 Fentanyl - reference spectrum
n/a
1210
79
F0055000 Fentanyl citrate - reference spectrum
n/a
1103
79
F0060000 Fenticonazole nitrate
50 mg
F0060040 Fenticonazole impurity D
20 mg
F0100000 Ferrous gluconate
100 mg
Y0001013 Ferulic acid
20 mg
Y0000789 Fexofenadine hydrochloride
60 mg
Y0000751 Fexofenadine impurity A
5 mg
Y0000752 Fexofenadine impurity B
Y0000753 Fexofenadine impurity C
Y0001173 Filgrastim
Y0000090 Finasteride
contains 1.3% of impurity A
1211
+5C
79
1211
+5C
79
0493
+5C
79
99.8% CHO
1834
+5C
79
99.8% CHClNO
2280
+5C
79
2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid
2280
+5C
79
0.01 mg
2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid
2280
+5C
79
5 mg
(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol
2280
+5C
79
0.2 ml
1.95 mg per ml of CHNOS
2206
-80C
79
60 mg
99.7% CHNO
1615
+5C
79
Y0000091 Finasteride for system suitability
100 mg
Contains 0.7% of impurity A
1615
+5C
79
Y0000736 Flavoxate hydrochloride
10 mg
1692
+5C
79
Y0000737 Flavoxate impurity A
10 mg
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid
1692
+5C
79
Y0000738 Flavoxate impurity B
10 mg
ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
1692
+5C
79
F0120000 Flecainide acetate
200 mg
1324
+5C
79
F0120005 Flecainide impurity A
50 mg
3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine
1324
+5C
79
F0120010 Flecainide impurity B
25 mg
(RS)-(piperidin-2-yl)methanamine
1324
+5C
79
Y0001274 Flecainide for system suitability
10 mg
1324
+5C
79
Y0000138 Flubendazole
25 mg
1721
+5C
79
Y0000139 Flubendazole for system suitability
20 mg
1721
+5C
79
()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate
28
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000892 Flucloxacillin magnesium octahydrate

Batch n
1
Quantity Sale
per vial Unit
5 mg
1
Information
Monograph
Leaflet
Storage
2346
+5C
Extra
Price
charges
79
a
Y0000889 Flucloxacillin impurity C
5 mg
6-aminopenicillanic acid
2346
+5C
79
Y0000890 Flucloxacillin impurity D
5 mg
3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
2346
+5C
79
Y0000891 Flucloxacillin impurity E
5 mg
6-aminopenicillanic acid flucloxacillin amide
250 mg
95.1% CHClFNNaOS ; Batch 6 is valid until 31 May 2012
Y0000557 Fluconazole
50 mg
Y0000558 Fluconazole for peak identification
10 mg
Y0000573 Fluconazole impurity B
10 mg
93.2% CHNOF ; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis

(1H-1,2,4 -triazol-1-yl)propan-2-ol
2287
Y0000574 Fluconazole impurity C
5 mg
1,1'-(1,3-phenylene)di-1H-1,2,4-triazole
F0175000 Flucytosine
100 mg
Y0001262 Flucytosine for system suitability
10 mg
Y0000419 Fludarabine phosphate
100 mg
F0180000 Fludrocortisone acetate
100 mg
F0188000 Flumazenil - reference spectrum
n/a
Y0000335 Flumazenil impurity B
5 mg
F0189000 Flumequine
60 mg
F0189020 Flumequine impurity B
0.1 mg
F0188500 Flumetasone pivalate
100 mg
F0189900 Flunarizine dihydrochloride
100 mg
Y0000265 Flunarizine dihydrochloride - reference spectrum
Y0000266 Flunarizine dihydrochloride for system suitability
F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine

Y0000444 Flunixin impurity B
Y0000445 Flunixin impurity C
F0200000 Fluocinolone acetonide
2346
Yes
+5C
79
0661,0663,06
68,2346
Yes
-20C
79
+5C
79
+5C
79
+5C
79
2287
+5C
79
0766
+5C
79
0766
+5C
79
1781
+5C
79
0767
+5C
79
79
1326
+5C
79
1517
+5C
79
1517
+5C
79
1327
+5C
79
0816
+5C
79
n/a
1722
79
20 mg
1722
+5C
79
100 mg
1280
+5C
79
n/a
0717
79
10 mg
1696
+5C
79
10 mg
2-methyl-3-(trifluoromethyl)aniline
1696
+5C
79
50 mg
ethyl 2-chloropyridine-3-carboxylate
1696
+5C
79
100 mg
0494
+5C
79
F0230000 Fluocortolone pivalate
100 mg
1212
+5C
79
Y0000796 Fluorescein
120 mg
99.2% CHO
2348
+5C
79
Y0000804 Fluorescein impurity C
0.01 mg
2-(2,4-dihydroxybenzoyl)benzoic acid
2348
+5C
79
Y0000454 Diacetylfluorescein
100 mg
99.6% CHO
1213
+5C
79
F0245000 Fluoresceine sodium - reference spectrum
n/a
79
F0250000 Fluorouracil
40 mg
+5C
79
New F0150000 Flucloxacillin sodium
2287
2287
97.6% CHFNOP
Yes
1326
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate
Yes
1213
29
0611,0766

Order
Reference Standard
Code
Y0000762 Fluorouracil impurity A

Batch n
1
Y0000763 Fluorouracil impurity B
Y0000764 Fluorouracil impurity C
Y0000765 Fluorouracil impurity F

Y0000791 Fluorouracil impurity mixture
Quantity Sale
Information
per vial Unit
10 mg
1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
10 mg
1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)
Monograph
Leaflet
Storage
0611
+5C
Extra
Price
charges
79
a
0611
+5C
79
10 mg
pyrimidine-2,4(1H,3H)-dione (uracil)
0611
+5C
79
10 mg
2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)
0611
+5C
79
0.0002 mg
+5C
79
F0253000 Fluoxetine hydrochloride
250 mg
99.9% CHClFNO
1104
+5C
79
F0253020 Fluoxetine impurity B
10 mg
methyl(3-phenylpropyl)amine ; Batch 4 is valid until 31 December 2011
1104
+5C
79
New F0253030 Fluoxetine impurity C
5 mg
()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine ; Batch 3

is valid until 30 April 2012
1104
+5C
79
Y0000064 Flupentixol dihydrochloride
100 mg
43.6% of Z-isomer CHClFNOS
1693
+5C
79
Y0000067 Flupentixol impurity D
15 mg
2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol
1693
+5C
79
Y0000078 Flupentixol impurity F
25 mg
80.9% CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
1693
+5C
79
F0260000 Fluphenazine decanoate
60 mg
1014,1015
+5C
g(b)
79
Y0000009 Fluphenazine enantate
100 mg
1014,1015
+5C
79
F0280000 Fluphenazine dihydrochloride
50 mg
0904,1014
+5C
79
Y0000708 Fluphenazine impurity mixture
0.07 mg
Y0000298 Fluphenazine octanoate
20 mg
Y0000299 Fluphenazine sulfoxide
10 mg
Y0000211 Flurazepam monohydrochloride - reference spectrum
F0285200 Flurbiprofen
F0285202 Flurbiprofen impurity A
20 mg
Y0000236 Fluspirilene
20 mg
Y0000375 Fluspirilene impurity C
10 mg
F0285600 Flutamide
50 mg
F0285603 Flutamide impurity C
20 mg
N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
Y0000284 Fluticasone propionate
100 mg
Y0000221 Fluticasone impurity D
20 mg
F0290000 Flutrimazole
100 mg
F0290010 Flutrimazole impurity B
60 mg
Y0001090 Fluvastatin sodium
110 mg
2333
Y0001082 Fluvastatin for system suitability
0.5 mg
2333
Y0000854 Fluvoxamine maleate
5 mg
1977
0611
0904
Yes
+5C
79
1014,1015
+5C
79
0904,1014,10
15
+5C
79
n/a
0905
79
50 mg
1519
+5C
79
1519
+5C
79
1723
+5C
79
1723
+5C
79
1423
+5C
79
1423
+5C
79
99.6% CHFOS
1750
+5C
79
S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative) ; Batch 1 is valid until 31 December 2011
1750
+5C
79
1424
+5C
79
1424
+5C
79
+5C
79
+5C
79
+5C
79
(2RS)-2-(biphenyl-4-yl)propanoic acid
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol
30
Yes
Yes

Order
Reference Standard
Code
Y0000853 Fluvoxamine for system suitability

Batch n
1
Quantity Sale
per vial Unit
1.004 mg 1
Information
Monograph
Leaflet
Storage
1977
Yes
+5C
Extra
Price
charges
79
g
Y0000916 Fluvoxamine impurity D
10 mg
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
1977
+5C
79
Y0000386 Foeniculin for peak identification
100 mg
Anise oil
0804
Yes
+5C
79
F0300000 Folic acid
150 mg
91.3 % CHNO ; Batch 7 is valid until 30 September 2011
0067
Yes
+5C
79
Y0001242 Folic acid impurity A
15 mg
(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)
0067
+5C
79
Y0001243 Folic acid impurity D
70 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid) ; Batch 1 is valid until 31 October 2011
0067
+5C
79
F0372000 Formoterol fumarate dihydrate
10 mg
1293,1724
+5C
79
Y0000339 Formoterol for impurity I identification
10 mg
1724
+5C
79
Y0000340 Formoterol fumarate for system suitability
10 mg
1724
Yes
+5C
79
F0380000 Formylfolic acid
30 mg
0978,1606
Yes
F0389000 Foscarnet sodium hexahydrate
50 mg
F0389004 Foscarnet impurity B
10 mg
Y0001222 Foscarnet impurity D
50 mg
Y0001213 Foscarnet impurity mixture
0.012 mg
1520
Y0000782 Fosfomycin calcium
10 mg
1328
F0399950 Fosfomycin sodium - reference spectrum
n/a
F0400000 Fosfomycin trometamol
1500 mg
Y0001227 Fosinopril sodium
60 mg
Y0001228 Fosinopril impurity A
5 mg
(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid
Y0001229 Fosinopril impurity B
5 mg
Y0001230 Fosinopril impurity C
10 mg
Y0001231 Fosinopril impurity D
Y0001232 Fosinopril impurity I
Yes
-20C
79
1520
+5C
79
1520
+5C
79
1520
+5C
79
+5C
79
+5C
79
79
+5C
79
1751
+5C
79
1751
+5C
79
(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
10 mg
(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
5 mg
[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid
1751
+5C
79
Y0001233 Fosinopril impurity K
5 mg
(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid
1751
+5C
79
Y0001212 Fosinopril impurity mixture
0.02 mg
25 mg
New F0450000 Framycetin sulfate
91.4% CHNO; 10-Formylfolic acid ; Batch 2 is valid until 31 August 2011

disodium (ethoxyoxydophosphanyl)formate
Yes
1329
1425
99.7% CHNOP ; Batch 1 is valid until 31 March 2011
17640 IU per vial CHNO,xHSO ; Batch 4 is valid until 30 April 2012
31
Yes
1751
Yes
+5C
79
0180,0197,20
702
Yes
-20C
79

Order
Code
F0550000 Fructose
Reference Standard

Batch n
1
New Y0001399 Fulvestrant
New Y0001413 Fulvestrant for system suitability
Quantity Sale
per vial Unit
100 mg
1
120 mg
Information
Monograph
98.8% CHFOS
Leaflet
Storage
+5C
Extra
Price
charges
79
a
0177,0178,01
87,
0188,0204,02
09,
1061,1570
2443
Yes
+5C
79
Yes
40 mg
2443
+5C
79
F0600000 Fumaric acid
100 mg
0365,0902,11
90, 1592
+5C
79
F0700000 Furosemide
100 mg
0391,2185
+5C
79
F0702000 Furosemide impurity A
5 mg
0391
+5C
79
-20C
79
79
New Y0001411 Fusidic acid
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid ; Batch 3 is valid until

30 June 2011
10 mg
0798
F1000000 Fusidic acid - reference spectrum
n/a
0798,0848
New Y0001394 Fusidic acid for peak identification
5 mg
0798,0848
Yes
-20C
79
Y0001280 Gabapentin
300 mg
99.9% CHNO
2173
Yes
+5C
79
Y0001281 Gabapentin impurity A
20
2-azaspiro[4.5]decan-3-one
2173
+5C
79
Y0001348 Gabapentin impurity B
20 mg
(1-cyanocyclohexyl)acetic acid
2173
-20C
79
Y0001349 Gabapentin impurity D
10 mg
[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid
2173
+5C
79
G0049000 Galactitol
50 mg
1381
+5C
79
G0050000 Galactose
60 mg
1215
+5C
79
Y0001279 Galantamine hydrobromide
10 mg
2366
+5C
79
Y0001190 Galantamine natural for system suitability
10 mg
2366
+5C
79
Y0001201 Galantamine racemic mixture
10 mg
2366
+5C
79
Y0001191 Galantamine synthetic for system suitability
5 mg
2366
+5C
79
G0100000 Gallamine triethiodide
100 mg
0181
+5C
79
G0150000 Gammacyclodextrin
50 mg
1070,1487
+5C
79
Y0001129 Ganciclovir
220 mg
1752
+5C
79
Y0001144 Ganciclovir impurity mixture
0.005 mg
+5C
79
Y0000675 Gemcitabine hydrochloride
50 mg
99.9% CHClFNO
2306
+5C
79
Y0000676 Gemcitabine impurity A
20 mg
4-aminopyrimidin-2(1H)-one (cytosine)
2306
+5C
79
Y0000513 Gemfibrozil
5 mg
1694
+5C
79
Y0000514 Gemfibrozil for system suitability
0.196 mg
G0200000 Gentamicin sulfate
25 mg
16500 IU per vial ; Batch 6 is valid until 31 October 2011
Y0001112 Gestodene
100 mg
99.4% CHO
Y0001363 Gentamicin for peak identification
10 mg
Y0001110 Gestodene for system suitability
10 mg
Y0001116 Gestodene impurity I
0.01 mg
1752
Yes
Yes
1694
Yes
+5C
79
0331,20702
Yes
-20C
79
+5C
79
0331
Yes
-20C
79
1726
Yes
+5C
79
+5C
79
1726
13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20yn-3-one
32
Yes
1726

Order
Reference Standard
Code
Y0001012 Ginkgo dry extract for peak identification
New Y0001010 Ginkgolic Acids

Batch n
1
Quantity Sale
per vial Unit
150 mg
1
Information
Monograph
Leaflet
Storage
1827
Yes
-20C
1827
Yes
Extra
Price
charges
79
c
20 mg
-20C
79
G0300000 Gitoxin
30 mg
0078,0079,21
68
+5C
79
G0325000 Glibenclamide
100 mg
0718
+5C
79
G0325010 Glibenclamide impurity A
10 mg
4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide
0718
+5C
79
Y0000242 Glibenclamide impurity B
20 mg
methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]
sulphonyl]carbamate ; Batch 1 is valid until 31 December 2011
0718
+5C
79
G0326000 Gliclazide
20 mg
0718,1524
+5C
79
G0326004 Gliclazide impurity B
25 mg
2-nitroso-octahydrocyclopenta[c]pyrrole
1524
+5C
79
G0326012 Gliclazide impurity F
50 mg
1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea ; Batch 3 is valid until 31 March 2012
1524
+5C
79
Y0000515 Glimepiride
60 mg
99.4% CHNOS
2223
+5C
79
Y0000516 Glimepiride for system suitability
0.012 mg
2223
+5C
79
G0340000 Glipizide
50 mg
0906
+5C
79
G0342000 Glipizide impurity A
10 mg
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide
0906
+5C
79
Y0000523 Glipizide impurity C
10 mg
ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate
0906
+5C
79
Y0000643 Glipizide impurity D
10 mg
6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
0906
Y0001140 Glipizide impurity mixture
0.002 mg
Y0001406 Glucosamine hydrochloride
10 mg
2.94 mg
Y0001381 Glucosamine for system suitability
40 mg
Y0001407 Glucosamine sulfate sodium chloride
15 mg
100 mg
G0355000 Glutamic acid
50 mg
Y0000517 Glutathione
G0360000 Glutethimide - * psy

G0400000 Glycerol (85 per cent) - reference spectrum
New Y0000191 Human glucagon
0.37% of ginkgolic acid C17 ; Batch 1 is valid until 31 May 2012
Yes
Yes
+5C
79
Yes
+5C
79
+5C
79
Yes
-20C
79
2446,2447
+5C
79
0906
2446
2.94 mg pure human glucagon per vial CHNOS ; Batch 1 is valid until
30 April 2012
1635
2447
+5C
79
0177,0178,01
87,
0188,0204,02
09,
1061,1215,15
70
+5C
79
0750,0797,14
45, 2076
+5C
79
10 mg
1670
+5C
79
50 mg
1291
+5C
79
n/a
0496,0497
79
G0400002 Glycerol dibehenate
2000 mg
1427
+5C
79
G0400004 Glycerol distearate
2000 mg
1428
+5C
79
Y0001391 Glycerol formal
20 mg
1671
+5C
79
Y0000794 Glycerol monocaprylate
400 mg
2213
+5C
79
New G0350500 Glucose
33
Yes

Order
Reference Standard
Code
Y0000795 Glycerol monocaprylocaprate

Batch n
1
Quantity Sale
Information
per vial Unit
500 mg
1 In the chromatogram supplied within the leaflet (Rev 02) of the current CRS
batch 1, some peaks have been mislabelled, the correct version of the leaflet
(Rev 03) is now available on the website. The quality of the product itself is
not questioned and can still to be used.
Monograph
Leaflet
Storage
2392
Yes
+5C
G0400006 Glycerol monolinoleate
2000 mg
1429
+5C
79
G0400007 Glycerol mono-oleate
2000 mg
1430
+5C
79
G0400008 Glycerol monostearate 40-55
2000 mg
0495
+5C
79
G0400101 Glyceryl trinitrate - reference spectrum
n/a
79
G0400100 Glyceryl trinitrate solution
0.5 ml
1331,1355
+5C
79
G0450000 Glycine
50 mg
0614,0752
+5C
79
Y0001308 Glycopyrronium bromide
10 mg
1783
+5C
79
Y0001309 Glycopyrronium for peak identification
10 mg
Y0001358 Glycopyrronium impurity N
10 mg
Y0000433 Ammonium glycyrrhizate
70 mg
G0460000 Glycyrrhizate (monoammonium)
300 mg
78.6% CHNO
G0525000 Gonadorelin
5 mg
Y0000125 Goserelin
2 mg
Y0000126 Gosereline - reference spectrum
n/a
1636
Y0000019 4-D-Ser-goserelin
0.1 mg
1636
Y0000194 Goserelin validation mixture
1 mg
Supplied with the Ph. Eur. reference chromatogram
G0550000 Gramicidin
250 mg
1081 IU per mg
Y0000396 Granisetron hydrochloride
120 mg
99.8% CHClNO
Y0000477 Granisetron impurity A
1 mg
Y0000478 Granisetron impurity B
1 mg
Y0000395 Granisetron impurity E
G0600000 Griseofulvin
Y0000619 Guaiacol
1331
1% m/m in ethanol CHNO
94.0% CHNO+; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)

oxy]-1,1-dimethylpyrrolidinium
Extra
Price
charges
79
g
1783
Yes
+5C
79
1783
Yes
+5C
79
+5C
79
1772
0277,1536,
2378
Yes
+5C
79
4.96 mg per vial of CHNO ; Batch 4 is valid until 31 March 2012
0827
Yes
-20C
79
1.87 mg per vial of CHNO
1636
-20C
79
79
-20C
79
1636
Yes
-20C
79
0907,1662,20
702
Yes
+5C
79
1695
+5C
79
2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide ; Batch 1 is valid until 31 January 2011
1695
+5C
79
N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide ; Batch 1 is valid until 31 March 2011
1695
+5C
79
15 mg
(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine ; Batch 2 is valid until

31 July 2011
1695
+5C
79
50 mg
0182
+5C
79
2200 mg
1978
+5C
79
G0700000 Guaifenesin
100 mg
Y0000117 Halofantrine hydrochloride
125 mg
99.6% CHClFNO
Y0000118 Halofantrine impurity C
10 mg
[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
H0100000 Haloperidol
50 mg
H0100100 Haloperidol decanoate
60 mg
1397,1431
99.5% CHO
0615
34
Yes
+5C
79
1979
Yes
+5C
79
1979
+5C
79
0616,0995,11
78, 1503
+5C
79
+5C
79

Order
Reference Standard
Code
H0150000 Halothane - reference spectrum
Quantity Sale
per vial Unit
n/a
1
1.03 mg
1.01mg per vial CHO
1 mg
Anti-IIa activity : 31 IU per vial; Anti-Xa activity : 104 IU per vial ; Batch 5 is
valid until 31 January 2011
H0190000 Heparin Low-Molecular-Mass for calibration CRS
25 mg
Mna = 3800
H0200000 Heparin sodium BRP
2 ml
1010 IU per ml
Y0001287 Heparin calcium for NMR identification
30 mg
Y0001283 Heparin sodium for NMR identification
Y0001282 Heparin for physico-chemical analysis
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
0.5 ml
262 IU per ml; Please contact us for information on the type needed for your
use
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed)
0.8 ml
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal

free)
0.5 ml
H0210010 Hepatitis B vaccine (rDNA) BRP method B
H0215000 Hepatitis C Virus RNA for NAT testing BRP
Y0000673 Harpagoside
New H0185000 Heparin Low-Molecular-Mass for assay BRP
Batch n
Information
Monograph
Leaflet
Storage
0393
1095, 1871
Extra
Price
charges
79
l
+5C
79
0828
Yes
+5C
90
0828
Yes
+5C
90
Yes
+5C
79
0332,0333,05
69,
0686,20705
0332
Yes
+5C
79
30 mg
0333
Yes
+5C
79
300 mg
0333
+5C
79
See leaflet,
20714
Yes
+5C
90
To be stored below -50C
20714,1526,1
935, 1107
Yes
-80C
90
16.6 micrograms per ml
See leaflet,
20715
Yes
+5C
90
1 ml
20 micrograms per ml
See leaflet,
1056
Yes
+5C
90
40 mg
HCV-RNA content 500 IU per vial; For plasma pool testing by NAT
See leaflet,
20621
Yes
-20C
e(d)
242
H0220000 Heptadecanol
600 mg
97.9% CHO
0801,0802,08
47
+5C
79
Y0000063 Heptaminol hydrochloride
150 mg
1980
+5C
79
Y0000057 Heptaminol impurity A
20 mg
1980
+5C
79
H0250000 alpha-Hexachlorocyclohexane
10 mg
0772
+5C
79
H0330000 Hexamidine diisetionate
50 mg
1436
+5C
79
H0325000 Hexetidine
100 mg
1221
+5C
79
H0400000 Hexobarbital
500 mg
0183
+5C
79
H0420000 Hexylresorcinol
100 mg
1437
+5C
79
H0500000 Hide powder
500 mg
20814
+5C
79
H0600000 Histamine dihydrochloride
250 mg
0143
+5C
79
H0700000 Histamine phosphate
250 mg
0144
+5C
79
H0750000 Histidine
100 mg
0911
+5C
79
H0755000 Histidine hydrochloride monohydrate
100 mg
0910
+5C
79
H0800000 Homatropine hydrobromide
100 mg
0500,0720
+5C
79
H0830000 Homatropine methylbromide
25 mg
0720
+5C
79
5 mg
0720
+5C
79
New Y0001383 Homatropine methylbromide for system suitability

93.4% CHN; (2RS)-6-methylhept-5-en-2-amine
35
Yes

Order
Reference Standard
Code
H0837000 L-Homocysteine thiolactone hydrochloride - reference
spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
0255
Yes
-20C
79
1617
Extra
Price
charges
79
l
H0900000 Human albumin for electrophoresis BRP
1 ml
96,7% to 99,2% of the total protein is the main band (albumin), protein
content : 5%
Y0000219 Human anti-D immunoglobulin BRP
1 uc
285 IU anti-D immunoglobulin per ampoule
See leaflet,
20713
Yes
-20C
90
Y0000667 Human coagulation factor VII concentrate BRP
26 mg
9.9 IU per vial
See leaflet,
20710
Yes
-20C
79
New H0920000 Human coagulation factor VIII concentrate BRP
37 mg
10.4 IU per vial; Common standard with FDA ; Batch 3 is valid until 31 March
2012
See leaflet,
20704
Yes
-20C
90
H0920500 Human coagulation factor IX concentrate BRP
30 mg
7.9 IU/vial; Common standard with FDA
See leaflet,
20711
Yes
-20C
90
H0950000 Human hepatitis A immunoglobulin BRP
10 mg
10.2 IU per vial
See leaflet,
0338, 0769
Yes
-20C
90
H0990000 Human immunoglobulin BRP
15800 mg
Instructions for use: see leaflet
See leaflet,
0338, 0918
Yes
+5C
90
H1000000 Human immunoglobulin for electrophoresis BRP
96 mg
75.7% to 80.9% of the total protein is the main band (Ig),

protein content: 5%
0338,0918
Yes
+5C
79
Y0000488 Human immunoglobulin (molecular size) BRP
700 mg
Each vial contains 0.7 gram of immunoglobulin G
See leaflet,
0338,
0918,1928
Yes
+5C
90
H1005000 Human Plasma Pools for NAT validation
3502 mg
Set of 103 plasma pool samples
See leaflet,
20621
Yes
-20C
400
H1100000 Human rabies immunoglobulin BRP
170 mg
91 IU per vial
See leaflet,
0723
Yes
-20C
90
H1110000 Human tetanus immunoglobulin BRP
87 mg
120 IU per vial
0398
Yes
-20C
90
Y0000502 Human vaccinia immunoglobulin
1 ml
23 IU per vial
See leaflet
Yes
-20C
270
H1115000 Hyaluronidase BRP
50 mg
328 IU per mg
0912
+5C
79
H1120000 Hydralazine hydrochloride
20 mg
0829
+5C
79
Y0001151 Hydrastine hydrochloride
20 mg
H1200000 Hydrochlorothiazide
160 mg
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc
10 mg
1784
Y0000710 Hydrocodone for peak identification - * narc
10 mg
1784
H1300000 Hydrocortisone
100 mg
0335,0353,05
61
Y0001092 Hydrocortisone for peak identification
5 mg
H1400000 Hydrocortisone acetate
125 mg
H1425000 Hydrocortisone hydrogen succinate
100 mg
H1426000 Hydrogenated wool fat
250 mg
99.7% CHClNOS ; Batch 5 is valid until 31 March 2012
1831,2500
Yes
-20C
79
0394,0546
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0335
Yes
+5C
79
0321,0334,07
34, 0767
+5C
79
0768,1131
-20C
79
0969
+5C
79
Hydrocortisone acetate CRS 8 is suitable for monographs 01/2011:0335,

01/2008:334, 01/2008:0321, 01/2008:0767 and 01/2008:0734 only.
36
Yes

Order
Reference Standard
Code
Y0000446 Hydromorphone hydrochloride - * narc

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
2099
Storage
+5C
Extra
Price
charges
79
k
B0650000 Hydrous benzoyl peroxide - reference spectrum
n/a
0704
79
H1428000 Hydroxocobalamin
10 mg
0913,0914,09
15
+5C
79
Y0000119 Hydroxycarbamide
175 mg
1616
+5C
79
H1429400 Hydroxyethyl salicylate
125 mg
H1429700 4-Hydroxyphenoxymethylpenicillin potassium
20 mg
98.4% CHKNOS
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine
50 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A
0813
Y0001277 Hydroxyethyl starch (medium MW)
1200 mg
Average Mw 130100 Da
1785
Yes
Y0001322 Hydroxyethyl starch (high Mw)
800 mg
507900 Da
1785
Yes
Y0000186 Hydroxypropylbetadex
10 mg
1804
H1435000 Hydroxyzine hydrochloride
600 mg
Y0000011 Hymecromone
100 mg
Y0000012 Hymecromone impurity A
25 mg
Resorcinol
Y0000013 Hymecromone impurity B
25 mg
7-hydroxy-2-methyl-4H-1-benzopyran-4-one.
Y0000483 Hyoscine
10 mg
Y0000484 Hyoscine impurity A
10 mg
H1450000 Hyoscine butylbromide
20 mg
Y0000447 Hyoscine butylbromide impurity E
10 mg
H1500000 Hyoscine hydrobromide
50 mg
Y0000448 Hyoscine hydrobromide impurity B
10 mg
H1600000 Hyoscyamine sulfate
100 mg
Y0000449 Hyoscyamine impurity E
10 mg
Y0000915 Hypromellose phthalate
10 mg
250 mg
B1220000 Ibuprofen impurity B
Y0000140 Ibuprofen impurity F
99.9% CHNO
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
0916,1086,10
92
+5C
79
1786
+5C
79
1786
+5C
79
1786
+5C
79
2167
+5C
79
2167
+5C
79
0737
+5C
79
0737
+5C
79
0106,0500
+5C
79
0106
+5C
79
0501
+5C
79
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate
0501
+5C
79
347
+5C
79
0721
+5C
79
1.15 mL
solution of 0.06% m/V in acetonitrile - to be diluted as appropriate.; (2RS)-2(4-Butylphenyl)propanoic acid ; Batch 5 is valid until 31 December 2011
0721
+5C
79
5 mg
3-[4-(2-methylpropyl)phenyl]propanoic acid ; Batch 1 is valid until 31 August

2011
0721
+5C
79
Y0000881 Ibuprofen for peak identification
0.09 mg
0721
I0050000 Idoxuridine
50 mg
I0060000 Ifosfamide
50 mg
I0060100 Ifosfamide - reference spectrum
n/a
New I0020000 Ibuprofen
1225
0148,0149
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
(1R,2R,4S,5S,7S)-9-butyl -7-[[(2S)-3-hydroxy2-phenylpropanoyl]oxy]-3-oxa -9-azoni atricyclo
[3.3.1.02,4]nonane
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
100.0% CHClNOP
+5C
79
0669
+5C
79
1529
+5C
79
79
1529
37
Yes
Yes

Order
Reference Standard
Code
New I0060002 Ifosfamide impurity A

Batch n
3
Quantity Sale
Information
per vial Unit
100 mg
2 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate ; Batch 1 is valid until
28 February 2011
Monograph
Leaflet
Storage
1529
-20C
Extra
Price
charges
79
g(c)
I0060004 Ifosfamide impurity B
20 mg
bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate
1529
+5C
79
I0060010 Ifosfamide impurity E
10 mg
3-chloro-N-(2-chloroethyl)propan-1-amine
1529
+5C
79
I0060012 Ifosfamide impurity F
10 mg
(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide
I0086000 Imidazole
100 mg
I0090000 Imipenem
100 mg
I0100000 Imipramine hydrochloride
50 mg
Y0000893 Imipramine for system suitability
10 mg
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test BRP
45 mg
Y0001152 Immunoglobulin panel for anti-A, anti-B antibodies test
96 mg
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP
2 uc
Y0001205 Imperatorin
20 mg
I0150000 Indapamide
150 mg
I0150020 Indapamide impurity B
5 mg
Y0000788 Indinavir
100 mg
Y0000880 Indinavir sulfate - reference spectrum
n/a
2214
Y0000746 Indinavir for system suitability
20 mg
2214
I0200000 Indometacin
50 mg
0092,0922,16
86
8 mg
I0305000 Insulin (bovine)
7.99 mg
I0310000 Insulin (human)
8 mg
Y0000348 Insulin lispro
I0320000 Insulin (porcine)
I0320300 Interferon alfa-2a
I0320301 Interferon alfa-2b

Y0001101 Interferon beta-1a
New Y0000349 Insulin aspart
New I0320330 Interferon gamma 1b
1529
+5C
79
0757,1424
+5C
79
1226
-20C
79
0029,0408,08
17,
0889,1787
0029
+5C
79
+5C
79
Yes
-20C
79
Yes
-20C
120
See leaflet,
20626
Yes
-20C
90
98.8 % CHO
2556
Yes
+5C
79
97.6% CHClNOS
1108
+5C
79
4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide
1108
+5C
79
97.2% CHNO
2214
+5C
79
79
+5C
79
+5C
79
92.9% CHNOS
Yes
7.45 mg of insulin aspart + B28iso insulin aspart + A21Asp insulin aspart +

B3Asp insulin
8 aspart + B3iso Asp insulin aspart per vial ; Batch 1 is valid until 30 April
2012
7.99 mg insulin + A21 desamido per vial CHNOS
2084
Yes
-20C
90
0854,1637
Yes
-20C
90
6.94 mg insulin + A21 desamido per vial CHNOS ; Batch 3 is valid

until 30 November 2011
0838,0854,16
37, 1638
Yes
-20C
90
5.93 mg
5.93 mg insulin lispro per vial
8.61 mg
8.61 mg insulin + A21-desamido per vial

see recommandations for use on accompagnying leaflet CHNOS
1 ml
About 1.52 mg per mL
200 L
About 9.74 mg per mL ; Batch 4 is valid until 31 July 2011
0.5 ml
2085
Yes
-20C
90
0838,0854,16
37, 1638
Yes
-20C
90
1110
Yes
-80C
90
1110
Yes
-80C
90
1639
Yes
-80C
90
Yes
0.5 mL
about 1 mg per ml ; Batch 1 is valid until 31 March 2012
1440
-80C
90
I0320331 Interferon gamma-1b validation solution
0.2 ml
about 1 mg per ml
1440
-80C
79
I0328000 Iobenguane sulfate
25 mg
97.2% CHINOS
1111,1112,111
3,2351
+5C
79
38

Order
Reference Standard
Code
Y0000839 Iobenguane sulfate - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
2351
Extra
Price
charges
79
l
Y0001294 Iodixanol
60 mg
2215
+5C
79
Y0001292 Iodixanol impurity C
10 mg
5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C
79
Y0001291 Iodixanol impurity E
10 mg
5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
2215
+5C
79
Y0001293 Iodixanol impurity H
10 mg
5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C
79
I0320800 Iohexol
150 mg
1114
+5C
79
I0320810 Iohexol impurity A
50 mg
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide
1114
+5C
79
I0320820 Iohexol impurity J
125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide
1114,2215
+5C
79
Y0000672 Iohexol for peak identification
10 mg
+5C
79
I0329000 Iopamidol
50 mg
1115
+5C
79
I0329010 Iopamidol impurity A
10 mg
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide
1115, 1754
+5C
79
Y0000406 Iopamidol impurity H
10 mg
4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
1115
+5C
79
I0330000 Iopanoic acid
100 mg
0700
+5C
79
Y0001297 Iopentol
10 mg
+5C
79
Y0001020 Iopromide
100 mg
98.7% CHINO
1753
+5C
79
Y0001077 Iopromide impurity A
0.125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide
1753
+5C
79
Y0001021 Iopromide for system suitability 1
5 mg
1753
+5C
79
Y0001022 Iopromide for system suitability 2
5 mg
1753
+5C
79
I0340000 Iotalamic acid
150 mg
0751
+5C
79
A0560000 Iotalamic acid impurity A
20 mg
0751
+5C
79
Y0000555 Iotrolan
100 mg
1754
+5C
79
Y0000658 Iotrolan for system suitability
5 mg
1754
+5C
79
Y0000141 Ioxaglic acid
125 mg
Y0000142 Ioxaglic acid impurity A
20 mg
I0360000 Ipratropium bromide
120 mg
Y0000276 Ipratropium impurity A
10 mg
1114
Yes
2215
5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid
2009
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane
39
Yes
Yes
+5C
79
2009
Yes
+5C
79
0919
+5C
79
0772
+5C
79

Order
Reference Standard
Code
I0361000 Ipratropium bromide impurity B

Batch n
3
Quantity Sale
Information
per vial Unit
10 mg
1 (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0919
+5C
2465
+5C
79
2465
+5C
79
Y0001166 Irbesartan
60 mg
Y0001156 Irbesartan impurity A
10 mg
I0375000 Isoconazole
200 mg
1018
+5C
79
I0380000 Isoconazole nitrate
200 mg
1017
+5C
79
I0400000 Isoemetine hydrobromide
25 mg
0080,0081
+5C
79
Y0000858 Isoflurane
1.5 ml
1666
+5C
79
Y0000037 Isoflurane - reference spectrum
n/a
1673
79
I0460000 Isoleucine
50 mg
0770
+5C
79
I0465000 Isomalt
3000 mg
1531
+5C
79
Y0000070 Isomaltooligosaccharide
0.9 mg
1506
+5C
79
I0500000 Isoniazid
100 mg
0146
+5C
79
I0599990 Isoprenaline hydrochloride
50 mg
1332
+5C
79
I0600000 Isoprenaline sulfate
500 mg
0502
+5C
79
I0725000 Isopropyl hexadecanoate
100 mg
94.3% CHO
0839
+5C
79
I0750000 Isopropyl tetradecanoate
2 ml
97.9% CHO
0725
+5C
79
I0775000 Isosorbide dinitrate
300 mg
39.9% CHNO
1117,1118
+5C
79
I0775010 Isosorbide mononitrate
100 mg
99.9% CHNO; Isosorbide-5-nitrate
1117,1118
+5C
79
I0775020 Isosorbide-2-nitrate
50 mg
1117,1118
+5C
79
I0800000 Isotretinoin
60 mg
0693,1019
+5C
g(b)
79
Y0001218 Isotretinoin for peak identification
10 mg
1019
+5C
g(b)
79
I0900000 Isoxsuprine hydrochloride
50 mg
+5C
79
Y0000366 Isradipine
125 mg
99.2% CHNO
2110
+5C
79
Y0000367 Isradipine impurity D
5 mg
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)

-2,6-dimethylpyridine-3,5-dicarboxylate
2110
+5C
79
I7000000 Itraconazole
150 mg
1335
+5C
79
Y0001100 Itraconazole for system suitability
15 mg
1335
Yes
+5C
79
Yes
New I8000010 Ivermectin
1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide
96.4% CHO (45.8% of 1,1 GPM, 50,6% of 1,6 GPS) CHO
Yes
1119
Yes
150 mg
90.6% of C48H74O14 (component H2B1a) ; Batch 1 is valid until 30 April 2012
1336
+5C
79
Y0000575 Ivy leaf standardised tincture
2 ml
0.20% (m/m) of hederacoside C
2148
-20C
g(c)
79
Y0000041 Josamycin
150 mg
1000 Ph. Eur. units per mg
1982,1983,20
702
+5C
79
Y0000042 Josamycin propionate
150 mg
975 Ph. Eur. units per mg
1982,1983,20
702
+5C
79
Y0001315 Josamycin for peak identification
25 mg
+5C
79
K0100000 Kanamycin B sulfate
20 mg
0032,0033,06
45
+5C
79
1983
40
Yes

Order
Reference Standard
Code
K0200000 Kanamycin monosulfate

Batch n
2
Quantity Sale
Information
per vial Unit
150 mg
1 799 IU per mg of CHNOS,HO
Monograph
Leaflet
Storage
0032,0033,00
53,
0485,0645,12
89,
1290,20702
1020
Yes
+5C
Y0000450 Ketamine hydrochloride - * narc
10 mg
K0551000 Ketamine impurity A
50 mg
Y0000246 Ketobemidone hydrochloride - reference spectrum
n/a
Y0000244 Ketobemidone impurity B
5 mg
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
1746
Y0000245 Ketobemidone impurity C
5 mg
1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one
1746
K0600000 Ketoconazole
150 mg
K1000000 3-Ketofusidic acid
10 mg
K2000000 Ketoprofen
50 mg
K2000010 Ketoprofen impurity A
10 mg
K2000015 Ketoprofen impurity C
5 mg
Y0000486 Ketorolac trometamol
10 mg
Y0000626 Ketorolac trometamol for peak identification
5 mg
1755
Y0000164 Ketotifen hydrogen fumarate - reference spectrum
n/a
1592
Y0000161 Ketotifen impurity G
0.0225 mg
Y0001200 Kudzuvine root dry extract
Extra
Price
charges
79
a
+5C
79
+5C
79
79
+5C
79
+5C
79
0921,1067,12
70
+5C
79
0798,0848
+5C
79
0922,1157,12
09
+5C
79
1-(3-benzoylphenyl)ethanone
0922
+5C
79
3-[(1RS)-1-carboxyethyl]benzoic acid
0922
+5C
79
1755
+5C
79
+5C
79
79
79
1020,1742
1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol
1746
4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione ; Batch 2 is valid until 28 February 2011
Yes
1592
+5C
n/a
200 mg
2434,2483
-20C
79
L0050000 Labetalol hydrochloride
80 mg
0923
+5C
79
L0129000 Lactitol monohydrate
60 mg
1337
+5C
79
Y0000257 Lactobionic acid
100 mg
1647
+5C
79
A1206000 Lactose (anhydrous)
100 mg
1061
+5C
79
L0100000 Lactose
100
+5C
79
L0130000 Lactulose
3000 mg
99.7% CHO
0177,0178,01
87,
0188,0204,02
09,
1215,1570
0924,1230
+5C
79
Y0000188 Lactulose for system suitability
12 mg
Y0000425 Lamivudine
150 mg
Y0000518 Lamivudine for system suitability 1
10 mg
Y0000426 Lamivudine for system suitability 2
10.3 mg
Y0001030 Lamotrigine
10 mg
1756
Y0001031 Lamotrigine for peak identification
20 mg
1756
Yes
Y0001085 Lamotrigine for system suitability
10 mg
1756
Yes
Y0001032 Lamotrigine impurity E
10 mg
93.8% CHO
0924,1230
99.7% CHNOS
2,3-dichlorobenzoic acid
41
Yes
+5C
79
2217
+5C
79
2217
+5C
79
2217
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1756
Yes

Order
Code
Y0000773 Lansoprazole
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
60 mg
1
Information
Monograph
2219
Y0000774 Lansoprazole for peak identification
1 mg
2219
Y0000654 Leflunomide
100 mg
2330
Y0000487 Leflunomide impurity A
25 mg
Y0000674 Leflunomide for peak identification
1 mg
Y0000685 Letrozole
70 mg
L0375000 Leucine
50 mg
L0376000 Leuprorelin
1 mg
L0376001 Leuprorelin - reference spectrum
n/a
Y0000047 Levamisole hydrochloride for system suitability
60 mg
L0380000 Levamisole hydrochloride
50 mg
0726
Y0000048 Levamisole - reference spectrum
n/a
1728
Y0001253 Levetiracetam
110 mg
100.0% CHNO
2535
Y0001254 Levetiracetam impurity A
10 mg
(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid
2535
Y0001255 Levetiracetam impurity B
10 mg
(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide
Y0001256 Levetiracetam impurity C
10 mg
pyridin-2-ol
Y0001257 Levetiracetam impurity D
10 mg
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam)
L0390000 Levocabastine hydrochloride
125 mg
L0390008 Levocabastine impurity D
20 mg
L0399900 Levocarnitine
125 mg
L0399905 Levocarnitine impurity A
50 mg
(E)- or (Z)-4-(trimethylammonio)but-2-enoate ; Batch 1 is valid until 28

February 2011
L0400000 Levodopa
100 mg
L0420000 Levodropropizine
60 mg
L0420002 Levodropropizine impurity A
20 mg
(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine)
Y0001033 Levodropropizine impurity B
50 mg
1-phenylpiperazine
1535
Y0001048 Levodropropizine impurity C
300 mg
2,3-epoxypropan-1-ol
1535
L0500000 Levomepromazine hydrochloride
100 mg
0505
L0505000 Levomepromazine maleate
50 mg
0925
L0551000 Levonorgestrel
30 mg
Y0001379 Levonorgestrel impurity B
10 mg
Y0001431 Levonorgestrel for system suitability
10 mg
L0570000 Levothyroxine sodium
100 mg
Y0001382 Levothyroxine for peak identification
10 mg
0401
L0595000 Lidocaine
50 mg
0727,1362
Leaflet
4-(trifluoromethyl)aniline ; Batch 1 is valid until 28 February 2011

99.7% CHN
0.99 mg per vial of pure leuprorelin peptide CHNO ; Batch 4 is valid
until 1 February 2012
Storage
+5C
Yes
2330
+5C
79
+5C
79
+5C
79
2330
Yes
+5C
79
2334
Yes
+5C
79
0771,0874
+5C
79
1442
-20C
79
79
+5C
79
+5C
79
79
+5C
79
+5C
79
2535
+5C
79
2535
+5C
79
2535
+5C
79
1484
+5C
79
1484
+5C
79
1339
+5C
79
1339
+5C
79
0038
+5C
79
1535
+5C
79
1535
+5C
79
+5C
79
-20C
g(c)
79
+5C
79
+5C
79
0926
+5C
79
0926
+5C
79
+5C
79
-20C
79
-20C
79
+5C
79
1442
0726,1728
1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic
acid
13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one
0926
89.3% CHINNaO
42
Extra
Price
charges
79
a
Yes
Yes
Yes
0401,0728
Yes

Order
Reference Standard
Code
L0600000 Lidocaine hydrochloride
L0650000 Lincomycin hydrochloride
New Y0001393 Lincomycin chlorhydrate for system suitability

Batch n
2
Quantity Sale
per vial Unit
100 mg
1
250 mg
10 mg
Information
Monograph
95.4% CHClNOS
Leaflet
Storage
Extra
Price
charges
79
g
0227,1242,13
63
+5C
0582,0583,09
96
+5C
79
-20C
79
0401,0728
-20C
79
0728
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
0583
Yes
L0700000 Liothyronine sodium
50 mg
Y0000860 Liothyronine for peak identification
0.0046 mg
L0702000 Lisinopril dihydrate
50 mg
Y0001235 Lisinopril for system suitability
2 mg
Lisinopril for performance test CRS 3 renamed as lisinopril for system

suitability CRS 1 for the implementation of 01/2011:1120
1120
Y0001234 Lisinopril impurity F
0.01 mg
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
1120
L0720000 Lithium clavulanate
125 mg
97.6% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO ;

1140,1653
L0720800 Lithocholic acid
60 mg
1189,1275
+5C
79
Y0000112 Lobeline hydrochloride
50 mg
1988
+5C
79
L0745000 Lomustine
50 mg
0928
+5C
79
L0750000 Loperamide hydrochloride
50 mg
0921,0929,17
29
+5C
79
Y0000322 Loperamide hydrochloride for system suitability
15 mg
0929
+5C
79
Y0000341 Loperamide oxide monohydrate
20 mg
1729
+5C
79
Y0000688 Loratadine
60 mg
2124
+5C
79
Y0000603 Loratadine for system suitability
20 mg
2124
+5C
79
Y0000604 Loratadine impurity F
10 mg
ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
2124
+5C
79
Y0000605 Loratadine impurity H
50 mg
ethyl 4-oxopiperidine-1-carboxylate
2124
+5C
79
L0750500 Lorazepam - * psy
100 mg
1121
+5C
79
Y0000576 Lorazepam for system suitability - * psy
0.8 mg
Y0000718 Lorazepam impurity D
10 mg
Y0001062 Losartan potassium
50 mg
Y0001072 Losartan impurity D
6 mg
Y0001076 Losartan for system suitability
0.0015 mg
L0790000 Lovastatin
40 mg
Y0001136 Lovastatin for peak identification
20 mg
Y0001284 Lufenuron
140 mg
Y0001261 Lufenuron for peak identification
0.4028 mg
96.6 % CHINNaO
1120
(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 1 is valid until 31 May
2011
99.5% CHClFNO
43
Yes
Yes
Yes
1121
+5C
79
1121
+5C
79
2232
+5C
79
2232
+5C
79
+5C
79
-20C
79
2232
99.7% CHO
Yes
Yes
1538,1563
1538
Yes
-20C
79
2177
Yes
+5C
79
2177
Yes
+5C
79

Order
Reference Standard
Code
Y0001265 Lufenuron impurity G

Batch n
1
Quantity Sale
Information
per vial Unit
15 mg
1 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
2177
+5C
+5C
79
L0800000 Lynestrenol
50 mg
0558
Y0001034 Lynestrenol for peak identification
20 mg
0558
+5C
79
Y0000397 Lysine acetate
60 mg
2114
+5C
79
L0900000 Lysine hydrochloride
50 mg
0805,0806,09
30, 1654
+5C
79
Y0000745 Macrogol 40 sorbitol heptaoleate
20 mg
2396
+5C
79
Y0001157 Macrogol polyvinyl alcohol grafted copolymer
400 mg
2523
+5C
79
Y0001369 Macrogol 30 dipolyhydroxystearate
100 mg
2584
+5C
79
M0088000 Magnesium aspartate dihydrate
60 mg
1445
+5C
79
M0120000 Malathion
250 mg
99.4% CHOPS
1343
+5C
79
M0120005 Malathion impurity A
10 mg
diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate
1343
-20C
g(c)
79
M0120010 Malathion impurity B
10 mg
diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate
1343
-20C
g(c)
79
M0100000 Maleic acid
100 mg
0365,0925
+5C
79
Y0000143 Malic acid - reference spectrum
n/a
79
M0160000 Maltitol
1200 mg
99.7% CHO
1235,1236
+5C
79
M0200000 Mannitol
1200 mg
98.8% CHO
0435,0559,13
81, 1531
+5C
79
M0206000 Maprotiline hydrochloride
100 mg
1237
+5C
79
M0206040 Maprotiline impurity D
25 mg
1237
+5C
79
Y0000819 Marbofloxacin
10 mg
2233
+5C
79
Y0000820 Marbofloxacin for peak identification
20 mg
2233
Yes
+5C
79
M0210000 Measles vaccine (live) BRP
5 uc
1057,0213
Yes
-20C
90
M0215000 Mebendazole
20 mg
1208,1254
+5C
79
Y0000144 Mebendazole for system suitability
20 mg
0845
+5C
79
Y0000168 Mebendazole - reference spectrum
n/a
0845
79
Y0001086 Mebrofenin
120 mg
2393
+5C
79
M0220000 Meclozine dihydrochloride
150 mg
Renammed for 01/2011:0622
0622
+5C
79
Y0001310 Meclozine impurity B
15 mg
4-chlorobenzhydrol
0622
+5C
79
Y0001311 Meclozine impurity H
15 mg
1-(4-chlorobenzhydryl)piperazine
0622
+5C
79
M0240000 Medronic acid
20 mg
0641, 2350
+5C
79
Y0001107 Medronic acid impurity A
60 l
Tris(1-methylethoxy)phosphane
2350
+5C
79
Y0001106 Medronic acid impurity B
40 l
Tetrakis(1-methylethyl)methhylenediphosphonate
2350
+5C
79
M0250000 Medroxyprogesterone acetate
100 mg
0673,1094,15
93
+5C
79
M0250010 Medroxyprogesterone acetate for performance test
50 mg
0673
+5C
79
Yes
2080
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine
4.3 log (ie 20000) infective viral units per vial
44
Yes

Order
Reference Standard
Code
Y0000598 Medroxyprogesterone acetate for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
M0252600 Mefenamic acid
50 mg
Y0001081 Mefenamic acid impurity A
100 mg
M0253000 Mefloquine hydrochloride
100 mg
M0260100 Megestrol acetate - reference spectrum
n/a
Y0001209 Meglumine
Y0001080 Meloxicam
Y0001035 Meloxicam impurity A

Y0001036 Meloxicam impurity B
Information
Monograph
Leaflet
Storage
0673
Yes
-20C
Extra
Price
charges
79
c
1240
+5C
79
1240
+5C
79
1241
+5C
79
1593
79
10 mg
2055
+5C
79
50 mg
2373
+5C
79
5 mg
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
2373
Yes
+5C
79
5 mg
5-methylthiazol-2-amine
2373
Yes
+5C
79
Y0001037 Meloxicam impurity C
5 mg
N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide ; Batch 1 is valid until 31 July 2011
2373
Yes
+5C
79
Y0001039 Meloxicam impurity D
5 mg
N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide ; Batch 1 is valid until 31 July 2011
2373
Yes
+5C
79
Yes
New Y0001457 Melphalan for system suitability
2,3-dimethylaniline
10 mg
1698
+5C
79
M0300000 Menadione
100 mg
0507
+5C
79
M0350000 Menthol
150 mg
0619,0623
+5C
79
M0370000 Mepivacaine hydrochloride
100 mg
1242
+5C
79
M0370020 Mepivacaine impurity B
60 mg
M0400000 Meprobamate - * psy
100 mg
M0500000 Mepyramine maleate
1000 mg
Y0000679 Mepyramine impurity A
10 mg
N-(4-methoxybenzyl)pyridin-2-amine
Y0000680 Mepyramine impurity C
10 mg
pyridin-2-amine
0278
Y0001252 Meropenem trihydrate
110 mg
87.0% CHNOS,3HO
2234
Y0000297 Mesalazine
125 mg
1699,1993
Y0001040 Mesityl oxide
100 mg
2358
Y0000337 Mesna - reference spectrum
n/a
Y0000316 Mesna impurity C
10 mg
2-(acetylsulphanyl)ethanesulphonic acid
1674
Y0000317 Mesna impurity D
10 mg
2,2'-(disulphanediyl)bis(ethanesulphonic acid)
1674
Y0000227 Meso-rich exametazime
0.5 mg
Y0000097 Mesterolone
60 mg
99.3% CHO
Y0000096 Mesterolone impurity A
30 mg
17-hydroxy-1alpha-methylandrost-4-en-3-one
M0600000 Mestranol
100 mg
Y0000301 Metacresol - reference spectrum
n/a
M0600500 Metacycline hydrochloride
M0600900 Metamizole sodium
M0600905 Metamizole impurity A
15 mg
M0605000 Metformin hydrochloride
50 mg
1242
+5C
79
0407,1689
+5C
79
0278
+5C
79
0278
+5C
79
+5C
79
+5C
79
+5C
79
+5C
g(b)
79
79
+5C
79
+5C
79
+5C
79
1730
+5C
79
1730
+5C
79
0509
+5C
79
2077
79
50 mg
0272,0820
+5C
79
100 mg
1346
+5C
79
1346
+5C
79
0931
+5C
79
(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Yes
1674
1925
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
45
Yes
Order
Reference Standard
Code
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A
Batch n
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B
200 mg
M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) - reference

spectrum
n/a
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),

dispersion 30%-ref.sp
M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1128
+5C
1128
+5C
79
1128
79
n/a
1129
79
n/a
1127
79
M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum
n/a
1130
79
M0800000 Methadone hydrochloride - reference spectrum
n/a
0408,1787
79
Y0000428 Methanol - reference spectrum
n/a
1989
79
M0900000 Methaqualone - reference spectrum
n/a
0510
79
Y0000754 Methenamine
10 mg
1545
+5C
79
M0950000 DL-Methionine
50 mg
0624
+5C
79
M0960000 Methionine
50 mg
0788,1027
+5C
79
M1000000 Methotrexate
100 mg
0560
+5C
79
Y0000602 Methotrexate for peak identification
20 mg
+5C
79
Y0000663 Methotrexate impurity C
10 mg
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)
0560
+5C
79
M1000008 Methotrexate impurity D
10 mg
4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino] benzoic acid
0560
+5C
79
Y0000664 Methotrexate impurity E
10 mg
4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)
0560
+5C
79
M1300000 Methylatropine bromide
100 mg
0511,0919
+5C
79
M1400000 Methylatropine nitrate
100 mg
0512
+5C
79
M1450000 Methylcarbidopa
1 mg
0755
+5C
79
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate
0.5 ml
0318
+5C
79
M1500000 Methyldopa
50 mg
0045,0755
+5C
79
Y0001374 Racemic methyldopa
5 mg
0045
+5C
79
Y0001083 Methyldopa for system suitability
0.024 mg
0045
+5C
79
M1550000 Methylene chloride
2 ml
0932
+5C
79
M1551000 2-(1-Methylethyl) pentanoic acid
25 mg
0678,1378
+5C
79
M1556000 Methyl 12-hydroxystearate
100 mg
1497
+5C
79
Y0000398 Methyl nicotinate
25 mg
2129
+5C
79
Y0000776 Methylergometrine maleate
10 mg
1788
+5C
79
Y0000777 Methylergometrine for system suitability
0.53 mg
+5C
79
M1625000 Methylnitrosoindoline
110 mg
+5C
79
Quantity Sale
per vial Unit
200 mg
1
88.9% CHNO
0560
1788
46
1108
Yes
Yes
Yes
Order
Reference Standard
Code
M1650000 Methyl parahydroxybenzoate
Batch n
Y0001017 Methylphenidate hydrochloride - * narc
40 mg
Y0000910 Methylphenidate impurity mixture
M1700000 Methylphenobarbital - * psy
M1750000 Methylprednisolone
M1755000 Methylprednisolone acetate
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0409,1262,21
34,1999
+5C
2235
+5C
79
0.04 mg
2235
+5C
79
500 mg
0189
+5C
79
150 mg
0312,0561
+5C
79
100 mg
0933
+5C
79
M1755200 Methylprednisolone hydrogen succinate
125 mg
0768,1131
+5C
79
M1755220 Methylprednisolone hydrogen succinate for performance

test
50 mg
1131
+5C
79
Y0001376 2-methylpyrazine
100 mg
2446
+5C
79
Y0000190 N-Methylpyrrolidone - reference spectrum
n/a
1675
79
M1770180 Methyl ricinoleate
125 mg
0051,2367
+5C
79
Y0000418 Methylrosanilinium chloride
40 mg
1990
+5C
79
Y0000407 Methylrosanilinium for system suitability
10 mg
1990
+5C
79
M1770200 Methyl stearate
100 mg
0051,1497
+5C
79
M1800000 Methyltestosterone
100 mg
0410
+5C
79
Y0000861 Methyltestosterone for system suitability
10 mg
0410
+5C
79
M1800900 Methylthioninium chloride
50 mg
1132
+5C
79
M1800902 Methylthioninium impurity A
20 mg
M1808000 Metixene hydrochloride
75 mg
M1824990 Metoclopramide
100 mg
M1825000 Metoclopramide hydrochloride
50 mg
M1824995 Metoclopramide impurity A
25 mg
M1825010 Metoclopramide impurity E
20 mg
Y0000701 Metolazone
80 mg
Y0000702 Metolazone for system suitability
10 mg
1757
Y0000171 Metoprolol succinate - reference spectrum
n/a
1448
M1830000 Metoprolol tartrate
60 mg
Y0000145 Metoprolol impurity A
10 mg
M1845000 Metrifonate
100 mg
M1850000 Metronidazole
50 mg
M1851000 Metronidazole benzoate
Y0000069 Metronidazole benzoate - reference spectrum
Y0000087 Metronidazole impurity A

M1860000 Mexiletine hydrochloride
Quantity Sale
Information
per vial Unit
150 mg
1 100.0% CHO; batch 2 valid until 31/12/10 for use with monograph 2134
and 1999.
Yes
Yes
Yes
1132
+5C
79
1347
+5C
79
1348
+5C
79
0674,0856,13
03
+5C
79
4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide
1348
+5C
79
N,N-diethylethane-1,2-diamine
1575
+5C
79
99.4% CHClNOS
1757
+5C
79
+5C
79
79
3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium
Yes
1028
+5C
79
1028,1448
+5C
79
1133
+5C
79
0675,0934
+5C
79
50 mg
1424
+5C
79
n/a
0934
79
10 mg
100 mg
(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
2-methyl-4-nitroimidazole
47
0675
+5C
79
1029
+5C
79

Order
Reference Standard
Code
Y0000202 Mexiletine impurity C

Batch n
1
Quantity Sale
Information
per vial Unit
2 mg
1 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine
2 mg
1 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine
Monograph
Leaflet
Storage
1029
+5C
Extra
Price
charges
79
a
Y0000203 Mexiletine impurity D
1029
+5C
79
M1875000 Mianserin hydrochloride
100 mg
0846
+5C
79
Y0001041 Mianserin impurity B
10 mg
(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid
0846
+5C
79
Y0000862 Mianserin for system suitability
1.01 mg
0846
+5C
79
M1880000 Miconazole
70 mg
0935,1335
+5C
79
M1900000 Miconazole nitrate
100 mg
0513,1148
+5C
79
M2200000 Midazolam - * psy
50 mg
0936,1065
+5C
79
Y0000562 Midazolam impurity C
0.08 mg
acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique ; Batch 1 is valid until 31 March 2011
Yes
+5C
79
+5C
79
Yes
-20C
79
New Y0000599 Midazolam for system suitability - * psy
0936
Yes
1 mg
Y0000539 Milk thistle standardised dry extract
120 mg
26.6% of silibinin (A+B)
M2280000 Minocycline hydrochloride
125 mg
90.8% CHClNO
1030
+5C
79
M2300000 Minoxidil
50 mg
0937
+5C
79
+5C
79
+5C
79
New Y0001432 Minoxidil for system suitability
0936
2071,1860
10 mg
0937
Y0000705 Mirtazapine
10 mg
2338
Y0000721 Mirtazapine for system suitability
10 mg
Y0000490 Misoprostol
60 mg
Y0001162 Misoprostol for system suitability
5 mg
Y0000378 Mitomycin
120 mg
99.1% CHNO
1655
M2305000 Mitoxantrone hydrochloride
50 mg
97.7% CHClNO
M2305005 Mitoxantrone impurity A
5 mg
1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione
Y0000635 Modafinil
110 mg
100.0% CHNOS
Y0000636 Modafinil for system suitability
0.1 mg
Y0000251 Molgramostim
0.3 ml
Y0000821 Molsidomine
5 mg
1701
Y0000822 Molsidomine impurity B
10 mg
N-nitrosomorpholine
1701
Y0000823 Molsidomine impurity D
10 mg
morpholine-4-carbaldehyde
M2900000 Mometasone furoate
100 mg
Y0001436 Montelukast dicyclohexylamine
150 mg
Y0001433 Montelukast racemate
20 mg
2583
Y0001434 Montelukast sodium
150 mg
2583
Y0001435 Montelukast for peak identification
20 mg
2583
Y0000028 Morantel hydrogen tartrate
50 mg
1546
98.5% CHO ; Batch 2 is valid until 28 February 2012
13.45 mg protein per ml CHNOS
99.4% CHClNOS
48
Yes
2338
Yes
+5C
79
1731
Yes
-20C
g(c)
79
1731
Yes
-20C
g(c)
79
+5C
79
1243
+5C
79
1243
+5C
79
2307
+5C
79
2307
Yes
+5C
79
1641
Yes
-80C
79
+5C
79
+5C
g(b)
79
1701
+5C
79
1449
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
2583
Yes
Yes

Order
Reference Standard
Code
Y0000451 Morphine hydrochloride (trihydrate) - * narc

Batch n
2
Quantity Sale
per vial Unit
25 mg
1 See leaflet
Information
Monograph
Leaflet
Storage
0097,1839,18
41
Yes
+5C
Y0000452 Morphine sulfate - * narc
40 mg
Y0000830 Morphine for system suitability - * narc
10 mg
70 mg
10 mg
110 mg
Y0000717 Moxifloxacin for peak identification
10 mg
Y0000226 Moxonidine
50 mg
99.7% CHClNO
Y0000222 Moxonidine impurity A
10 mg
4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine
M3600000 Mumps vaccine (live) BRP
5 uc
4.6 log (ie40000) infective viral units per vial
M3805000 Mupirocin - reference spectrum
n/a
M3805500 Mupirocin calcium - reference spectrum
n/a
M3806000 Mupirocin lithium
100 mg
Y0000489 Mycophenolate mofetil
30 mg
Y0000519 Mycophenolate mofetil for peak identification
10 mg
1700
Y0000692 Mycoplasma fermentans BRP
1 ml
20607
Y0000690 Mycoplasma hyorhinis BRP
1 ml
Y0000691 Mycoplasma orale BRP
1 ml
Y0000689 Mycoplasma synoviae BRP
1 ml
Y0000485 Myo-inositol
1020 mg
99.8% CHO
1805
N0020000 Nabumetone
60 mg
99.8% CHO
N0020020 Nabumetone impurity D
10 mg
(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one
N0020030 Nabumetone impurity F
10 mg
6,6'-dimethoxy-2,2'-binaphthalenyl
Y0000146 Nadolol
100 mg
Y0001215 Nadolol impurity mixture
0.01 mg
1789
N0025000 Nadroparin calcium
250 mg
0828,1134
Y0000077 Naftidrofuryl - reference spectrum
n/a
Y0000120 Naftidrofuryl impurity A
10 mg
2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid
Y0000121 Naftidrofuryl impurity B
25 mg
Y0000331 Naftidrofuryl impurity F
10 mg
N0050000 Nalidixic acid
100 mg
N0075000 Naloxone hydrochloride dihydrate
100 mg
Y0000695 Naloxone for peak identification
Y0000400 Naltrexone hydrochloride
New Y0000772 Moxidectin

Y0000747 Moxidectin for system suitability
New Y0000703 Moxifloxacin hydrochloride
1244,1784
97.4% CHNO ; Batch 1 is valid until 31 May 2012
96.1 % CHClFNO ; Batch 1 is valid until 31 May 2012
+5C
Extra
Price
charges
79
k
k
79
1244, 0097
Yes
+5C
79
1656
Yes
+5C
79
1656
Yes
+5C
79
2254
Yes
+5C
79
2254
Yes
+5C
79
+5C
79
+5C
79
-80C
90
1450
79
1451
79
1758
1758
0538,1057
Yes
1450,1451
+5C
79
1700
+5C
79
Yes
+5C
79
Yes
-80C
120
20607
Yes
-80C
120
20607
Yes
-80C
120
20607
Yes
-80C
120
+5C
79
1350
+5C
79
1350
+5C
79
1350
+5C
79
1789
+5C
79
+5C
79
+5C
79
79
1594
+5C
79
98% CHO; ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)

propanoate
1594
+5C
79
2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)

propanoate
1594
+5C
79
0701
+5C
79
0729,2099
+5C
79
10 mg
0729
+5C
79
50 mg
1790
+5C
79
93.7% CHOLi
Yes
1594
49
Yes

Order
Reference Standard
Code
Y0000410 Naltrexone impurity C

Batch n
1
Quantity Sale
Information
per vial Unit
15 mg
1 N-(3-butenyl)-noroxymorphone
Monograph
1790
Y0000542 Nandrolone decanoate
5 mg
1992
Y0000547 Nandrolone decanoate for peak identification
10 mg
1992
Y0000548 Nandrolone decanoate for system suitability
10 mg
1992
N0080000 Naphazoline hydrochloride
50 mg
0730,1162
N0100000 Naphazoline nitrate
10 mg
N0200000 Naphazoline impurity A
10 mg
N0250000 Naproxen
100 mg
Y0000399 Naproxen (racemic)
10 mg
Y0000631 Naproxen impurity L
10 mg
1-(6-methoxynaphthalen-2-yl)ethanone
New Y0001437 Nateglinide
200 mg
99.9% CHNO
2575
New Y0001440 Nateglinide impurity A
10 mg
trans-4-(1-methylethyl)cyclohexanecarboxylic acid
2575
New Y0001441 Nateglinide impurity B
15 mg
N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)
2575
New Y0001442 Nateglinide impurity C
N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)
Storage
+5C
Yes
Extra
Price
charges
79
a
-20C
79
-20C
79
-20C
79
+5C
79
0147
+5C
79
0147,0730
+5C
79
0731,1702
+5C
79
0731,1702
+5C
79
1702
+5C
79
+5C
79
+5C
79
+5C
79
10 mg
N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)
N0300000 Neamine
0.5 mg
76.3% CHNO ; Batch 3 is valid until 31 March 2011
N0399000 Neohesperidin-dihydrochalcone
125 mg
N0399004 Neohesperidin-dihydrochalcone impurity B
10 mg
N0400000 Neomycin sulfate
50 mg
Not to be used for microbiological assay
N0401000 Neomycin sulfate for microbiological assay
25 mg
19850 IU per vial
N0500000 Neostigmine bromide
50 mg
N0550000 Neostigmine metilsulfate
50 mg
N0559000 Netilmicin sulfate
25 mg
14656 IU per vial
Y0000520 Nevirapine (anhydrous)
30 mg
99.8% CHNO
2255
Y0000521 Nevirapine for peak identification
0.058 mg
Y0000388 Newcastle Disease Vaccine (inactivated) BRP
4 uc
Y0001373 Nicergoline
50 mg
Y0000287 Nicergoline - reference spectrum
n/a
Y0000283 Nicergoline impurity A
10 mg
[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10aoctahydroindol[4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate
Y0001356 Nicergoline impurity D
20 mg
5-bromopyridine-3-carboxylic acid
Leaflet
Yes
+5C
79
0180,0197
2575
Yes
+5C
79
89.9% CHO
1547
Yes
-20C
79
86.4% CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin) ; Batch 1 is valid until 31 October 2011
1547
Yes
+5C
79
0032,0033,00
53,
0180,0197,04
85, 0645
Yes
-20C
79
0197,20702
Yes
-20C
79
+5C
79
0626
+5C
79
1351,20702
-20C
79
0046
The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
+5C
79
2255
Yes
+5C
79
0870
Yes
-20C
180
+5C
79
79
1998
+5C
79
1998
+5C
79
1998
1998
50

Order
Reference Standard
Code
Y0001362 Nicergoline for peak identification

Batch n
1
Quantity Sale
per vial Unit
1 mg
1
Information
Monograph
Leaflet
1998
Storage
+5C
Y0001352 Nicergoline for system suitability
10 mg
1998
+5C
79
N0560000 Niclosamide (anhydrous)
50 mg
0679,0680
+5C
79
N0600000 Nicotinamide
50 mg
0047
+5C
79
N0590000 Nicotine - reference spectrum
n/a
1452,1792
79
N0590200 Nicotine ditartrate
120 mg
1792
+5C
79
15 mg
2599
+5C
79
Y0001023 Nicotine for system suitability
1.25 mg
1452, 1792,
2599
-20C
g(c)
79
N0700000 Nicotinic acid
100 mg
0459,0859
+5C
79
Y0001268 Nicotinic acid impurity mixture
0.12 mg
0459
+5C
79
N0750000 Nifedipine
50 mg
0627,1013
+5C
79
N0750010 Nifedipine impurity A
20 mg
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
0627
+5C
79
N0750015 Nifedipine impurity B
20 mg
Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate
0627
+5C
79
Y0000824 Niflumic acid
10 mg
2115
+5C
79
Y0000825 Niflumic acid impurity A
10 mg
2-chloropyridine-3-carboxylic acid
2215
+5C
79
Y0000826 Niflumic acid impurity B
10 mg
2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide
2115
+5C
79
Y0000827 Niflumic acid impurity E
15 mg
6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid
2115
+5C
79
Y0000836 Nifuroxazide
10 mg
1999
+5C
79
N0800000 Nikethamide
1 ml
0233
+5C
79
Y0000829 Nilutamide
110 mg
2256
+5C
79
Y0000894 Nilutamide impurity B
5 mg
2256
+5C
79
N0845000 Nimesulide
100 mg
1548
+5C
79
Y0001237 Nimesulide for peak identification
10 mg
+5C
79
N0845008 Nimesulide impurity D
0.004 mg
+5C
79
N0850000 Nimodipine
50 mg
+5C
79
N0850010 Nimodipine impurity A
1 ml
+5C
79
N0900000 Nitrazepam - * psy
100 mg
0415,0898,11
21
+5C
79
N0900010 Nitrazepam impurity A
25 mg
0415
+5C
79
N0905000 Nitrendipine
60 mg
1246
+5C
79
10 mg
1246
+5C
79
N0905005 Nitrendipine impurity A
30 mg
+5C
79
N0930000 Nitric oxide - reference spectrum
n/a
79
N0950000 Nitrofural
100 mg
+5C
79
New Y0001425 Nicotine ditartrate dihydrate
New Y0001456 Nitrendipine for peak identification
92.8% CHN x 2 CHO
4-nitro-3-(trifluoromethyl)aniline
1548
Yes
Extra
Price
charges
79
g
Yes
Yes
Yes
1548
4-nitro-2-phenoxyaniline
1245
1245
2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)

pyridine-3,5-dicarboxylate
3-amino-6-nitro-4-phenylquinol-2-one
ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;

(nitrophenylpyridine analogue)
1246
Yes
Yes
1550
99.8% CHNO
51
1135

Order
Reference Standard
Code
Y0001377 Nitrofural for peak identification

Batch n
1
Quantity Sale
per vial Unit
0.11 mg
1
Information
Monograph
Leaflet
Storage
1135
+5C
Extra
Price
charges
79
a
N1000000 Nitrosotriaminopyrimidine
50 mg
0058
+5C
79
N1090000 Nizatidine
250 mg
99.3% CHNOS
1453
+5C
79
N1090060 Nizatidine impurity F
10 mg
(EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)]bis(N'methyl-2-nitroethene-1,1-diamine)
1453
+5C
79
N1080000 Nomegestrol acetate
100 mg
1551
+5C
79
N1080005 Nomegestrol acetate impurity A
50 mg
1551
+5C
79
Y0001314 1-nonadecanol
400 mg
0801,0802,08
47
+5C
79
Y0000670 Nonivamide
10 mg
2336,2337
+5C
79
Y0000755 Nonoxinol 9
10 mg
1454
+5C
79
N1100000 Noradrenaline tartrate
200 mg
0254,0285,07
32, 2303
+5C
79
Y0000681 Noradrenaline impurity D
15 mg
+5C
79
Y0000682 Noradrenaline impurity E
10 mg
4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732

2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732
+5C
79
Y0000686 Noradrenaline impurity F
10 mg
N-benzyl-1-phenylmethanamine
0285,0732
+5C
79
N1130000 Norcyclobenzaprine
25 mg
0941
+5C
79
N1140000 Nordazepam -* psy
50 mg
Dipotassium clorazepate impurity B
0898,1466
+5C
79
N1200000 Norethisterone
100 mg
0234,1212
+5C
79
N1225000 Norethisterone acetate
100 mg
0850
+5C
79
Y0000522 Norethisterone for system suitability
10 mg
0234
-20C
79
N1230000 Norfloxacin
50 mg
1248
+5C
79
N1230010 Norfloxacin impurity A
20 mg
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)
1460
+5C
79
Y0001015 Norfloxacin for system suitability
8 mg
1248
Yes
+5C
79
Y0001301 Norfloxacin for peak identification
10 mg
1248
Yes
+5C
79
Y0000724 Norgestimate
10 mg
1732
+5C
79
Y0000725 Norgestimate for system suitability
5 mg
1732
+5C
79
N1250000 Norgestrel
30 mg
0940
+5C
79
N1279000 Norpseudoephedrine hydrochloride - * psy
50 mg
0683
+5C
79
N1280000 Nortriptyline hydrochloride
10 mg
0941
+5C
79
Y0001296 Nortriptyline for system suitability
20 mg
0941
+5C
79
N1300000 Noscapine
100 mg
0102,0515,05
16
+5C
79
N1400000 Nystatin
100 mg
-20C
79
O0100900 Octoxinol 10
300 mg
+5C
79
6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate ; Batch 1 is valid

until 30 September 2011
99.1% CHNO
Cathine hydrochloride
5825 IU per mg CHNO
0517,1292,20
702
1553
52
Yes
Yes
Yes

Order
Code
Y0000368 Octyl gallate
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
30 mg
1
O0101000 Octyldodecanol
400 mg
O0120000 Ofloxacin
50 mg
O0120010 Ofloxacin impurity A
20 mg
O0120050 Ofloxacin impurity E
20 mg
Y0001370 Olanzapine
Y0001392 Olanzapine impurity A
Y0001380 Olanzapine for system suitability

Y0000805 Oleuropein
Information
Monograph
Leaflet
Storage
2057
+5C
Extra
Price
charges
79
a
1136
+5C
79
1455
+5C
79
(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA)
1455
+5C
79
(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
1455
+5C
79
200 mg
99.8% CHNS
2258
+5C
79
5 mg
5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2258
+5C
79
10 mg
+5C
79
20 mg
+5C
79
Y0001424 Olmesartan medoxomil for system suitability
10 mg
2600
+5C
79
O0146000 Olsalazine sodium
60 mg
1457
+5C
79
O0146010 Olsalazine sodium for performance test
60 mg
50 mg
Y0001043 Omeprazole magnesium
10 mg
2374
Y0001042 Omeprazole for peak identification
10 mg
0942,2372,23
74
O0151000 Omeprazole impurity D
10 mg
Omeprazole sulphone
Y0000218 Ondansetron hydrochloride dihydrate
200 mg
90.2% CHClNO
Y0000197 Ondansetron for LC system suitability
10 mg
Y0000196 Ondansetron for TLC system suitability
30 mg
Y0001345 Ondansetron impurity A
10 mg
(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one
Y0000195 Ondansetron impurity D
10 mg
Y0001326 Ondansetron impurity E
10 mg
Y0001320 Ondansetron impurity F
10 mg
Y0001346 Ondansetron impurity G
10 mg
Y0001125 Orbifloxacin
200 mg
2259
Y0001147 Orbifloxacin impurity mixture
0.0008 mg
2259
O0180000 Orciprenaline sulfate
100 mg
1033,1332
Y0000895 Orciprenaline for system suitability
5 mg
1033
Y0000100 Orphenadrine hydrochloride
100 mg
Y0000101 Orphenadrine citrate
100 mg
Y0001337 Oseltamivir phosphate (impurity B free)
300 mg
Y0001181 Orphenadrine for peak identification
0.42 mg
New O0150000 Omeprazole
94.8% CHO
2258
Yes
Yes
1878
82.2% CHO
Yes
1457
Yes
+5C
79
0942,1032
Yes
-20C
79
+5C
79
Yes
-20C
79
0942,1032
-20C
79
2016
+5C
79
2016
+5C
79
2016
+5C
79
2016
+5C
79
9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one
2016
+5C
79
Imidazole
2016
+5C
79
2016
+5C
79
2016
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1760
+5C
79
1759
+5C
79
(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
99.7% CHNOP
53
Yes
Yes
2422
Yes
+5C
79
1759,1760
Yes
+5C
79

Order
Reference Standard
Code
Y0001338 Oseltamivir impurity A

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
2422
+5C
1759,1760
+5C
79
Y0000102 Orphenadrine impurity E
30 mg
(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer)
Y0001339 Oseltamivir impurity B
10 mg
ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate
2422
+5C
79
Y0001340 Oseltamivir impurity C
10 mg
(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
+5C
79
Y0001341 Oseltamivir impurity H
30 mg
tributylphosphane oxide
2422
+5C
79
Y0001207 Osthole
20 mg
98.3 % CHO
2557
Yes
+5C
79
O0200000 Ouabain
150 mg
80.0% CHO ; Batch 1 is valid until 30 June 2011
0048
Yes
+5C
79
Y0000638 Oxacillin sodium monohydrate
110 mg
93.8% CHNNaOS
2260
+5C
79
Y0000560 Oxacillin for peak identification
10 mg
+5C
79
Y0000271 Oxaliplatin
250 mg
99.8 % CHNOPt
2017
+5C
79
Y0000272 Oxaliplatin impurity B
15 mg
(SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']
platinum (diaquodiaminocyclohexaneplatinum) ; Batch 5 is valid until 31 July
2011
2017
+5C
79
Y0000273 Oxaliplatin impurity C
15 mg
(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum
2017
+5C
79
Y0000274 Oxaliplatin impurity D
10 mg
(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin)
2017
+5C
79
O0225000 Oxazepam - * psy
50 mg
0778
+5C
79
Y0000543 Oxazepam for peak identification
0.008 mg
0778
+5C
79
Y0000350 Oxeladin hydrogen citrate
50 mg
1761
+5C
79
Y0000404 Oxeladin impurity C
10 mg
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate
1761
+5C
79
Y0000390 Oxeladin impurity D
20 mg
2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate
1761
+5C
79
O0225800 Oxfendazole for veterinary use
50 mg
1458
+5C
79
Y0000224 Oxfendazole impurity B
10 mg
1458
+5C
79
Y0000225 Oxfendazole with impurity D
10 mg
1458
+5C
79
Y0000709 Oxitropium bromide
50 mg
2170
+5C
79
Y0000715 Oxitropium bromide impurity B
15 mg
(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
2170
+5C
79
Y0000713 Oxitropium bromide impurity D
10 mg
(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)
2170
+5C
79
O0240000 Oxolinic acid
50 mg
1353
+5C
79
O0240005 Oxolinic acid impurity A
20 mg
8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
1353
+5C
79
O0240010 Oxolinic acid impurity B
20 mg
ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate
1353
+5C
79
O0250000 Oxprenolol hydrochloride
50 mg
0628,0876,10
72
+5C
79
2260
methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate
54
Yes
Yes
Yes

Order
Code
O0260000 Oxibendazole
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
1386
+5C
Extra
Price
charges
79
a
O0270000 Oxybuprocane hydrochloride
150 mg
1251
+5C
79
O0288000 Oxybutynin hydrochloride
150 mg
1354
+5C
79
O0288005 Oxybutynin impurity A
10 mg
+5C
79
Y0000492 Oxycodone hydrochloride - * narc
100 mg
Y0000453 Oxycodone impurity D
50 mg
O0290000 Oxymetazoline hydrochloride
80 mg
Y0001044 Oxymetazoline impurity A
10 mg
N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide
O0400000 Oxytetracycline
100 mg
90.2% CHNO
O0500000 Oxytetracycline hydrochloride
20 mg
O0700000 Oxytocin
1 mg
O0770000 Oxytocin/Desmopressin validation mixture
0.2 mg
about 0.1 mg oxytocin + 0.1 mg desmopressin per vial
Y0000698 Paclitaxel
40 mg
99.4% CHNO ; Batch 1 is valid until 31 August 2011
1794
Y0000699 Paclitaxel impurity C
5 mg
N-debenzoyl-N-hexanoylpaclitaxel
1794
Y0000700 Paclitaxel natural for peak identification
10 mg
1794
Y0000719 Paclitaxel semi-synthetic for peak identification
10 mg
1794
Y0000739 Paclitaxel semi-synthetic for system suitability
1 mg
1794
P0090000 Palmitic acid
100 mg
Y0000524 Pamidronate disodium pentahydrate
10 mg
P0100000 Pancreas powder (amylase and lipase) BRP
2000 mg
41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity
per mg
P0200000 Pancreas powder (protease) BRP
2000 mg
P0250000 Pancuronium bromide
20 mg
Y0000577 Pancuronium bromide for system suitability
20 mg
Y0000835 Pantoprazole sodium sesquihydrate
20 mg
Y0001001 Pantoprazole for system suitability
0.5055 mg
P0270000 Papaverine hydrochloride
25 mg
0102,0573
P0300000 Paracetamol
50 mg
Y0000780 Paraffin (hard)
10 mg
Y0000058 Paraffin (liquid) - reference spectrum
n/a
0239,0240
Y0000913 Paraffin (White soft)
10 mg
Y0000912 Paraffin (Yellow soft)
10 mg
4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2- cyclohexyl-2hydroxyacetate
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone) ; Batch 1 is valid until 31
December 2011
1354
Yes
1793
+5C
79
1793
+5C
79
0943
+5C
79
0943
+5C
79
0198,0199
+5C
79
0198,1030
+5C
79
0779,0780
-20C
g(c)
90
0712,0779,07
80
-20C
g(c)
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
Yes
+5C
79
0229,0882,14
74,2058
+5C
79
1779
+5C
79
0350
+5C
79
1.48 Ph. Eur. U. per mg
0350
+5C
79
Vecuronium impurity B
0681,1769
+5C
79
0681
+5C
79
2296
+5C
79
+5C
79
+5C
79
0049
+5C
79
1034
+5C
79
79
1799
+5C
79
1554
+5C
79
55
2296
Yes
Order
Reference Standard
Code
P0305000 Parnaparin sodium
Batch n
Y0000578 Paroxetine hydrochloride (anhydrous)
100 mg
Y0000281 Paroxetine hydrochloride hemihydrate
200 mg
97.4% CHClFNO
Y0000233 Paroxetine impurity A
15 mg
(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine)
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
10 mg
Y0000256 Paroxetine impurity D
5 mg
Y0000580 Paroxetine impurity E
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H

Y0000630 Paroxetine for system suitability
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0828,1252
+5C
2283
+5C
79
2018,2283
+5C
79
2018,2283
+5C
79
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)
piperidine (N-benzylparoxetine)
2283
+5C
79
(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
((+)-trans-paroxetine)
2018,2283
+5C
79
5 mg
(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)
2283
+5C
79
10 mg
[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol
2283
+5C
79
5 mg
2018
+5C
79
P0309000 Pefloxacin mesilate dihydrate
200 mg
1460
+5C
79
P0309020 Pefloxacin impurity B
10 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (chlorinated homologue of pefloxacin)
1460
+5C
79
P0309030 Pefloxacin impurity C
0.01 mg
1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (isopefloxacin)
1460
+5C
79
P0307000 Penbutolol sulfate
100 mg
1461
+5C
79
P0307005 Penbutolol impurity A
20 mg
1461
+5C
79
P0310000 Penicillamine
100 mg
0566
+5C
79
P0320000 Penicillamine disulfide
100 mg
0566
+5C
79
P0405000 Pentamidine diisetionate
30 mg
1137,1436
+5C
79
P0405500 Pentazocine - reference spectrum
n/a
1462
79
P0405510 Pentazocine hydrochloride - reference spectrum
n/a
1463
79
Y0000417 Pentazocine lactate - reference spectrum
n/a
2000
Y0001051 Pentetate sodium calcium
100 mg
2353
+5C
P0500000 Pentobarbital - * psy
500 mg
0200,0419
P0510000 Pentoxifylline
100 mg
0851
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum
n/a
Y0000098 Pentoxyverine impurity A
10 mg
1-phenylcyclopentanecarboxylic acid
Y0000099 Pentoxyverine impurity B
10 mg
P0525000 Pepsin powder
2000 mg
Y0000010 Pergolide mesilate
150 mg
Y0000237 Perindopril impurity A
10 mg
Y0000207 Perindopril for stereochemical purity
40 mg
Quantity Sale
per vial Unit
250 mg
1
(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]
propan-2-ol
93.0% CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid
79
79
+5C
79
+5C
79
79
1621
+5C
79
2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)
1621
+5C
79
0.99 Ph. Eur. U. per mg
0682
+5C
79
99.9% CHNOS
1555
+5C
79
(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid
2019
+5C
79
+5C
79
1621
2019
56
Yes

Order
Reference Standard
Code
Y0000238 Perindopril tert-butylamine

Batch n
2
Quantity Sale
per vial Unit
40 mg
1
Information
Monograph
Leaflet
2019
+5C
Y0000771 Perindopril for peak identification
5 mg
2019
P0550000 Perphenazine
100 mg
0629,0904
Y0001045 Perphenazine for system suitability
5 mg
0629
Yes
Y0000021 Pertussis toxin BRP
0.05 mg
See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329
Yes
P0600000 Pethidine hydrochloride - reference spectrum
n/a
0420
P0600002 Pethidine impurity A
20 mg
P0800000 Phenazone
20 mg
Y0001138 Phenazone impurity A
20 mg
P0850000 Pheniramine maleate
250 mg
New Y0001428 Pheniramine impurity A
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one
Storage
Yes
Extra
Price
charges
79
a
+5C
79
+5C
79
+5C
79
-20C
g(d)
90
79
0420
+5C
79
0421
+5C
79
0421
+5C
79
1357
+5C
79
1357
+5C
79
0189,0201,06
30
+5C
79
+5C
79
20 mg
2-benzylpyridine
P0900000 Phenobarbital - * psy
200 mg
Y0001350 Phenobarbital impurity A
15 mg
0201
Y0001351 Phenobarbital impurity B
15 mg
0201
+5C
79
P0950000 Phenoxyethanol
2 ml
0781
+5C
79
P1000000 Phenoxymethylpenicillin
250 mg
P1100000 Phenoxymethylpenicillin potassium
250 mg
Y0001127 Phentolamine mesilate
10 mg
Y0001251 Phentolamine mesilate for system suitability
P1109000 Phentolamine mesilate - reference spectrum
P1150000 Phenylalanine
Yes
0148
+5C
79
0113,0114,01
48, 0149
+5C
79
1138
+5C
79
10 mg
1138
+5C
79
n/a
1138
79
60 mg
P1200000 Phenylbutazone
100 mg
Y0000147 Phenylbutazone impurity B
20 mg
P1240000 Phenylephrine
60 mg
P1250000 Phenylephrine hydrochloride
50 mg
Y0000683 Phenylephrine hydrochloride for peak identification
2 mg
Y0000229 Phenylmercuric acetate - reference spectrum
n/a
P1255100 Phenylmercuric borate - reference spectrum
n/a
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor
50 mg
P1290000 Phenytoin
100 mg
99.2% CHKNOS
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
Yes
0782,0796,11
61
+5C
79
0422,1574
+5C
79
0422
+5C
79
1035
+5C
79
0632,1205
+5C
79
0632,1035
+5C
79
2042
79
0103
Norephedrin hydrochloride
57
79
0683
+5C
79
1253,1988
+5C
79

Order
Reference Standard
Code
Y0001167 Phenytoin for system suitability

Batch n
1
Quantity Sale
per vial Unit
20 mg
1
Information
Monograph
Leaflet
Storage
0521,1253
Yes
+5C
Extra
Price
charges
79
a
P1300000 Phenytoin sodium
250 mg
0521
+5C
79
Y0000493 Phloroglucinol (anhydrous)
210 mg
2301,2302
+5C
79
Y0000761 Pholcodine - * narc
10 mg
0522
+5C
79
Y0000798 Pholcodine for peak identification - * narc
10 mg
0522
+5C
79
Y0000766 Phthalic acid
20 mg
2348
+5C
79
P1500000 Phthalylsulfathiazole
100 mg
0352
+5C
79
P1600000 Physostigmine salicylate
100 mg
0286
+5C
79
P1605000 Physostigmine sulfate
100 mg
0684
+5C
79
P1609000 Phytomenadione
150 mg
+5C
79
P1609010 trans-Epoxyphytomenadione
10 mg
1036
+5C
79
P1645000 Picotamide monohydrate
125 mg
1358
+5C
79
P1645005 Picotamide impurity A
25 mg
4-methoxybenzene-1,3-dicarboxylic acid
1358
+5C
79
Y0000124 Pidolate impurity B
60 mg
(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid
1619
+5C
79
Y0000123 Pidolic acid
125 mg
1619
+5C
79
P1650000 Pilocarpine hydrochloride
50 mg
0633
+5C
79
P1700000 Pilocarpine nitrate
50 mg
0104
+5C
79
Y0000106 Pilocarpine nitrate for system suitability
20 mg
0104,0633
+5C
79
Y0000525 Pimobendan
10 mg
2179
+5C
79
Y0000401 Pimobendan for system suitability
0.1 mg
2179
+5C
79
P1750000 Pimozide
150 mg
1254
+5C
79
P1800000 Pindolol
100 mg
0634,0871,17
89
+5C
79
Y0000061 Pipemidic acid trihydrate - reference spectrum
n/a
1743
79
P1890000 Piperacillin
100 mg
1168,1169
+5C
79
P1900000 Piperazine adipate
250 mg
0423
+5C
79
P2000000 Piperazine citrate
250 mg
0424
+5C
79
P2100000 Piperazine hydrate
250 mg
0425
+5C
79
Y0000288 Piracetam
120 mg
1733
+5C
79
Y0000038 Pirenzepine dihydrochloride monohydrate
250 mg
2001
+5C
79
P2120000 Piretanide
100 mg
1556
+5C
79
10 mg
1556
+5C
79
1556
+5C
79
0944
+5C
79
+5C
79
+5C
79
New Y0001458 Piretanide for system suitability

P2120002 Piretanide impurity A
20 mg
P2130000 Piroxicam
100 mg
P2130100 Piroxicam for system suitability
10 mg
P2150000 Pivampicillin
50 mg
benzene-1,2-dicarboxylic acid
87.0% trans-phytomenadione, 12.6% cis-phytomenadione, 0.09% transepoxyphytomenadione CHO; Vitamin K1
94.5% CHNOS
99.8% CHNO
4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid
1036
0944
99.2% CHNOS
58
0808,0852
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
P2152000 Pivmecillinam hydrochloride

Batch n
2
Quantity Sale
Information
per vial Unit
100 mg
1 99.6% CHClNOS
10 mg
1 methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)
methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
Monograph
Leaflet
Storage
Extra
Price
charges
79
c
1359
-20C
1359
+5C
79
P2152015 Pivmecillinam impurity C
P2155001 Plastic additive 01
2 ml
(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate
90001,90002,
30114
+5C
79
100 mg
N,N'-ethylenedialcanamide
90001,30114
+5C
79
E0800000 Plastic additive 04
500 mg
Epoxidised soya oil
90001,30114
+5C
79
500 mg
Epoxidised linseed oil
90001,30114
+5C
79
New P2155008 Plastic additive 08
500 mg
ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate] ;
30103,30104,
30105,30106
+5C
79
250 mg
pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] ;
30103,30105,
30106,30107
+5C
79
250 mg
4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]
30103,30105,
30106,30107
+5C
79
500 mg
Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
30103,30105,
30106,30107
+5C
79
250 mg
Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R
30103,30105,
30106,30107
+5C
79
250 mg
1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione
30103,30105,
30106
+5C
79
250 mg
2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R
30103,30105,
30106
+5C
79
500 mg
Dioctadecyl disulphide ; Batch 1 is valid until 29 August 2012
30103,30104,
30105,30106
+5C
79
250 mg
Didodecyl 3,3'-thiodipropionate R
30103,30105,
30106
+5C
79
250 mg
Dioctadecyl 3,3'-thiodipropionate R
30103,30105,
30106
+5C
79
100 mg
30103
+5C
79
O0140000 Plastic additive 20
100 mg
Oleamide R
30103,30105,
30106,30107
+5C
79
E1260000 Plastic additive 21
100 mg
Erucamide R
30103,30107
+5C
79
100 mg
Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol

Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol
30103
+5C
79
200 mg
di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
Tin-content of 15.4%
30110,30111
+5C
79
59
Yes

Order
Reference Standard
Code
P2160000 Poliomyelitis vaccine (inactivated) BRP

Batch n
2
Quantity Sale
Information
per vial Unit
0.5 ml
5 320-67-282 Ph. Eur. D-Antigen Units per ml for types 1-2-3, respectively
Monograph
Leaflet
Storage
Extra
Price
charges
90
d
0214,2066,20
65,
2328,2061,20
67,
1934,2329,20
720
Yes
-80C
See leaflet,
0215
Yes
-20C
90
P2161000 Poliomyelitis vaccine (oral) BRP
1 ml
P2163920 Poloxamer 124
30 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
P2170000 Polyacrylate - reference spectrum
n/a
79
P2400000 Polymyxin B sulfate
25 mg
65.1% polymyxin B1, 12.5% polymyxin, 3.3% polymyxin B3, 9.1% polymyxin
B1-I
+5C
79
Y0000355 Polymyxin B sulfate for microbiological assay
25 mg
205000 IU per vial
-20C
79
Y0000289 Polysorbate 20 - reference spectrum
n/a
0426
79
n/a
1914
79
n/a
0427
79
n/a
0428
79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent
1500 mg
2152
+5C
79
P2600000 Poly(vinyl chloride)
100 mg
90001,90002,
30114
+5C
79
P2649610 Potassium clavulanate - reference spectrum
n/a
1140
79
Y0001168 Potassium clavulanate impurity G
5 mg
1653
-20C
g(c)
79
Y0000315 Potassium hydrogen aspartate hemihydrate
50 mg
2076
+5C
79
P2650000 Potassium sorbate
100 mg
0618
+5C
79
Y0001275 Potassium sucrose octasulfate
100 mg
1796
+5C
79
P2660000 Povidone
50 mg
0685
+5C
79
Y0000466 Povidone (iodinated)
10 mg
1142
+5C
79
Y0001266 Pramipexole dihydrochloride monohydrate
5 mg
2416
+5C
79
Y0001187 Pramipexole for system suitability
15 mg
2416
+5C
79
Y0001267 Pramipexole impurity D
5 mg
+5C
79
Y0000215 Pravastatin sodium - reference spectrum
n/a
79
Y0000223 Pravastatin impurity A
0.1 mg
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin) ; Batch 4 is valid until 30 September 2011
2059
-20C
79
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine
30 mg
76.4% CHO
2059
-20C
79
log CCID50/ml for types 1,2,3 and total virus content: 6.99, 6.06, 6.83 and
7.20, respectively
0733
(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
0203
2416
Yes
Yes
Yes
2059
60

Order
Reference Standard
Code
P2669000 Prazepam -* psy

Batch n
1
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
Storage
1466
+5C
Extra
Price
charges
79
j
P2670000 Praziquantel
150 mg
99.8% CHNO
0855
+5C
79
P2675000 Praziquantel impurity A
10 mg
(11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]
isoquinolin-4-one
0855
+5C
79
P2680000 Prazosin hydrochloride
50 mg
0856
+5C
79
P2698000 Prednicarbate
100 mg
+5C
79
Y0001443 Prednicarbate for system suitability
10 mg
+5C
79
P2698060 Prednicarbate impurity F
10 mg
P2700000 Prednisolone
150 mg
Y0001359 Prednisolone for peak identification
10 mg
Y0001355 Prednisolone for system suitability
10 mg
P2800000 Prednisolone acetate
120 mg
Y0000582 Prednisolone acetate for peak identification
10 mg
0734,0736,09
33,
0975,1467
0734
P2804000 Prednisolone hexanoate
10 mg
1212
P2805000 Prednisolone pivalate
100 mg
P2810000 Prednisolone sodium phosphate
100 mg
P2900000 Prednisone
100 mg
0354
P2920000 Pregnenolone isobutyrate
150 mg
1 mL
P2939000 Prilocaine
150 mg
P2939060 Prilocaine hydrochloride
100 mg
Y0001408 Prilocaine impurity B
80 mg
2-methylbenzenamine hydrochloride
P2939025 Prilocaine impurity E
25 mg
(RS)-N-(methylphenyl)-2-(propylamino)propanamide
P2940000 Primaquine diphosphate
500 mg
New Y0000263 Prekallikrein activator in albumin BRP
New P2950000 Primidone
99.1% CHO
1467
1467
1467
Prednisolone CRS 6 is suitable for monographs 01/2011:0335, 01/2008:0353, 0335,0353,03
01/2008:0354 and 01/2008:0735 only. ; Batch 6 is valid until 31 December
54, 0735
2011
Yes
+5C
79
Yes
+5C
79
0353
Yes
+5C
79
0353
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0734,0736
+5C
79
0549,0735,08
10
+5C
79
+5C
79
-20C
79
-20C
90
1362
+5C
79
1363
+5C
79
1362,1363
+5C
79
1362,1363
+5C
79
0635
+5C
79
1,2-dihydroprednicarbate
Yes
0993
30 IU per ml ; Batch 2 is valid until 30 April 2012
See leaflet,
20615
Yes
150 mg
0584
Yes
+5C
79
Y0000369 Primidone for peak identification
5 mg
0584
Yes
+5C
79
P3000000 Probenecid
100 mg
0243
+5C
79
P3050000 Procainamide hydrochloride
100 mg
0567
+5C
79
P3090000 Procaine benzylpenicillin
250 mg
0115
+5C
79
P3100000 Procaine hydrochloride
100 mg
0050
+5C
79
P3200000 Prochlorperazine maleate
100 mg
0244,20303
+5C
79
P3300000 Progesterone
50 mg
0429
+5C
79
Y0000148 Progesterone impurity C
10 mg
0429
+5C
79
39.7% CHNO (procaine); 96.3% CHNOS
(20R)-20-hydroxypregn-4-en-3-one
61

Order
Reference Standard
Code
Y0000179 Proguanil hydrochloride - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
2002
Extra
Price
charges
79
l
Y0000181 Proguanil impurity C
10 mg
1,5-bis(4-chlorophenyl)biguanide
2002
+5C
79
Y0000182 Proguanil impurity D
10 mg
1,5-bis(1-methylethyl)biguanide
2002
+5C
79
P3350000 Proline
60 mg
0785,0910,09
11, 1049
+5C
79
P3390000 Promazine hydrochloride
100 mg
0475,1365,20
303
+5C
79
P3400000 Promethazine hydrochloride
50 mg
0524
+5C
79
Y0000769 Promethazine impurity D
10 mg
0524
+5C
79
Y0000797 Promethazine for peak identification
10 mg
0524
+5C
79
P3490000 Propacetamol hydrochloride - reference spectrum
n/a
1366
79
Y0000455 Propafenone hydrochloride
10 mg
Y0000456 Propafenone impurity B
10 mg
Y0000278 Propanol - reference spectrum
n/a
Y0000016 Propofol
290 mg
Y0000017 Propofol for peak identification
0.1 ml
Y0000018 Propofol impurity J
20 mg
P3500000 Propranolol hydrochloride
30 mg
P3600000 Propranolol hydrochloride for performance test
20 mg
0568
Y0000318 Propylene glycol dilaurate
100 mg
2087
Y0000319 Propylene glycol monolaurate
100 mg
P3640000 Propyl gallate
50 mg
P3650000 Propyl parahydroxybenzoate
150 mg
P3700000 Propylthiouracil
100 mg
P3750000 Propyphenazone
200 mg
P3760000 Protirelin
5.03 mg
P3760020 D-His-Protirelin
0.1 mg
P3800000 Proxyphylline
100 mg
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor
100 mg
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification
100 mg
P3900000 Purpureaglucoside A
25 mg
P4000000 Purpureaglucoside B
25 mg
Y0000402 Pyrantel embonate
10 mg
Y0000403 Pyrantel impurity A
20 mg
P4050000 Pyrazinamide
30 mg
(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one
Yes
2103
+5C
79
2103
+5C
79
79
2036
1558
+5C
79
1558
+5C
79
1558
+5C
79
0568,0923
+5C
79
+5C
79
+5C
79
1915
+5C
79
1039
+5C
79
0431,0852,12
63
+5C
79
0525
+5C
79
0636
+5C
79
5.03 mg per vial of pure protirelin peptide CHNO
1144
-20C
79
approx. 0.1 mg per vial
1144
-20C
79
0526
+5C
79
0487,1367
+5C
79
99.9% CHO
2,6-bis (1-methylethyl)-1,4-benzoquinone
99.9% CHO; batch 2 valid until 31/12/10 for use with monograph 0852
and 1263.
2108
Yes
+5C
79
0117
+5C
79
0117
+5C
79
1680
+5C
79
1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine
1680
+5C
79
0859
+5C
79
Star anise oil
62
Yes

Order
Reference Standard
Code
P4099900 Pyridostigmine bromide

Batch n
3
Quantity Sale
Information
per vial Unit
50 mg
1 Batch 2 is valid until 31 January 2012
20 mg
1 pyridin-3-yl-dimethylcarbamate
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
1255
+5C
1255
+5C
79
0245
+5C
79
0245
+5C
79
P4099910 Pyridostigmine impurity A
P4100000 Pyridoxine hydrochloride
100 mg
Y0001226 Pyridoxine impurity A
5 mg
P4200000 Pyrimethamine
250 mg
0288
+5C
79
Y0000659 Pyrrolidone
20 mg
2180
+5C
79
Y0001009 Quercetin dihydrate
20 mg
+5C
79
Q0100000 Quinidine sulfate
300 mg
0017,0018,00
19
+5C
79
Q0200000 Quinine sulfate
300 mg
0017,0018,00
19
+5C
79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP
86 mg
11 IU per vial
-20C
90
Y0000896 Racecadotril
110 mg
99.9% CHNOS
2171
+5C
79
Y0000897 Racecadotril impurity A
1 ml
ethanethioic acid
2171
+5C
79
Y0000898 Racecadotril impurity G
10 mg
benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate
2171
+5C
79
Y0000902 Racecadotril for peak identification
5 mg
+5C
79
Y0001134 Raloxifene hydrochloride
110 mg
+5C
79
Y0001135 Raloxifene hydrochloride for peak identification
10 mg
2375
+5C
79
R0145000 Ramipril
20 mg
1368
+5C
79
R0145005 Ramipril impurity A
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)
1368
+5C
79
R0145010 Ramipril impurity B
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester) ; Batch 2 is valid until 31 January 2011
1368
+5C
79
R0145015 Ramipril impurity C
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril) ; Batch 2 is valid until 31 March 2011
1368
+5C
79
R0145020 Ramipril impurity D
10 mg
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril

diketopiperazine) ; Batch 3 is valid until 30 November 2011
1368
+5C
79
R0150000 Ranitidine hydrochloride
100 mg
0946,1453
+5C
79
Y0000416 Ranitidine impurity J
0.00025
mg
1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine) ; Batch 4 is valid until 1 February 2012
0946
-20C
79
Y0000411 Ranitidine for system suitability
20 mg
0946
+5C
79
Y0000457 Repaglinide
20 mg
2135
+5C
79
Y0000458 Repaglinide for system suitability
6 mg
2135
+5C
79
6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol ; Batch 1 is valid until 31 January

2011
1827
92.9% CHO
See leaflet,
0451
2171
Yes
Yes
2375
99.7% CHClNOS
63
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000459 Repaglinide impurity E
R0200000 Reserpine
New R0250000 Residual solvents solution class 1

Batch n
2
Quantity Sale
Information
per vial Unit
10 mg
1 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid ; Batch 1 is valid until 30 September 2011
Monograph
Extra
Price
charges
79
a
+5C
+5C
79
+5C
79
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
2109
+5C
79
0292,0786
+5C
79
100 mg
99.8% CHNO
0528
1.4 mL
20424
20 mg
benzene-1,3-diol
2348
R0300000 Retinol acetate
1000 mg
1 050 000 IU per g
R0290000 Retinol esters
100 mg
R0500500 Reviparin sodium
250 mg
150 mg
0218,0219,02
20, 1192,1193
Yes
Yes
0217,0218,02
19, 0220
0828
2109
Storage
2135
Y0000767 Resorcinol
New Y0000377 Ribavirin
Leaflet
Yes
Y0000353 Ribavirin for system suitability
1 mg
R0600000 Riboflavin
100 mg
Y0000757 Riboflavin for peak identification
0.1 mg
+5C
79
R0630000 Riboflavin sodium phosphate
250 mg
0786
+5C
79
Y0000662 Ribonucleic acid
100 mg
100.0 %
2090
+5C
79
Y0000149 Rifabutin
150 mg
95.5% CHNO
1657
+5C
79
Y0000184 Rifabutin impurity A
20 mg
1-(2-methylpropyl)piperidin-4-one
1657
+5C
79
R0700000 Rifampicin
100 mg
0052
+5C
79
R0800000 Rifampicin quinone
100 mg
0052
+5C
79
R0900000 Rifamycin B
50 mg
0432
+5C
79
R0950000 Rifamycin S
50 mg
0432
+5C
79
R1000000 Rifamycin sodium
300 mg
856 IU per mg
0432,20702
-20C
79
Y0001074 Rifaximin
160 mg
98.0% CHNO
+5C
79
Y0001075 Rifaximin for system suitability
10 mg
2362
+5C
79
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum
n/a
2020
79
Y0000187 Rilmenidine for system suitability
30 mg
2020
+5C
79
R1000600 Risperidone
50 mg
1559
+5C
79
Y0000370 Risperidone for system suitability
20 mg
1559
+5C
79
Y0001276 Risperidone impurity K
0.015 mg
3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)
1559
+5C
79
Y0000714 Ritonavir
80 mg
99.6% CHNOS
2136
+5C
79
Y0000706 Ritonavir for peak identfication
10 mg
2136
Yes
+5C
79
Y0001302 Rizatriptan benzoate
200 mg
2585
Yes
+5C
79
Y0001303 Rizatriptan for system suitability
15 mg
2585
Yes
+5C
79
R1300000 RK 13 cells
1 ml
0162,1057
Yes
Liquid
nitrogen
100
n/a
Y0000594 Rocuronium bromide - reference spectrum

Vitamin B2
0292
Rifamycin impurity A
2362
cell lines (kidney, rabbit) titration of live measles, mumps and rubella
vaccines
64
Yes
Yes
Yes
79
1764
l
Order
Reference Standard
Code
Y0000527 Rocuronium for peak identification
Batch n
Y0000742 Ropivacaine hydrochloride monohydrate
10 mg
Y0000743 Ropivacaine impurity G
5 mg
(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)
Y0000786 Rosmarinic acid
40 mg
95.5% CHO
R1500000 Roxithromycin
125 mg
96.7% CHNO
Y0000220 Roxithromycin for system suitability
5 mg
R2000000 Rubella vaccine (live) BRP
5 uc
3.6 log (ie 4000) infective viral units per vial
Y0000494 Ruscogenins
10 mg
Y0000105 Rutoside trihydrate
100 mg
S0040000 Saccharin
30 mg
S0050000 Saccharin sodium
50 mg
S0100000 Salbutamol
50 mg
Y0000030 Salbutamol impurity B
5 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol
Y0000071 Salbutamol impurity D
5 mg
5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde
0529,0687
Y0000031 Salbutamol impurity F
5 mg
93.4% CHNO x HSO; 1,1'-[oxybis[methylene(4-hydroxy-1,3phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol]
Y0000034 Salbutamol impurity G
5 mg
Y0000032 Salbutamol impurity I
0.006 mg
Y0001186 Salbutamol impurity J
S0150000 Salbutamol sulfate
50 mg
0687
Y0001288 Salbutamol sulfate for system suitability
10 mg
0687
Y0000669 Salicin
50 mg
S0200000 Salicylic acid
100 mg
Y0000405 Salicylic acid impurity B
10 mg
50 mg
Y0000423 Salmeterol xinafoate for system suitability
25 mg
Y0001052 Santonin
20 mg
99.8% CHO
Y0001049 Saquinavir mesilate
70 mg
99.5% CHNOS
Y0001056 Saquinavir for system suitability
0.3033 mg
Y0000814 Selamectin
100 mg
S0360000 Selegiline hydrochloride
50 mg
S0360090 (RS)-Selegiline hydrochloride
25 mg
New Y0000422 Salmeterol xinafoate
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1764
Yes
-20C
Extra
Price
charges
79
g(c)
2335
+5C
79
2335
+5C
79
1447,2382,
2524
+5C
79
1146
+5C
79
+5C
79
1057,0162
1146
Yes
-80C
90
38.2% ruscogenin
60.4% neoruscogenin
1847
Yes
+5C
79
87.6% CHO ; Batch 2 is valid until 31 January 2012
1795
Yes
+5C
79
0947
+5C
79
0787
+5C
79
0529,1033
+5C
79
+5C
79
+5C
79
0529,0687
+5C
79
2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]
ethanone
0529
+5C
79
(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol ; Batch 3 is valid until 31 March 2011
0529
+5C
79
+5C
79
+5C
79
+5C
79
2312,1583
+5C
79
0366,1185
+5C
79
4-hydroxyisophthalic acid
0366
+5C
79
99.6% CHNO ; Batch 1 is valid until 30 April 2012
1765
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
2268
+5C
79
1260
+5C
79
1260
+5C
79
0.00045 mg 1
0529
0687
99,6% CHO
1765
65
Yes
Yes
Yes
1391,1809
2267
2267
97.6% CHNO
Yes
Yes

Order
Code
S0400000 Senna extract
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
c
0206,0207,02
08, 1261
-20C
0788,1027
+5C
79
S0450000 Serine
50 mg
S0460000 Sertaconazole nitrate
125 mg
+5C
79
200 mg
99.9% CHClN ; Batch 1 is valid until 31 March 2012
1705
Yes
+5C
79
Y0001285 Sertraline impurity E
15 mg
Mandelic acid CRS has been labelled as sertraline impurity E CRS in

anticipation of 01/2011:1705 corrected 7.1
1705
Yes
+5C
79
Y0000866 Sertraline for peak identification
5.4 mg
1705
Yes
+5C
79
Y0000867 Sertraline for system suitability
6.18 mg
1705
+5C
79
Y0000371 Sestamibi labelling kit
22 mg
1926
Yes
+5C
79
Y0001046 Sevoflurane
1 ml
2269
Yes
+5C
g(b)
79
S0500000 Silicone elastomer
2000 mg
30109
+5C
79
S0600000 Silicone oil
1 ml
30108
+5C
79
S0650000 Simvastatin
100 mg
Y0001066 Simvastatin for peak identification
10 mg
S0660000 Sisomicin sulfate
50 mg
77.7% CHNOS ; Batch 1 is valid until 29 February 2012
Y0000014 Sodium alendronate
150 mg
83.3% CHNNaOP
S0695000 Sodium amidotrizoate
125 mg
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum
n/a
Y0000039 Sodium ascorbate
S0700000 Sodium calcium edetate
S0710000 Sodium cetostearyl sulfate
S0750000 Sodium cromoglicate
Y0001300 Sodium cromoglicate for system suitability

S0760000 Sodium cyclamate
S0765000 Diclofenac sodium
New Y0000828 Sertraline hydrochloride
New Y0001410 Sodium fusidate
1148

99.4% CHO ; Batch 3 is valid until 31 August 2011
1538,1563
Yes
-20C
g(c)
79
1563
Yes
-20C
g(c)
79
0331, 1351
Yes
-20C
79
1564
+5C
79
1150
+5C
79
1993
79
50 mg
1791
+5C
79
100 mg
0231
+5C
79
100 mg
0847
+5C
79
10 mg
0562
+5C
79
20 mg
0562
+5C
79
100 mg
0774
+5C
79
100 mg
1002,1281
+5C
79
10 mg
0848
+5C
79
S0781000 Sodium hyaluronate - reference spectrum
n/a
1472
79
S0780000 Sodium hyaluronate BRP
300 mg
0912
+5C
79
New Y0001468 Sodium iodohippurate
15 mg
2352
+5C
79
Y0000620 Sodium laurilsulfate
40 mg
0802
+5C
79
Y0000808 Sodium phenylbutyrate
5 mg
2183
+5C
79
Y0000809 Sodium phenylbutyrate impurity C
10 mg
2183
+5C
79
S0785000 Sodium picosulfate
100 mg
1031
+5C
79
Y0001104 Picosulfate for system suitability
0.5 mg
1031
+5C
79
Y0000210 Sodium polystyrene sulfonate - reference spectrum
n/a
1909
79
Y0000268 Sodium propionate - reference spectrum
n/a
2041
79
4-cyclohexylbutanoic acid
66
Yes

Order
Reference Standard
Code
S0800000 Sodium salicylate

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0413
+5C
1567
+5C
79
1567
+5C
79
S0808000 Sodium stearyl fumarate
50 mg
S0808060 Sodium stearyl maleate
10 mg
S0900000 Sodium taurocholate BRP
10000 mg
0350
+5C
79
S0930000 Sodium valproate
150 mg
0678
+5C
79
S0945000 Somatostatin
2.32 mg
2.32mg somatostatin peptide per vial CHNOS
S0947000 Somatropin
35 mg
1.69 mg somatropin monomer per vial
Y0000711 Somatropin/desamidosomatropin resolution mixture
33 mg
1.7 mg somatropin per vial
S0950000 Sorbic acid
10 mg
Y0000385 1,4-Sorbitan
50 mg
99.2% CHO
S1000000 Sorbitol
1200 mg
97.9 % CHO
Y0000114 Sotalol hydrochloride
25 mg
Y0000115 Sotalol impurity B
20 mg
Y0001011 Spanish sage oil for peak identification
250 mg
Y0000597 Spectinomycin hydrochloride
100 mg
Y0000549 Spectinomycin for system suitability
20 mg
1152
Y0000655 Spectinomycin sulfate tetrahydrate
10 mg
1658
Y0001126 Spike lavender oil
400 l
S1100000 Spiramycin
200 mg
4500 IU per mg
Spiramycin I: 87.3%, Spiramycin II: 0.2%, Spiramycin III: 4.4%
Y0000381 Spirapril hydrochloride monohydrate
60 mg
95.9% CHClNOS
Y0000332 Spirapril for system suitability
15 mg
S1200000 Spironolactone
150 mg
Y0001295 Spironolactone for system suitability
2.055 mg
Y0000185 Squalane
250 l
99.7% CH
1630
Y0001050 St. John's wort standardised dry extract
500 mg
0.050% of hypericin
Y0001091 Standardised artichoke leaf dry extract
60 mg
S1250000 Stanozolol
125 mg
S1250010 Stanozolol impurity A
10 mg
Y0001420 Stanozolol impurity B
10 mg
0949
N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide
-20C
90
See leaflet,
0950,
0951,0952
Yes
-20C
150
0950,0951,09
52
Yes
-20C
150
0592
+5C
79
2048
+5C
79
0435,0436,04
37,
1235,1236,13
37,
1381,1531,20
48
+5C
79
2004
+5C
79
2004
+5C
79
1849
Yes
1152
81.3% CHClNO and CHClNO
Yes
+5C
79
-20C
79
-20C
79
-20C
79
2419
Yes
+5C
79
0179,0293,19
82,
1983,20702
1766
Yes
-20C
79
+5C
79
1766
+5C
79
0688
Yes
+5C
79
0688
Yes
+5C
79
+5C
79
1874
Yes
-20C
79
2389
Yes
-20C
79
1568
+5C
79
1568
+5C
79
1568
+5C
79
99.6% CHOS; Spironolactone CRS 2 is suitable for monograph

01/2008:0688 only.
(5,17)-17-hydroxy-17-methylandrostan-3-one
67

Order
Code
S1300000 Starch BRP
Reference Standard

Batch n
4
Quantity Sale
per vial Unit
50000 mg 1
Information
Monograph
Leaflet
0350
Y0000408 Stavudine
100 mg
Y0000421 Stavudine for system suitability
10 mg
S1340000 Stearic acid
100 mg
Plastic additive 19
S1350000 Stearyl alcohol
250 mg
100% CHO
Y0000868 Streptokinase for system suitability
30 l
S1400000 Streptomycin sulfate
100 mg
S1500000 Succinylsulfathiazole
100 mg
Y0001324 Sucralfate
Y0001344 Sucralose
Y0001342 Sucralose impurity B
0.5 mg
S1600000 Sucrose
100 mg
S1608100 Sufentanil - reference spectrum
S1609000 Sufentanil citrate - reference spectrum
Y0000529 Sulbactam sodium

Y0000528 Sulbactam
+5C
2130
99.6% CHNO
2130
Storage
Yes
0229,0882,14
74,
2058,30103,
30105,
30106,
30107
0702,0753,08
01,
0802,0847,09
69,
1123,1340,14
11
Extra
Price
charges
79
a
+5C
79
+5C
79
+5C
79
+5C
79
0356
Yes
-20C
79
Yes
-20C
79
0032,0033,00
53,
0485,20702
0357
+5C
79
10 mg
1796
+5C
79
550 mg
2368
+5C
79
2368
+5C
79
0177,0178,01
87,
0188,0204,02
09,
1061,1570,23
18
+5C
79
n/a
1569
79
n/a
1269
79
10 mg
150 mg
Y0000550 Sulbactam for peak identification
20 mg
2209
S1700000 Sulfacetamide sodium
50 mg
0107
S1800000 Sulfadiazine
100 mg
S1900000 Sulfadimidine
100 mg
S1950000 Sulfadoxine
50 mg
S1975000 Sulfafurazole
100 mg
S1975600 Sulfaguanidine
60 mg
S2000000 Sulfamerazine
100 mg
S2050000 Sulfamethizole
100 mg
77 000 IU per vial ; Batch 3 is valid until 31 August 2011
1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose)
Yes
2209
+5C
79
2209
-20C
79
+5C
79
+5C
79
0294
+5C
79
0295
+5C
79
0740
+5C
79
0741
+5C
79
1476
+5C
79
0358,1571
+5C
79
0637
+5C
79
99.7% CHNOS
68
Yes

Order
Reference Standard
Code
S2100000 Sulfamethoxazole

Batch n
1
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
Storage
0108
+5C
Extra
Price
charges
79
a
Y0000412 Sulfamethoxazole impurity A
5 mg
N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide
0108
+5C
79
Y0000413 Sulfamethoxazole impurity F
5 mg
4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide
0108
+5C
79
S2150000 Sulfamethoxypyridazine
50 mg
0638
+5C
79
S2151000 Sulfanilamide
100 mg
1571
+5C
79
S2159100 Sulfapyridine
20 mg
S2155000 Sulfasalazine
250 mg
99.9 % CHNOS
S2155010 Sulfasalazine derivative for resolution
20 mg
2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid
S2158000 Sulfathiazole
100 mg
S2159000 Sulfinpyrazone
30 mg
Y0001238 Sulfinpyrazone for system suitability
0.5 mg
S2159010 Sulfinpyrazone impurity A
20 mg
1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
0790
S2159015 Sulfinpyrazone impurity B
20 mg
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
S2160000 Sulfisomidine
50 mg
S2180000 Sulindac
50 mg
S2190000 Sulpiride
100 mg
S2191000 Sulpiride impurity A
20 mg
[(2RS)-1-ethylpyrrolidin-2-yl]methanamine
S2192000 Sulpiride impurity B
20 mg
methyl 2-methoxy-5-sulphamoylbenzoate
Y0000530 Sultamicillin
10 mg
Y0000531 Sultamicillin tosilate
200 mg
Y0000532 Sultamicillin for peak identification
10 mg
Y0000022 Sumatriptan succinate
50 mg
Y0000026 Sumatriptan impurity mixture
Y0000027 Sumatriptan for system suitability
S2200000 Suxamethonium chloride

S2400000 Suxibuzone
0863
+5C
79
0863,1457
+5C
79
0863
+5C
79
0742
+5C
79
0790
+5C
79
+5C
79
+5C
79
0790
+5C
79
0639
+5C
79
0790
Contains 0.3% m/m of E-isomer
Yes
0864
+5C
79
1045,1348
+5C
79
1045,1490
+5C
79
1045
+5C
79
+5C
79
+5C
79
2211
92.5% CHNOS
2211,2212
Yes
2211
Yes
98.8% CHNOS
1573
3 mg
1573
2 mg
1573
1000 mg
50 mg
S2400004 Suxibuzone impurity B
10 mg
S2400006 Suxibuzone impurity C
10 mg
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.

use) BRP
1 mg
6.5 x10 Cfu per vial
See leaflet,
0064
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.

use) BRP
1 mg
2.6 x10 Cfu per vial

99.9% CHNO
New Y0001417 Tadalafil
+5C
79
-20C
79
Yes
-20C
79
Yes
-20C
79
0248
+5C
79
1574
+5C
79
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
1574
+5C
79
4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione
1574
+5C
79
Yes
+5C
e(b)
90
See leaflet,
0064
Yes
+5C
e(b)
90
2606
Yes
+5C
79
+5C
79
+5C
79
+5C
79
200 mg
T0010000 Talampicillin hydrochloride
50 mg
0808,0852
T0014000 Tamoxifen citrate
80 mg
1046
T0015000 Tamoxifen citrate for performance test
30 mg
1046
69
Yes

Order
Reference Standard
Code
Y0000650 Tamsulosin hydrochloride

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
2131
+5C
Extra
Price
charges
79
a
Y0000653 Tamsulosin racemate
10 mg
2131
+5C
79
Y0000651 Tamsulosin impurity D
10 mg
2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide
2131
+5C
79
Y0000652 Tamsulosin impurity H
10 mg
(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine
2131
+5C
79
Y0001102 Teicoplanin
52 mg
51550 IU per ampoule
2358
-20C
79
Y0001047 Teicoplanin for identification
40 mg
2358
-20C
79
Y0000648 Telmisartan
30 mg
2154
+5C
79
Y0000649 Telmisartan for peak identification
10 mg
2154
Yes
+5C
79
Y0001003 Telmisartan for system suitability
0.26 mg
2154
Yes
T0040000 Temazepam - * psy
50 mg
Y0000344 Temazepam impurity C
5 mg
Y0000345 Temazepam impurity D
5 mg
Y0000346 Temazepam impurity F
Y0000347 Temazepam impurity G
Yes
+5C
79
0879
+5C
79
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate
0954
+5C
79
(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one
0954
+5C
79
5 mg
(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
0954
+5C
79
5 mg
(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
0954
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
T0040800 Tenoxicam
100 mg
1156
Y0001114 Tenoxicam impurity mixture
0.0042 mg
1156
Y0000621 Terazosin hydrochloride dihydrate
40 mg
2021
Y0000666 Terazosin for system suitability
0.5 mg
2021
Y0000622 Terazosin impurity A
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2021
Y0000665 Terazosin impurity E
10 mg
2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
2021
Y0000623 Terazosin impurity L
10 mg
1-(furan-2-ylcarbonyl)piperazine
2021
Y0000624 Terazosin impurity N
10 mg
1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine
2021
Y0000535 Terbinafine hydrochloride
10 mg
1734
Y0001143 Terbinafine for system suitability
10 mg
1734
T0050000 Terbutaline sulfate
100 mg
0690
+5C
79
T0050015 Terbutaline impurity C
15 mg
1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone
0690
+5C
79
T0060000 Terconazole
250 mg
1270
+5C
79
T0071000 Terfenadine
100 mg
0955
+5C
79
T0080000 Terfenadine impurity A
20 mg
0955
+5C
79
T0100000 Testosterone
30 mg
1373
+5C
79
T0200000 Testosterone acetate
10 mg
0297
+5C
79
T0210000 Testosterone caproate
50 mg
1048
+5C
79
1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
butan-1-one
70
Yes
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
T0240000 Testosterone decanoate

Batch n
2
Quantity Sale
per vial Unit
50 mg
1 99.8% CHO
Information
Monograph
Leaflet
1048, 1736
Y0000696 Testosterone decanoate for system suitability
0.4 mg
1736
T0250000 Testosterone enantate
100 mg
1048
Y0001317 Testosterone enantate for system suitability
2 mg
1048
Y0001312 Testosterone enantate for peak identification
10 mg
1048
Y0001313 Testosterone enantate impurity H
10 mg
delta-5-testosterone-3,17-dienantate
Y0000342 Testosterone for impurity D identification
20 mg
Y0000343 Testosterone for system suitability
20 mg
T0260000 Testosterone isocaproate
50 mg
Y0000716 Testosterone isocaproate for system suitability
5 mg
T0300000 Testosterone propionate
50 mg
Y0000170 Testosterone propionate - reference spectrum
n/a
0297
New Y0001409 Testosterone propionate for system suitability
5 mg
0297
T0400000 Tetanus vaccine (adsorbed)
30 mg
490 IU per ampoule for challenge assays in guinea-pigs

260 IU per ampoule for challenge assays in mice ; Batch 2 is valid until 31
July 2011
See leaflet,
20708
Y0001087 Tetra-O-acetyl-mannose triflate
60 mg
100.0% CHFOS
99.9% CHO
-20C
Yes
Extra
Price
charges
79
g(c)
-20C
g(c)
79
-20C
g(c)
79
Yes
-20C
g(c)
79
Yes
-20C
g(c)
79
1048
-20C
g(c)
79
1373
+5C
79
1373
+5C
79
1048,1737
+5C
79
+5C
79
+5C
79
79
Yes
+5C
79
Yes
-20C
90
-20C
79
1737
Testosterone propionate CRS 1 is suitable for 01/2008:1048 only
Storage
Yes
1048
2294
T0500000 Tetracaine hydrochloride
100 mg
0057
+5C
79
Y0001002 Tetracaine for system suitability
2 mg
0057
Yes
+5C
79
T0550000 Tetracosactide
0.366 mg
366 g per vial of CHNOS
0644
Yes
T0600000 Tetracycline hydrochloride
100 mg
96.7% CHClNO
Y0001165 Tetrandrine
20 mg
Y0000015 Tetrazepam - reference spectrum
n/a
Y0000008 Tetrazepam impurity C
20 mg
Y0000460 Tetryzoline hydrochloride
10 mg
Y0000723 Thebaine - * narc
10 mg
T0700000 Theobromine
100 mg
T0800000 Theophylline
100 mg
Y0000294 Theophylline - reference spectrum
Y0000336 Thiamazole
Y0000372 Thiamazole impurity A
15 mg
Y0000373 Thiamazole impurity C
20 mg
Y0000467 Thiamine hydrochloride
10 mg
Y0000059 Thiamine impurity E
10 mg
-20C
79
0173,0198,01
99,
0210,0211,16
54
+5C
79
2478
+5C
79
79
1738
+5C
79
1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
2101
+5C
79
1839,1841
+5C
79
0298
+5C
79
0300,0301
+5C
79
n/a
0299,0302
79
125 mg
1706
+5C
79
2,2-dimethoxy-N-methylethanamine
1706
+5C
79
1-methyl-2-(methylsulphanyl)-1H-imidazole
1706
+5C
79
0303
+5C
79
0303,0531
+5C
79
99.5% CHNO
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
71

Order
Reference Standard
Code
Y0000060 Thiamine nitrate - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Storage
0531
T1100000 Thiamphenicol
125 mg
Y0000546 Thioctic acid
110 mg
Y0000592 Thioctic acid for system suitability
10 mg
Y0000545 Thioctic acid containing impurity B
30 mg
Y0000109 Thiomersal
T1200000 Thiopental
Y0000704 Thioridazine
T1300000 Thioridazine hydrochloride
Y0000541 Thioridazine for system suitability
0.21 mg
T1305100 Thioxanthene
20 mg
T1305000 Thioxanthone
10 mg
T1340000 Threonine
50 mg
T1350000 Thymol
50 mg
T1410000 Tiabendazole
50 mg
Y0000414 Tiamulin for peak identification
10 mg
Y0000333 Tiamulin hydrogen fumarate
500 mg
Y0000379 Tiamulin - reference spectrum
n/a
Y0000151 Tianeptine sodium - reference spectrum
n/a
Y0000152 Tianeptine for system suitability
30 mg
Y0000153 Tianeptine impurity A
20 mg
T1405000 Tiapride hydrochloride
60 mg
T1405050 Tiapride N-oxide
20 mg
T1410900 Tiaprofenic acid
50 mg
T1410910 Tiaprofenic acid impurity C
20 mg
Y0000748 Tibolone - reference spectrum
n/a
1739
Y0000668 Tibolone for system suitability
10 mg
1739
Y0000465 Ticarcillin monosodium
250 mg
93.2% CHNNaOS
Correction factor 1.054
T1420010 Ticarcillin impurity A
50 mg
89.8% CHNOS; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)

acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)
T1423000 Ticlopidine hydrochloride
50 mg
Extra
Price
charges
79
l
0109
+5C
79
1648
+5C
79
1648
+5C
79
1648
+5C
79
30 mg
1625
+5C
79
500 mg
0212
+5C
79
10 mg
2005
+5C
79
100 mg
0586
+5C
79
99.8% CHOS
+5C
79
1347
+5C
79
1347
+5C
79
0785,1049
+5C
79
0791
+5C
79
0866
+5C
79
0586, 2005
98.6% CHNOS ; Batch 1 is valid until 31 July 2011
Yes
1659
Yes
+5C
79
1659,1660
Yes
+5C
79
1660
79
2022
79
2022
+5C
79
2022
+5C
79
1575
+5C
79
1575
+5C
79
1157
+5C
79
1157
+5C
79
79
+5C
79
0956
+5C
79
0956
+5C
79
1050
+5C
79
1050
+5C
79
79
T1423025 Ticlopidine impurity F
10 mg
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum
n/a
T1450000 Timolol maleate
100 mg
Y0000644 (R)-timolol
20 mg
Leaflet
ethyl 7-bromoheptanoate
(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid
6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
Yes
1767
72
0572
+5C
79
0572
+5C
79

Order
Reference Standard
Code
Y0001270 Timolol for system suitability

Batch n
1
Quantity Sale
per vial Unit
5.045 mg 1
Information
Monograph
Leaflet
Storage
0572
Yes
+5C
Extra
Price
charges
79
a
T1470000 Tinidazole
100 mg
1051
+5C
79
Y0000899 Tinidazole impurity A
10 mg
2-methyl-5-nitro-1H-imidazole
1051
+5C
79
T1471000 Tinidazole impurity B
20 mg
1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole
1051
+5C
79
T1490000 Tinzaparin sodium
250 mg
0828
+5C
79
Y0000292 Tioconazole - reference spectrum
n/a
2074
79
Y0000282 Tioconazole for system suitability
50 mg
2074
+5C
79
Y0001188 Tiotropium bromide monohydrate
10 mg
2420
+5C
79
Y0001189 Tiotropium for system suitability
10 mg
2420
+5C
79
Y0001179 Tiotropium impurity mixture
0.08 mg
2420
+5C
79
Y0001216 Tiotropium impurity F
10 mg
dithiophen-2-ylmethanone
2420
+5C
79
T1500000 Tobramycin
49 mg
49 mg per vial of CHNO; Suitable for LC assay only ; Batch 3 is valid until
1 August 2011
0645
Yes
+5C
79
Y0000383 All-rac-alpha-tocopherol for peak identification
15 mg
0692
Yes
+5C
79
Y0000384 All-rac-alpha-tocopheryl acetate for peak identification
30 mg
0439
Yes
+5C
79
T1550000 alpha-Tocopherol
500 mg
97.4% CHO ; Vitamin E
0692,1256,20
432
+5C
79
T1600000 alpha-Tocopheryl acetate
500 mg
97.8% CHO
0439,0691,12
57
+5C
79
Y0001210 Tobramycin for identification
250 mg
Suitable for identification tests only
T1610000 RRR-alpha-Tocopheryl hydrogen succinate
125 mg
98.6% CHO
Yes
Yes
0645
+5C
79
1258,1259
+5C
79
T1700000 Tolbutamide
100 mg
0304
+5C
79
Y0000154 Tolfenamic acid
100 mg
2039
+5C
79
T1707000 Tolnaftate
60 mg
1158
+5C
79
Y0001123 Tolnaftate for system suitability
10 mg
1158
+5C
79
Y0000461 Torasemide anhydrous
10 mg
2132
+5C
79
Y0001366 Torasemide impurity E
0.0006 mg
ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
2132
+5C
79
Y0000462 Torasemide for system suitability
5 mg
2132
Y0000155 Tramadol hydrochloride
75 mg
Y0000156 Tramadol impurity A
15 mg
Y0000157 Tramadol impurity E
15 mg
Y0000072 Tramazoline hydrochloride monohydrate
20 mg
Y0000065 Tramazoline impurity A
10 mg
Y0000066 Tramazoline impurity B
10 mg
Y0000501 Trandolapril
10 mg
+5C
79
1681
+5C
79
(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol
1681
+5C
79
(2RS)-2-[(dimethylamino)methyl]cyclohexanone ; Batch 2 is valid until 31

August 2011
1681
+5C
79
1597
+5C
79
N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine
1597
+5C
79
75% CHNO; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one
1597
+5C
79
2245
+5C
79
73
Yes

Order
Reference Standard
Code
Y0000495 Trandolapril impurity C

Batch n
1
Quantity Sale
Information
Monograph
per vial Unit
10 mg
1 (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
2245
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
Y0000496 Trandolapril impurity D
10 mg
T1810000 Tranexamic acid
50 mg
0875
T1820000 Trapidil
50 mg
1576
T1820002 Trapidil impurity A
20 mg
5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
T1820004 Trapidil impurity B
20 mg
1,2,4-triazol-3-amine
Y0001172 Trehalose dihydrate
250 mg
89.8% CHO,2HO
T1850000 Tretinoin
50 mg
T1899000 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum
n/a
1325
G0400010 Triacetin - reference spectrum
n/a
T1899990 Triamcinolone
150 mg
T1900000 Triamcinolone acetonide
100 mg
New Y0001459 Triamcinolone acetonide for system suitability
ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)
Leaflet
Storage
+5C
2245
Extra
Price
charges
79
a
+5C
79
+5C
79
+5C
79
1576
+5C
79
1576
+5C
79
2297
+5C
79
0693,1019,13
85
+5C
g(b)
79
79
Yes
79
1376
1106
+5C
79
0533,0867,10
75
+5C
79
10 mg
0533
+5C
79
T1950000 Triamcinolone hexacetonide
100 mg
0533,0867
+5C
79
Y0000050 Triamcinolone impurity C
10 mg
1376
+5C
79
Y0000837 Triamterene
10 mg
0058
+5C
79
Y0000870 Triamterene impurity B
0.5 mg
+5C
79
T1975000 Triazolam - * psy
10 mg
+5C
79
Y0000165 Tribenoside
150 mg
98.9% CHO
1740
Y0000166 Tribenoside impurity A
60 mg
90.2% CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose ; Batch 2 is valid until 31 January 2012
1740
Y0001055 Tributyl acetylcitrate
1 mL
1770
Y0000279 Tri-n-butyl phosphate
300 l
1682
Y0000799 Tributyl acetylcitrate for peak identification
25 mg
1770
T1977990 Tricaprin
150 mg
T1977995 Tricaproin
40 mg
9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
0058
2,7-diamino-6-phenylpteridin-4-ol
Yes
Yes
1065
+5C
79
-20C
g(c)
79
+5C
79
+5C
79
+5C
79
1410
-20C
79
1410
-20C
79
-20C
79
79
79
79
Yes
Yes
T1978000 Tricaprylin
225 mg
1410
Y0000111 Trichloroacetic acid - reference spectrum
n/a
1967
T1985000 Trichlorotrifluoroethane
2.5 ml
0393
T1986000 Triethyl citrate - reference spectrum
n/a
1479
T2000000 Trifluoperazine hydrochloride
100 mg
0059,20303
+5C
79
T2005000 Triflusal
50 mg
1377
+5C
79
T2005010 Triflusal impurity B
25 mg
1377
+5C
79
2-hydroxy-4-(trifluoromethyl)benzoic acid
74
Yes
+5C

Order
Reference Standard
Code
Y0000720 Triglycerol diisostearate

Batch n
1
Quantity Sale
per vial Unit
200 mg
1
Y0000108 Trihexyphenidyl hydrochloride
100 mg
Y0000068 Trihexyphenidyl impurity A
20 mg
Information
Monograph
1-phenyl-3-(piperidin-1-yl)propan-1-one
Leaflet
Storage
Extra
Price
charges
79
a
2032
+5C
1626
+5C
79
1626
+5C
79
T2009000 Trilaurin
1250 mg
1410
-20C
79
Y0001319 Trimebutine maleate
10 mg
2182
+5C
79
Y0001260 Trimebutine for system suitability
1.017 mg
2181,2182
+5C
79
Y0000092 Trimetazidine dihydrochloride - reference spectrum
n/a
1741
79
Y0000093 Trimetazidine for system suitability
50 mg
T2100000 Trimethadione
250 mg
50 mg
Yes
1741
+5C
79
0440
+5C
79
0060
+5C
79
0.00075 mg 1
0060
+5C
79
0060
+5C
79
100% CHNO
T2200000 Trimethoprim
Y0000684 Trimethoprim for system suitability
T2200010 Trimethoprim impurity B
10 mg
T2450000 Trimethyltetradecylammonium bromide
200 mg
0378
+5C
79
T2500000 Trimipramine maleate
100 mg
0534
+5C
79
Y0000759 Trimipramine for peak identification
0.51 mg
0534
+5C
79
T2500100 Trimyristin
500 mg
1410
-20C
79
T2501200 Tristearin
100 mg
1410
-20C
79
T2545000 Trolamine
2250 mg
1577
+5C
79
Y0001184 Trolamine impurity A
250 mg
Ethanolamine
1577
+5C
79
Y0001183 Trolamine impurity B
1 ml
Diethanolamine
1577
+5C
79
T2550000 Trometamol
100 mg
1053
+5C
79
T2580000 Tropicamide
50 mg
1159,1197
+5C
79
Y0001247 Tropicamide impurity C
10 mg
(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)
1159
+5C
79
Y0001248 Tropicamide impurity D
10 mg
Phenylacetic acid
1159
+5C
79
Y0001316 Tropicamide for peak identification
10 mg
1159
+5C
79
Y0000616 Tropisetron hydrochloride
40 mg
2102
+5C
79
Y0000618 Tropisetron impurity B
10 mg
2102
+5C
79
T2580300 Tropine
50 mg
1308
+5C
79
Y0000429 Trospium chloride
10 mg
1798
+5C
79
Y0000432 Trospium impurity A
20 mg
hydroxydiphenylacetic acid (benzilic acid)
1798
+5C
79
Y0000431 Trospium impurity B
15 mg
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate
1798
+5C
79
Y0000430 Trospium impurity C
5 mg
(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
1798
+5C
79
Y0000497 Troxerutin
30 mg
T2600000 Trypsin BRP
100 mg
T2610000 Tryptophan
100 mg
(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone ; Batch 3 is
valid until 2 February 2012
1H-indole-3-carboxylic acid
0.707 microkatal per mg
75
Yes
2133
+5C
79
0476,0579,05
80, 0694
+5C
79
1272
+5C
79

Order
Reference Standard
Code
T2800000 Tubocurarine chloride

Batch n
1
Quantity Sale
per vial Unit
100 mg
1 87.75% CHClNO
150 mg
1 1035 IU per mg
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
0305
+5C
1273,1274,16
61, 20702
+5C
79
+5C
79
+5C
79
79
+5C
79
+5C
79
T2880000 Tylosin
T2880100 Tylosin D
5 mg
1273,1274,16
61
Y0000498 Tylosin phosphate for peak identification
10 mg
1273,1274,16
61
T2880200 Tylosin tartrate - reference spectrum
n/a
1274
T2900000 Tyrosine
50 mg
T3000000 Tyrothricin
20 mg
0782,0895,11
61,
1272,1384
0907,1662
U0020000 Ubidecarenone
50 mg
1578
+5C
79
U0020001 Ubidecarenone for system suitability
1 mg
1578
+5C
79
U0020008 Ubidecarenone impurity D
5 mg
5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione ; Batch 1 is valid until 31 August 2011
1578
+5C
79
U0100000 Uracil arabinoside
60 mg
0760
+5C
79
U0600000 Urea
100 mg
0743
+5C
79
U0800000 Ursodeoxycholic acid
100 mg
1189,1275
+5C
79
Y0001163 Ursodeoxycholic acid for system suitability
1.26 mg
1275
Yes
+5C
79
Y0000834 Valaciclovir hydrochloride (anhydrous)
100 mg
1768
Yes
+5C
79
Y0001225 Valaciclovir for system suitability
10 mg
1768
Yes
+5C
79
Y0001096 Valaciclovir impurity D
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate
1768
+5C
79
Y0001097 Valaciclovir impurity E
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate
1768
+5C
79
Y0001098 Valaciclovir impurity F para-toluenesulfonate
12 mg
2-hydroxyethyl L-valinate
1768
+5C
79
Y0001099 Valaciclovir impurity G
10 mg
N,N-dimethylpyridin-4-amine
1768
+5C
79
Y0000583 Valerian standardised dry extract
400 mg
0.38% CHO
-20C
79
V0030000 Valine
50 mg
0770,0771,07
96
+5C
79
Y0000584 Valnemulin hydrochloride
10 mg
2137
+5C
79
Y0000533 Valnemulin hydrogen tartrate
120 mg
2137
+5C
79
Y0000585 Valnemulin for peak identification
20 mg
+5C
79
Y0000586 Valnemulin impurity E
10 mg
+5C
79
V0033000 Valproic acid
100 mg
1378
+5C
79
Y0001422 Valproic acid for system suitability
10 mg
1378,0678
+5C
79
0453,1898,18
99,2400,2526
98.7% CHNOS
2137
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
76
Yes
Yes
Yes
Yes
2137
Yes

Order
Code
Y0001132 Valsartan
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
2423
Storage
+5C
Extra
Price
charges
79
a
Y0001131 Valsartan for peak identification
10 mg
2423
Yes
+5C
79
Y0001145 Valsartan for system suitability
0.202 mg
2423
Yes
+5C
79
V0045000 Vancomycin hydrochloride
100 mg
1058,20702
Yes
-20C
79
V0050000 Vanillin
100 mg
0747
+5C
79
Y0001198 Varicella vaccine ( live)
420 mg
0648
-80C
90
Y0000561 Vecuronium bromide
10 mg
1769
+5C
79
Y0000625 Vecuronium for peak identification
10 mg
1769
+5C
79
Y0001093 Vedaprofen
5 mg
2248
+5C
79
Y0001118 Vedaprofen impurity mixture
0.006 mg
50 mg
New Y0000587 Venlafaxine hydrochloride
102000 IU per vial ; Batch 2 is valid until 31 July 2011
2248
Yes
Yes
+5C
79
2119
Yes
+5C
79
Y0000588 Venlafaxine for system suitability
1 mg
2119
+5C
79
V0100000 Verapamil hydrochloride
100 mg
0573
+5C
79
V0100018 Verapamil impurity I
5 mg
(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride
0573
+5C
79
V0100026 Verapamil impurity M
10 mg
5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]
0573
+5C
79
Y0000661 Verbenalin
11 mg
0.97 mg per vial of CHO
V0180000 VERO cells
1 ml
Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of

live measles, mumps and rubella vaccines
New Y0001400 Vigabatrin
10 mg
New Y0001401 Vigabatrin impurity A
25 mg
94.7% CHNO; (5RS)-5-ethenylpyrrolidin-2-one
2305
New Y0001402 Vigabatrin impurity B
20 mg
(2E)-2-(2-aminoethyl)but-2-enoic acid
2305
New Y0001404 Vigabatrin impurity D
50 mg
4-aminobutanoic acid
New Y0001403 Vigabatrin impurity E
n/a
10 mg
2-[(2RS)-2-aminobut-3-enyl]propanedioic acid
V0300000 Vinblastine sulfate
5 mg
V0305000 Vinblastine sulfate - reference spectrum
n/a
V0400000 Vincristine sulfate
4.98 mg
V0405000 Vincristine sulfate - reference spectrum
n/a
V0500000 Vindesine sulfate
5.11 mg
V0500010 Vindesine sulfate - reference spectrum
n/a
Y0000463 Vinorelbine tartrate
50 mg
Y0000464 Vinorelbine impurity B
7 mg
Y0000589 Vinpocetine
10 mg
Y0000590 Vinpocetine impurity A
10 mg
1854
+5C
79
Liquid
nitrogen
100
+5C
79
-20C
79
+5C
79
2305
+5C
79
2305
+5C
79
0748,0749
-80C
g(d)
79
79
79
79
g(d)
79
79
0213,0538,10
57
Yes
2305
Yes
0748
4.98 mg per vial of CHNOS ; Batch 4 is valid until 31 January 2011
0748,0749
-80C
0749
1276
-80C
1276
4-O-deacetylvinorelbine ; Batch 2 is valid until 31 March 2011
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
77
2107
-80C
g(d)
79
2107
-80C
g(d)
79
2139
+5C
79
2139
+5C
79

Order
Reference Standard
Code
Y0000591 Vinpocetine impurity B

Batch n
1
Quantity Sale
Information
Monograph
per vial Unit
10 mg
1 (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
2139
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
Leaflet
+5C
Y0000790 Vinpocetine impurity C
10 mg
ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)
2139
Y0000760 Vinpocetine impurity D
10 mg
(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
Y0000793 Vinyl acetate
200 mg
Y0001395 Voriconazole
120 mg
Y0001396 Voriconazole impurity B
10 mg
(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol
2576
Y0001398 Voriconazole impurity D
10 mg
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)
Y0001397 Voriconazole impurity E
50 mg
[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)
W0100000 Warfarin sodium
10 mg
Y0000778 Warfarin sodium clathrate
X0075000 Xylazine hydrochloride
Y0000158 Xylazine impurity C
50 mg
2,6-dimethylphenyl isothiocyanate
1481
Y0000159 Xylazine impurity E
15 mg
87.5% CHNS ; methyl (2,6-dimethylphenyl)carbamodithioate ; Batch 1 is

valid until 31 May 2011
1481
Yes
Y0001224 Xylazine impurity mixture
0.02 mg
1481
Yes
X0080000 Xylitol
500 mg
X0100000 Xylometazoline hydrochloride
100 mg
X0101000 Xylometazoline impurity A
10 mg
X0200000 Xylose
100 mg
Y0000656 Yohimbine hydrochloride
20 mg
99.1% CHClNO
2172
Z1900000 Zidovudine
60 mg
99.5% CHNO
1059
Z1902000 Zidovudine impurity A
10 mg
1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl pyrimidine-2,4
(1,3)-dione
Z1904000 Zidovudine impurity B
10 mg
1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione
Z2000000 Zinc acexamate
50 mg
Z2000010 Zinc acexamate impurity A
50 mg
6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid
Y0001286 Ziprasidone hydrochloride monohydrate
100 mg
95.6% CHClNOS
2421
Y0001272 Ziprasidone for system suitability 1
10 mg
2421
Y0001241 Ziprasidone for system suitability 2
0.465 mg
2421
Z2500000 Zolpidem tartrate - * psy
200 mg
1280
Storage
+5C
79
2139
+5C
79
2152
+5C
79
+5C
79
+5C
79
2576
+5C
79
2576
+5C
79
0698,0699
+5C
79
10 mg
0699
+5C
79
125 mg
1481
+5C
79
+5C
79
+5C
79
+5C
79
2576
99.2% CHO
N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide
78
Yes
Extra
Price
charges
79
a
Yes
1381
+5C
79
0972,1162
+5C
79
1162
+5C
79
1278
+5C
79
+5C
79
+5C
79
1059
+5C
79
1059
+5C
79
1279
+5C
79
1279
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
Yes

Order
Reference Standard
Code
Z2500010 Zolpidem impurity A

Batch n
3
Quantity Sale
Information
per vial Unit
10 mg
1 N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide
Monograph
Leaflet
Storage
1280
+5C
Extra
Price
charges
79
a
Z3000000 Zopiclone -* psy
60 mg
1060
+5C
79
Z3001000 Zopiclone oxide
20 mg
1060
+5C
79
Y0000062 Zuclopenthixol decanoate - reference spectrum
n/a
1707
79
Y0000534 Zuclopenthixol for system suitability
0.26 mg
+5C
79
Y0000083 Zuclopenthixol impurity B
10 mg
+5C
79
1707
2-chloro-9H-thioxanthen-9-one
79
1707
Yes

Web Catalog CRS

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Web Catalog CRS

Uploaded by

Copyright:

Available Formats

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Y0000116 Acamprosate impurity A

Y0000354 Acarbose for identification

Y0000427 Acarbose for peak identification

A0040000 Acebutolol hydrochloride

Y0000359 Acebutolol impurity B

Y0000127 Acebutolol impurity C

Y0000128 Acebutolol impurity I

Y0000056 Aceclofenac - reference spectrum

Y0001094 Aceclofenac for peak identification

Y0000085 Aceclofenac impurity F

Y0000086 Aceclofenac impurity H

Y0000811 Acemetacin impurity A

Y0000842 Acemetacine impurity mixture

A0070000 Acesulfame potassium

A0070020 Acesulfame potassium impurity B

Y0001084 Acetazolamide for system suitability

Y0000002 Acetylcholine chloride

Batch 2 is valid until 29 February 2012

A0152000 Acetylcysteine impurity C

88.5% CHNOS; N,N'-diacetyl-L-cystine ; Batch 6 is valid until 31

A0153000 Acetylcysteine impurity D

Y0000642 -Acetyldigoxin for peak identification

A0200000 Acetylsalicylic acid

Batch 3 is valid until 29 February 2012

Batch 1 is valid until 31 July 2011

Y0000693 Acholeplasma laidlawii BRP

Y0001271 Aciclovir for peak identification 1

Y0001269 Aciclovir for peak identification 2

Batch 2 is valid until 31 January 2012

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Y0001120 Adapalene impurity C

1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 1 is valid until 31 July

Y0001119 Adapalene for peak identification

Y0000110 Adipic acid

Y0000883 Adrenaline with impurity F

A0300000 Adrenaline tartrate

Batch 4 is valid until 31 August 2011

Batch 1 is valid until 30 April 2012

New Y0000740 Adrenaline impurity mixture

Y0000728 Agnus castus fruit standardised dry extract

Batch 2 is valid until 31 July 2011

A0325200 Alcuronium chloride

New A0325450 Alfacalcidol

99.8% CHO ; Batch 6 is valid until 31 March 2012

A0325451 Alfacalcidol - reference spectrum

A0325500 Alfentanil hydrochloride - reference spectrum

A0325800 Alfuzosin hydrochloride

Y0000832 Alfuzosin for system suitability

A0350010 Allopurinol impurity A

A0350020 Allopurinol impurity B

A0350030 Allopurinol impurity C

A0350040 Allopurinol impurity D

A0350050 Allopurinol impurity E

A0351000 Allylstrychnine bromide

Y0000255 Almagate - reference spectrum

A0357000 Alprazolam - * psy

A0360000 Alprenolol hydrochloride

Council of Europe, all rights reserved 2012

13.4% carbonic acid

For extra charges, please see supply terms and conditions.